CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: enol ether
Accession: CHEBI:47985
browse the term
Definition: Ethers ROR' where R has a double bond adjacent to the oxygen of the ether linkage.
Synonyms: related_synonym: Formula=C2OR4; SMILES=[*]\\C([*])=C(\\[*])O[*]; enol ethers
G
MMP9
matrix metallopeptidase 9
decreases activity
EXP
2-methoxy-1,4-naphthoquinone results in decreased activity of MMP9 protein
CTD
PMID:24291160
NCBI chr20:46,008,908...46,016,561
Ensembl chr20:46,008,908...46,016,561
G
NQO1
NAD(P)H quinone dehydrogenase 1
increases activity
ISO
2-methoxy-1,4-naphthoquinone results in increased activity of NQO1 protein
CTD
PMID:17265417
NCBI chr16:69,709,401...69,726,560
Ensembl chr16:69,706,996...69,726,668
G
CCND1
cyclin D1
multiple interactions
EXP
antroquinonol results in decreased expression of and results in decreased localization of CCND1 protein
CTD
PMID:19723512
NCBI chr11:69,641,156...69,654,474
Ensembl chr11:69,641,156...69,654,474
G
CCNE1
cyclin E1
multiple interactions
EXP
antroquinonol results in decreased expression of and results in decreased localization of CCNE1 protein
CTD
PMID:19723512
NCBI chr19:29,811,991...29,824,312
Ensembl chr19:29,811,991...29,824,312
G
CDH1
cadherin 1
multiple interactions
EXP
antroquinonol inhibits the reaction [Tetradecanoylphorbol Acetate results in decreased expression of CDH1 protein]
CTD
PMID:25656647
NCBI chr16:68,737,292...68,835,537
Ensembl chr16:68,737,292...68,835,537
G
CDH2
cadherin 2
multiple interactions
EXP
antroquinonol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of CDH2 protein]
CTD
PMID:25656647
NCBI chr18:27,932,879...28,177,130
Ensembl chr18:27,932,879...28,177,946
G
CDK2
cyclin dependent kinase 2
multiple interactions
EXP
antroquinonol results in decreased expression of and results in decreased localization of CDK2 protein
CTD
PMID:19723512
NCBI chr12:55,966,830...55,972,789
Ensembl chr12:55,966,781...55,972,789
G
CDK4
cyclin dependent kinase 4
multiple interactions
EXP
antroquinonol results in decreased expression of and results in decreased localization of CDK4 protein
CTD
PMID:19723512
NCBI chr12:57,747,727...57,752,310
Ensembl chr12:57,747,727...57,756,013
G
EIF4EBP1
eukaryotic translation initiation factor 4E binding protein 1
decreases phosphorylation
EXP
antroquinonol results in decreased phosphorylation of EIF4EBP1 protein
CTD
PMID:19723512
NCBI chr 8:38,030,534...38,060,365
Ensembl chr 8:38,030,534...38,060,365
G
JUN
Jun proto-oncogene, AP-1 transcription factor subunit
multiple interactions decreases expression
EXP
antroquinonol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of JUN protein] antroquinonol results in decreased expression of JUN protein
CTD
PMID:25656647
NCBI chr 1:58,780,791...58,784,047
Ensembl chr 1:58,776,845...58,784,048
G
MAPK1
mitogen-activated protein kinase 1
multiple interactions decreases phosphorylation
EXP
antroquinonol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK1 protein] antroquinonol results in decreased phosphorylation of MAPK1 protein
CTD
PMID:25656647
NCBI chr22:21,759,657...21,867,680
Ensembl chr22:21,759,657...21,867,680
G
MAPK3
mitogen-activated protein kinase 3
multiple interactions decreases phosphorylation
EXP
antroquinonol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK3 protein] antroquinonol results in decreased phosphorylation of MAPK3 protein
CTD
PMID:25656647
NCBI chr16:30,114,105...30,123,220
Ensembl chr16:30,114,105...30,123,506
G
MMP9
matrix metallopeptidase 9
multiple interactions
EXP
antroquinonol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA]; antroquinonol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 protein]
CTD
PMID:25656647
NCBI chr20:46,008,908...46,016,561
Ensembl chr20:46,008,908...46,016,561
G
MTOR
mechanistic target of rapamycin kinase
decreases phosphorylation
EXP
antroquinonol results in decreased phosphorylation of MTOR protein
CTD
PMID:19723512
NCBI chr 1:11,106,535...11,262,551
Ensembl chr 1:11,106,535...11,262,556
G
NFKBIA
NFKB inhibitor alpha
multiple interactions
EXP
antroquinonol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of NFKBIA protein]
CTD
PMID:25656647
NCBI chr14:35,401,513...35,404,749
Ensembl chr14:35,401,079...35,404,749
G
RELA
RELA proto-oncogene, NF-kB subunit
multiple interactions decreases phosphorylation
EXP
antroquinonol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of RELA protein] antroquinonol results in decreased phosphorylation of RELA protein
CTD
PMID:25656647
NCBI chr11:65,653,601...65,663,857
Ensembl chr11:65,653,599...65,663,090
G
SNAI1
snail family transcriptional repressor 1
multiple interactions
EXP
antroquinonol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of SNAI1 protein]
CTD
PMID:25656647
NCBI chr20:49,982,980...49,988,886
Ensembl chr20:49,982,980...49,988,886
G
TSC1
TSC complex subunit 1
multiple interactions
EXP
antroquinonol promotes the reaction [TSC2 protein binds to TSC1 protein]
CTD
PMID:19723512
NCBI chr 9:132,891,349...132,945,378
Ensembl chr 9:132,891,348...132,946,874
G
TSC2
TSC complex subunit 2
multiple interactions
EXP
antroquinonol promotes the reaction [TSC2 protein binds to TSC1 protein]
CTD
PMID:19723512
NCBI chr16:2,047,985...2,089,491
Ensembl chr16:2,047,967...2,089,491
G
AARS1
alanyl-tRNA synthetase 1
decreases expression
EXP
azoxystrobin results in decreased expression of AARS1 mRNA
CTD
PMID:33512557
NCBI chr16:70,252,298...70,289,506
Ensembl chr16:70,251,983...70,289,707
G
ABCA1
ATP binding cassette subfamily A member 1
decreases expression
EXP
azoxystrobin results in decreased expression of ABCA1 mRNA
CTD
PMID:33512557
NCBI chr 9:104,781,006...104,928,155
Ensembl chr 9:104,781,006...104,928,155
G
ABCC5
ATP binding cassette subfamily C member 5
decreases expression
EXP
azoxystrobin results in decreased expression of ABCC5 mRNA
CTD
PMID:33512557
NCBI chr 3:183,919,934...184,017,884
Ensembl chr 3:183,919,934...184,017,939
G
ABCF3
ATP binding cassette subfamily F member 3
decreases expression
EXP
azoxystrobin results in decreased expression of ABCF3 mRNA
CTD
PMID:33512557
NCBI chr 3:184,186,199...184,194,005
Ensembl chr 3:184,186,095...184,194,012
G
ABHD6
abhydrolase domain containing 6, acylglycerol lipase
decreases expression
EXP
azoxystrobin results in decreased expression of ABHD6 mRNA
CTD
PMID:33512557
NCBI chr 3:58,237,792...58,294,734
Ensembl chr 3:58,237,532...58,295,693
G
ACACA
acetyl-CoA carboxylase alpha
increases phosphorylation multiple interactions
ISO EXP
azoxystrobin results in increased phosphorylation of ACACA protein [azoxystrobin co-treated with Dietary Fats] affects the phosphorylation of ACACA protein dorsomorphin inhibits the reaction [azoxystrobin results in increased phosphorylation of ACACA protein]
CTD
PMID:24726979
NCBI chr17:37,084,992...37,406,836
Ensembl chr17:37,084,992...37,406,836
G
ACADM
acyl-CoA dehydrogenase medium chain
increases expression
EXP
azoxystrobin results in increased expression of ACADM mRNA
CTD
PMID:33512557
NCBI chr 1:75,724,709...75,763,679
Ensembl chr 1:75,724,431...75,787,575
G
ACADVL
acyl-CoA dehydrogenase very long chain
decreases expression
EXP
azoxystrobin results in decreased expression of ACADVL mRNA
CTD
PMID:33512557
NCBI chr17:7,217,125...7,225,266
Ensembl chr17:7,217,125...7,225,266
G
ACAT2
acetyl-CoA acetyltransferase 2
increases expression
EXP
azoxystrobin results in increased expression of ACAT2 mRNA
CTD
PMID:33512557
NCBI chr 6:159,762,045...159,779,112
Ensembl chr 6:159,762,045...159,779,112
G
ACOT2
acyl-CoA thioesterase 2
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of ACOT2 gene
CTD
PMID:33854195
NCBI chr14:73,567,620...73,575,658
Ensembl chr14:73,567,620...73,575,658
G
ACOT4
acyl-CoA thioesterase 4
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of ACOT4 mRNA
CTD
PMID:33854195
NCBI chr14:73,591,873...73,595,766
Ensembl chr14:73,591,873...73,595,766
G
ACTN1
actinin alpha 1
decreases expression
EXP
azoxystrobin results in decreased expression of ACTN1 mRNA
CTD
PMID:33512557
NCBI chr14:68,874,128...68,979,302
Ensembl chr14:68,874,128...68,979,440
G
ACY1
aminoacylase 1
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of ACY1 mRNA
CTD
PMID:33854195
NCBI chr 3:51,983,535...51,989,197
Ensembl chr 3:51,983,340...51,989,197
G
ADAM12
ADAM metallopeptidase domain 12
decreases expression
EXP
azoxystrobin results in decreased expression of ADAM12 mRNA
CTD
PMID:33512557
NCBI chr10:126,012,391...126,388,477
Ensembl chr10:126,012,381...126,388,477
G
ADAM15
ADAM metallopeptidase domain 15
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of ADAM15 gene
CTD
PMID:33854195
NCBI chr 1:155,051,316...155,062,775
Ensembl chr 1:155,050,566...155,062,775
G
ADAM8
ADAM metallopeptidase domain 8
decreases expression
EXP
azoxystrobin results in decreased expression of ADAM8 mRNA
CTD
PMID:33512557
NCBI chr10:133,262,423...133,276,868
Ensembl chr10:133,262,420...133,276,868
G
ADAMTSL3
ADAMTS like 3
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of ADAMTSL3 gene
CTD
PMID:33854195
NCBI chr15:83,654,123...84,039,842
Ensembl chr15:83,654,088...84,039,842
G
ADCY6
adenylate cyclase 6
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of ADCY6 mRNA
CTD
PMID:33854195
NCBI chr12:48,766,194...48,789,974
Ensembl chr12:48,766,194...48,789,089
G
ADRM1
ADRM1 26S proteasome ubiquitin receptor
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of ADRM1 mRNA
CTD
PMID:33854195
NCBI chr20:62,302,896...62,308,862
Ensembl chr20:62,302,093...62,308,862
G
AEN
apoptosis enhancing nuclease
increases expression
EXP
azoxystrobin results in increased expression of AEN mRNA
CTD
PMID:33512557
NCBI chr15:88,604,683...88,632,281
Ensembl chr15:88,621,337...88,632,281
G
AFP
alpha fetoprotein
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of AFP mRNA
CTD
PMID:33854195
NCBI chr 4:73,436,221...73,456,174
Ensembl chr 4:73,431,138...73,456,174
G
AGT
angiotensinogen
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of AGT mRNA
CTD
PMID:33854195
NCBI chr 1:230,702,523...230,745,583
Ensembl chr 1:230,690,776...230,745,576
G
AHCY
adenosylhomocysteinase
increases expression
EXP
azoxystrobin results in increased expression of AHCY mRNA
CTD
PMID:33512557
NCBI chr20:34,231,981...34,311,836
Ensembl chr20:34,280,268...34,311,802
G
AHSA1
activator of HSP90 ATPase activity 1
increases expression
EXP
azoxystrobin results in increased expression of AHSA1 mRNA
CTD
PMID:33512557
NCBI chr14:77,457,867...77,469,472
Ensembl chr14:77,457,870...77,469,472
G
AIG1
androgen induced 1
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of AIG1 gene
CTD
PMID:33854195
NCBI chr 6:143,059,213...143,343,883
Ensembl chr 6:143,060,496...143,341,058
G
AKAP8
A-kinase anchoring protein 8
multiple interactions decreases expression
ISO EXP
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of AKAP8 mRNA azoxystrobin results in decreased expression of AKAP8 mRNA
CTD
PMID:33512557 PMID:33854195
NCBI chr19:15,353,385...15,379,787
Ensembl chr19:15,353,385...15,379,815
G
AKAP8L
A-kinase anchoring protein 8 like
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of AKAP8L mRNA
CTD
PMID:33854195
NCBI chr19:15,380,050...15,418,988
Ensembl chr19:15,380,050...15,419,141
G
AKR1B1
aldo-keto reductase family 1 member B
decreases expression
EXP
azoxystrobin results in decreased expression of AKR1B1 mRNA
CTD
PMID:33512557
NCBI chr 7:134,442,350...134,459,239
Ensembl chr 7:134,442,356...134,459,284
G
AKR7A2
aldo-keto reductase family 7 member A2
decreases expression
EXP
azoxystrobin results in decreased expression of AKR7A2 mRNA
CTD
PMID:33512557
NCBI chr 1:19,302,708...19,312,146
Ensembl chr 1:19,303,965...19,312,144
G
AKT1
AKT serine/threonine kinase 1
decreases phosphorylation
EXP
azoxystrobin results in decreased phosphorylation of AKT1 protein
CTD
PMID:32339800
NCBI chr14:104,769,349...104,795,748
Ensembl chr14:104,769,349...104,795,751
G
ALDH2
aldehyde dehydrogenase 2 family member
decreases expression
EXP
azoxystrobin results in decreased expression of ALDH2 mRNA
CTD
PMID:33512557
NCBI chr12:111,766,933...111,817,532
Ensembl chr12:111,766,887...111,817,532
G
ALDH9A1
aldehyde dehydrogenase 9 family member A1
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of ALDH9A1 mRNA
CTD
PMID:33854195
NCBI chr 1:165,662,216...165,698,562
Ensembl chr 1:165,662,216...165,698,562
G
ALDOA
aldolase, fructose-bisphosphate A
increases expression
EXP
azoxystrobin results in increased expression of ALDOA mRNA
CTD
PMID:33512557
NCBI chr16:30,064,279...30,070,420
Ensembl chr16:30,064,164...30,070,457
G
ALG2
ALG2 alpha-1,3/1,6-mannosyltransferase
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of ALG2 mRNA
CTD
PMID:33854195
NCBI chr 9:99,216,425...99,221,942
Ensembl chr 9:99,216,425...99,221,942
G
AMDHD2
amidohydrolase domain containing 2
decreases expression
EXP
azoxystrobin results in decreased expression of AMDHD2 mRNA
CTD
PMID:33512557
NCBI chr16:2,520,371...2,531,417
Ensembl chr16:2,520,357...2,531,422
G
AMER1
APC membrane recruitment protein 1
decreases expression
EXP
azoxystrobin results in decreased expression of AMER1 mRNA
CTD
PMID:33512557
NCBI chr X:64,185,117...64,205,708
Ensembl chr X:64,185,117...64,205,708
G
AMZ2
archaelysin family metallopeptidase 2
increases expression
EXP
azoxystrobin results in increased expression of AMZ2 mRNA
CTD
PMID:33512557
NCBI chr17:68,206,129...68,257,164
Ensembl chr17:68,205,481...68,257,712
G
ANGPTL4
angiopoietin like 4
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of ANGPTL4 mRNA
CTD
PMID:33854195
NCBI chr19:8,364,155...8,374,370
Ensembl chr19:8,363,289...8,374,370
G
ANKRD20A13P
ankyrin repeat domain 20 family member A13, pseudogene
decreases expression
EXP
azoxystrobin results in decreased expression of ANKRD20A13P mRNA
CTD
PMID:33512557
G
ANKS3
ankyrin repeat and sterile alpha motif domain containing 3
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of ANKS3 mRNA
CTD
PMID:33854195
NCBI chr16:4,696,511...4,734,271
Ensembl chr16:4,696,510...4,734,378
G
ANXA11
annexin A11
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of ANXA11 mRNA
CTD
PMID:33854195
NCBI chr10:80,150,889...80,205,808
Ensembl chr10:80,150,889...80,205,572
G
ANXA2
annexin A2
decreases expression
EXP
azoxystrobin results in decreased expression of ANXA2 mRNA
CTD
PMID:33512557
NCBI chr15:60,347,151...60,397,986
Ensembl chr15:60,347,134...60,402,883
G
AP2M1
adaptor related protein complex 2 subunit mu 1
decreases expression
EXP
azoxystrobin results in decreased expression of AP2M1 mRNA
CTD
PMID:33512557
NCBI chr 3:184,174,855...184,184,091
Ensembl chr 3:184,174,689...184,184,214
G
APLF
aprataxin and PNKP like factor
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of APLF mRNA
CTD
PMID:33854195
NCBI chr 2:68,467,585...68,580,162
Ensembl chr 2:68,467,572...68,655,862
G
APLP1
amyloid beta precursor like protein 1
decreases expression
EXP
azoxystrobin results in decreased expression of APLP1 mRNA
CTD
PMID:33512557
NCBI chr19:35,868,574...35,879,792
Ensembl chr19:35,867,899...35,879,792
G
APOF
apolipoprotein F
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of APOF mRNA
CTD
PMID:33854195
NCBI chr12:56,360,568...56,362,857
Ensembl chr12:56,360,568...56,362,857
G
ARF4
ADP ribosylation factor 4
increases expression
EXP
azoxystrobin results in increased expression of ARF4 mRNA
CTD
PMID:33512557
NCBI chr 3:57,571,363...57,597,344
Ensembl chr 3:57,571,363...57,598,220
G
ARG1
arginase 1
decreases expression
EXP
azoxystrobin results in decreased expression of ARG1 mRNA
CTD
PMID:32194361
NCBI chr 6:131,573,226...131,584,329
Ensembl chr 6:131,470,832...131,584,332
G
ARHGAP8
Rho GTPase activating protein 8
increases expression
EXP
azoxystrobin results in increased expression of ARHGAP8 mRNA
CTD
PMID:33512557
NCBI chr22:44,752,575...44,862,784
Ensembl chr22:44,752,558...44,862,788
G
ARL17B
ADP ribosylation factor like GTPase 17B
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of ARF2 mRNA
CTD
PMID:33854195
NCBI chr17:46,274,184...46,361,787
Ensembl chr17:46,274,784...46,361,766 Ensembl chr17:46,274,784...46,361,766
G
ARL4D
ADP ribosylation factor like GTPase 4D
decreases expression
EXP
azoxystrobin results in decreased expression of ARL4D mRNA
CTD
PMID:33512557
NCBI chr17:43,398,993...43,401,137
Ensembl chr17:43,398,993...43,401,137
G
ARPC1A
actin related protein 2/3 complex subunit 1A
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of ARPC1A gene
CTD
PMID:33854195
NCBI chr 7:99,325,898...99,366,262
Ensembl chr 7:99,325,898...99,366,262
G
ARPP19
cAMP regulated phosphoprotein 19
increases expression
EXP
azoxystrobin results in increased expression of ARPP19 mRNA
CTD
PMID:33512557
NCBI chr15:52,547,045...52,569,446
Ensembl chr15:52,547,045...52,569,883
G
ARRDC4
arrestin domain containing 4
decreases expression
EXP
azoxystrobin results in decreased expression of ARRDC4 mRNA
CTD
PMID:33512557
NCBI chr15:97,960,703...97,973,833
Ensembl chr15:97,960,703...97,973,833
G
ARSG
arylsulfatase G
affects expression
EXP
azoxystrobin affects the expression of ARSG mRNA
CTD
PMID:33512557
NCBI chr17:68,259,170...68,452,019
Ensembl chr17:68,259,182...68,422,731
G
ASAH1
N-acylsphingosine amidohydrolase 1
increases expression
EXP
azoxystrobin results in increased expression of ASAH1 mRNA
CTD
PMID:33512557
NCBI chr 8:18,055,992...18,084,961
Ensembl chr 8:18,055,992...18,084,998
G
ASB7
ankyrin repeat and SOCS box containing 7
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of ASB7 mRNA
CTD
PMID:33854195
NCBI chr15:100,602,589...100,651,701
Ensembl chr15:100,602,589...100,651,701
G
ASF1B
anti-silencing function 1B histone chaperone
decreases expression
EXP
azoxystrobin results in decreased expression of ASF1B mRNA
CTD
PMID:33512557
NCBI chr19:14,119,512...14,136,589
Ensembl chr19:14,119,512...14,136,613
G
ASNS
asparagine synthetase (glutamine-hydrolyzing)
increases expression
EXP
azoxystrobin results in increased expression of ASNS mRNA
CTD
PMID:33512557
NCBI chr 7:97,851,677...97,928,441
Ensembl chr 7:97,851,677...97,872,542
G
ASS1
argininosuccinate synthase 1
multiple interactions increases expression
ISO EXP
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of ASS1 mRNA azoxystrobin results in increased expression of ASS1 mRNA
CTD
PMID:33512557 PMID:33854195
NCBI chr 9:130,444,707...130,501,274
Ensembl chr 9:130,444,961...130,501,274
G
ATF4
activating transcription factor 4
increases expression
EXP
azoxystrobin results in increased expression of ATF4 mRNA
CTD
PMID:33512557
NCBI chr22:39,520,559...39,522,686
Ensembl chr22:39,519,695...39,522,683
G
ATF5
activating transcription factor 5
decreases expression
EXP
azoxystrobin results in decreased expression of ATF5 mRNA
CTD
PMID:33512557
NCBI chr19:49,928,906...49,933,935
Ensembl chr19:49,928,702...49,933,935
G
ATOSA
atos homolog A
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of ATOSA mRNA
CTD
PMID:33854195
NCBI chr15:52,581,321...52,709,815
Ensembl chr15:52,581,317...52,709,817
G
ATP11C
ATPase phospholipid transporting 11C
decreases expression
EXP
azoxystrobin results in decreased expression of ATP11C mRNA
CTD
PMID:33512557
NCBI chr X:139,726,348...139,936,903
Ensembl chr X:139,726,346...139,945,276
G
ATP5F1C
ATP synthase F1 subunit gamma
decreases expression
EXP
azoxystrobin results in decreased expression of ATP5F1C mRNA
CTD
PMID:33512557
NCBI chr10:7,788,177...7,807,801
Ensembl chr10:7,788,147...7,807,815
G
ATP5MC1
ATP synthase membrane subunit c locus 1
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of ATP5MC1 mRNA
CTD
PMID:33854195
NCBI chr17:48,892,787...48,895,871
Ensembl chr17:48,892,765...48,895,871
G
ATP5MK
ATP synthase membrane subunit k
increases expression
EXP
azoxystrobin results in increased expression of ATP5MK mRNA
CTD
PMID:33512557
NCBI chr10:103,389,050...103,396,475
Ensembl chr10:103,389,041...103,396,492
G
ATP6V0D1
ATPase H+ transporting V0 subunit d1
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of ATP6V0D1 mRNA
CTD
PMID:33854195
NCBI chr16:67,438,019...67,481,157
Ensembl chr16:67,438,014...67,481,181
G
ATP6V1B2
ATPase H+ transporting V1 subunit B2
decreases expression
EXP
azoxystrobin results in decreased expression of ATP6V1B2 mRNA
CTD
PMID:33512557
NCBI chr 8:20,197,381...20,221,696
Ensembl chr 8:20,197,381...20,226,819
G
AURKA
aurora kinase A
increases expression
EXP
azoxystrobin results in increased expression of AURKA mRNA
CTD
PMID:33512557
NCBI chr20:56,369,390...56,392,215
Ensembl chr20:56,369,389...56,392,337
G
B2M
beta-2-microglobulin
increases expression
EXP
azoxystrobin results in increased expression of B2M mRNA
CTD
PMID:33512557
NCBI chr15:44,711,517...44,718,145
Ensembl chr15:44,711,358...44,718,851
G
B3GALT6
beta-1,3-galactosyltransferase 6
decreases expression
EXP
azoxystrobin results in decreased expression of B3GALT6 mRNA
CTD
PMID:33512557
NCBI chr 1:1,232,237...1,235,041
Ensembl chr 1:1,232,237...1,235,041
G
BAG3
BAG cochaperone 3
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of BAG3 mRNA
CTD
PMID:33854195
NCBI chr10:119,651,380...119,677,819
Ensembl chr10:119,651,380...119,677,819
G
BANF1
BAF nuclear assembly factor 1
increases expression
EXP
azoxystrobin results in increased expression of BANF1 mRNA
CTD
PMID:33512557
NCBI chr11:66,002,079...66,004,149
Ensembl chr11:66,002,228...66,004,149
G
BANP
BTG3 associated nuclear protein
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of BANP mRNA
CTD
PMID:33854195
NCBI chr16:87,949,238...88,077,318
Ensembl chr16:87,949,244...88,077,318
G
BAX
BCL2 associated X, apoptosis regulator
increases expression
EXP
azoxystrobin results in increased expression of BAX mRNA
CTD
PMID:33512557
NCBI chr19:48,954,875...48,961,798
Ensembl chr19:48,954,815...48,961,798
G
BBC3
BCL2 binding component 3
decreases expression
EXP
azoxystrobin results in decreased expression of BBC3 mRNA
CTD
PMID:33512557
NCBI chr19:47,220,824...47,232,860
Ensembl chr19:47,220,822...47,232,766
G
BCL2L11
BCL2 like 11
decreases expression
EXP
azoxystrobin results in decreased expression of BCL2L11 mRNA
CTD
PMID:33512557
NCBI chr 2:111,120,914...111,168,445
Ensembl chr 2:111,119,378...111,168,444
G
BCL9
BCL9 transcription coactivator
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of BCL9 mRNA
CTD
PMID:33854195
NCBI chr 1:147,541,501...147,626,216
Ensembl chr 1:147,541,501...147,626,216
G
BHMT
betaine--homocysteine S-methyltransferase
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of BHMT mRNA
CTD
PMID:33854195
NCBI chr 5:79,111,809...79,132,288
Ensembl chr 5:79,111,809...79,132,288
G
BLCAP
BLCAP apoptosis inducing factor
decreases expression
EXP
azoxystrobin results in decreased expression of BLCAP mRNA
CTD
PMID:33512557
NCBI chr20:37,517,417...37,527,876
Ensembl chr20:37,492,472...37,527,931
G
BMF
Bcl2 modifying factor
decreases expression
EXP
azoxystrobin results in decreased expression of BMF mRNA
CTD
PMID:33512557
NCBI chr15:40,087,890...40,108,879
Ensembl chr15:40,087,890...40,108,892
G
BRD2
bromodomain containing 2
increases expression
EXP
azoxystrobin results in increased expression of BRD2 mRNA
CTD
PMID:33512557
NCBI chr 6:32,968,594...32,981,505
Ensembl chr 6:32,968,594...32,981,505
G
BRD3
bromodomain containing 3
decreases expression
EXP
azoxystrobin results in decreased expression of BRD3 mRNA
CTD
PMID:33512557
NCBI chr 9:134,030,305...134,068,548
Ensembl chr 9:134,030,305...134,068,535
G
BRMS1L
BRMS1 like transcriptional repressor
decreases expression
EXP
azoxystrobin results in decreased expression of BRMS1L mRNA
CTD
PMID:33512557
NCBI chr14:35,826,338...35,871,963
Ensembl chr14:35,826,338...35,932,325
G
BZW2
basic leucine zipper and W2 domains 2
increases expression
EXP
azoxystrobin results in increased expression of BZW2 mRNA
CTD
PMID:33512557
NCBI chr 7:16,646,181...16,706,517
Ensembl chr 7:16,646,131...16,706,523
G
C11orf54
chromosome 11 open reading frame 54
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of C8H11ORF54 mRNA
CTD
PMID:33854195
NCBI chr11:93,741,672...93,764,749
Ensembl chr11:93,741,591...93,764,749
G
C1QC
complement C1q C chain
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of C1QC mRNA
CTD
PMID:33854195
NCBI chr 1:22,643,633...22,648,108
Ensembl chr 1:22,643,014...22,648,110
G
C1S
complement C1s
decreases expression
EXP
azoxystrobin results in decreased expression of C1S mRNA
CTD
PMID:33512557
NCBI chr12:7,060,718...7,071,032
Ensembl chr12:6,988,259...7,071,032
G
C2CD5
C2 calcium dependent domain containing 5
decreases expression
EXP
azoxystrobin results in decreased expression of C2CD5 mRNA
CTD
PMID:33512557
NCBI chr12:22,448,583...22,544,542
Ensembl chr12:22,448,583...22,544,546
G
CALCOCO1
calcium binding and coiled-coil domain 1
decreases expression
EXP
azoxystrobin results in decreased expression of CALCOCO1 mRNA
CTD
PMID:33512557
NCBI chr12:53,708,517...53,727,452
Ensembl chr12:53,708,517...53,727,745
G
CALR
calreticulin
decreases expression
EXP
azoxystrobin results in decreased expression of CALR mRNA
CTD
PMID:33512557
NCBI chr19:12,938,609...12,944,489
Ensembl chr19:12,938,578...12,944,489
G
CAMK2B
calcium/calmodulin dependent protein kinase II beta
decreases expression
EXP
azoxystrobin results in decreased expression of CAMK2B mRNA
CTD
PMID:33512557
NCBI chr 7:44,217,154...44,326,013
Ensembl chr 7:44,210,019...44,334,577
G
CAMK2G
calcium/calmodulin dependent protein kinase II gamma
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of CAMK2G mRNA
CTD
PMID:33854195
NCBI chr10:73,812,501...73,874,555
Ensembl chr10:73,812,501...73,874,591
G
CAP1
cyclase associated actin cytoskeleton regulatory protein 1
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of CAP1 mRNA
CTD
PMID:33854195
NCBI chr 1:40,040,240...40,072,648
Ensembl chr 1:40,040,233...40,072,649
G
CAPS
calcyphosine
decreases expression
EXP
azoxystrobin results in decreased expression of CAPS mRNA
CTD
PMID:33512557
NCBI chr19:5,914,254...5,916,211
Ensembl chr19:5,912,339...5,916,211
G
CAPS2
calcyphosine 2
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of CAPS2 mRNA
CTD
PMID:33854195
NCBI chr12:75,275,979...75,390,901
Ensembl chr12:75,275,979...75,390,928
G
CASP3
caspase 3
decreases expression
EXP
azoxystrobin results in decreased expression of CASP3 mRNA
CTD
PMID:33512557
NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062
G
CBLB
Cbl proto-oncogene B
decreases expression
EXP
azoxystrobin results in decreased expression of CBLB mRNA
CTD
PMID:33512557
NCBI chr 3:105,655,461...105,869,449
Ensembl chr 3:105,655,461...105,869,552
G
CBS
cystathionine beta-synthase
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of CBS mRNA
CTD
PMID:33854195
NCBI chr21:43,053,191...43,076,873
Ensembl chr21:43,053,191...43,076,943
G
CCDC125
coiled-coil domain containing 125
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of CCDC125 mRNA
CTD
PMID:33854195
NCBI chr 5:69,273,039...69,332,801
Ensembl chr 5:69,280,175...69,332,809
G
CCDC92
coiled-coil domain containing 92
decreases expression
EXP
azoxystrobin results in decreased expression of CCDC92 mRNA
CTD
PMID:33512557
NCBI chr12:123,935,626...123,972,831
Ensembl chr12:123,918,660...123,972,831
G
CCNE2
cyclin E2
decreases expression
EXP
azoxystrobin results in decreased expression of CCNE2 mRNA
CTD
PMID:33512557
NCBI chr 8:94,880,224...94,896,693
Ensembl chr 8:94,879,770...94,896,678
G
CCNG1
cyclin G1
increases expression
EXP
azoxystrobin results in increased expression of CCNG1 mRNA
CTD
PMID:33512557
NCBI chr 5:163,437,571...163,457,640
Ensembl chr 5:163,437,569...163,446,151
G
CCNL1
cyclin L1
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of CCNL1 mRNA
CTD
PMID:33854195
NCBI chr 3:157,143,121...157,160,147
Ensembl chr 3:157,146,508...157,160,760
G
CD24
CD24 molecule
decreases expression
EXP
azoxystrobin results in decreased expression of CD24 mRNA
CTD
PMID:33512557
NCBI chr 6:106,969,831...106,976,855
Ensembl chr 6:106,969,831...106,975,627
G
CD55
CD55 molecule (Cromer blood group)
decreases expression
EXP
azoxystrobin results in decreased expression of CD55 mRNA
CTD
PMID:33512557
NCBI chr 1:207,321,678...207,360,966
Ensembl chr 1:207,321,519...207,386,804
G
CDC20
cell division cycle 20
increases expression
EXP
azoxystrobin results in increased expression of CDC20 mRNA
CTD
PMID:33512557
NCBI chr 1:43,358,981...43,363,203
Ensembl chr 1:43,358,981...43,363,203
G
CDC45
cell division cycle 45
decreases expression
EXP
azoxystrobin results in decreased expression of CDC45 mRNA
CTD
PMID:33512557
NCBI chr22:19,479,466...19,520,612
Ensembl chr22:19,479,457...19,520,612
G
CDCA3
cell division cycle associated 3
increases expression
EXP
azoxystrobin results in increased expression of CDCA3 mRNA
CTD
PMID:33512557
NCBI chr12:6,844,798...6,851,286
Ensembl chr12:6,844,793...6,851,292
G
CDH11
cadherin 11
increases expression
EXP
azoxystrobin results in increased expression of CDH11 mRNA
CTD
PMID:33512557
NCBI chr16:64,943,753...65,123,744
Ensembl chr16:64,943,753...65,126,112
G
CDH2
cadherin 2
decreases expression
EXP
azoxystrobin results in decreased expression of CDH2 mRNA
CTD
PMID:33512557
NCBI chr18:27,932,879...28,177,130
Ensembl chr18:27,932,879...28,177,946
G
CDK5
cyclin dependent kinase 5
decreases expression
EXP
azoxystrobin results in decreased expression of CDK5 mRNA
CTD
PMID:33512557
NCBI chr 7:151,053,815...151,057,897
Ensembl chr 7:151,053,815...151,057,897
G
CDK5R1
cyclin dependent kinase 5 regulatory subunit 1
decreases expression
EXP
azoxystrobin results in decreased expression of CDK5R1 mRNA
CTD
PMID:33512557
NCBI chr17:32,486,993...32,491,253
Ensembl chr17:32,486,993...32,491,253
G
CDKN1A
cyclin dependent kinase inhibitor 1A
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of CDKN1A mRNA
CTD
PMID:33854195
NCBI chr 6:36,676,463...36,687,332
Ensembl chr 6:36,676,460...36,687,337
G
CDT1
chromatin licensing and DNA replication factor 1
affects expression
EXP
azoxystrobin affects the expression of CDT1 mRNA
CTD
PMID:33512557
NCBI chr16:88,803,789...88,809,258
Ensembl chr16:88,803,789...88,809,258
G
CEBPB
CCAAT enhancer binding protein beta
affects expression
EXP
azoxystrobin affects the expression of CEBPB mRNA
CTD
PMID:33512557
NCBI chr20:50,190,583...50,192,690
Ensembl chr20:50,190,830...50,192,668
G
CEBPD
CCAAT enhancer binding protein delta
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of CEBPD mRNA
CTD
PMID:33854195
NCBI chr 8:47,736,913...47,738,164
Ensembl chr 8:47,736,913...47,738,164
G
CEL
carboxyl ester lipase
decreases expression
EXP
azoxystrobin results in decreased expression of CEL mRNA
CTD
PMID:33512557
NCBI chr 9:133,061,981...133,071,861
Ensembl chr 9:133,061,981...133,071,861
G
CENPH
centromere protein H
increases expression
EXP
azoxystrobin results in increased expression of CENPH mRNA
CTD
PMID:33512557
NCBI chr 5:69,189,583...69,210,357
Ensembl chr 5:69,189,574...69,210,357
G
CENPK
centromere protein K
decreases expression
EXP
azoxystrobin results in decreased expression of CENPK mRNA
CTD
PMID:33512557
NCBI chr 5:65,495,624...65,563,168
Ensembl chr 5:65,517,766...65,563,168
G
CEP57
centrosomal protein 57
decreases expression
EXP
azoxystrobin results in decreased expression of CEP57 mRNA
CTD
PMID:33512557
NCBI chr11:95,790,498...95,832,693
Ensembl chr11:95,789,965...95,832,693
G
CEP85
centrosomal protein 85
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of CEP85 mRNA
CTD
PMID:33854195
NCBI chr 1:26,234,200...26,278,808
Ensembl chr 1:26,234,200...26,278,808
G
CERK
ceramide kinase
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of CERK mRNA
CTD
PMID:33854195
NCBI chr22:46,684,410...46,738,252
Ensembl chr22:46,684,410...46,738,252
G
CETN3
centrin 3
increases expression
EXP
azoxystrobin results in increased expression of CETN3 mRNA
CTD
PMID:33512557
NCBI chr 5:90,392,257...90,409,756
Ensembl chr 5:90,392,257...90,409,766
G
CFB
complement factor B
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of CFB mRNA
CTD
PMID:33854195
NCBI chr 6:31,946,095...31,952,084
Ensembl chr 6:31,945,650...31,952,086
G
CFL1
cofilin 1
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of CFL1 mRNA
CTD
PMID:33854195
NCBI chr11:65,854,673...65,858,180
Ensembl chr11:65,823,022...65,862,026
G
CHCHD10
coiled-coil-helix-coiled-coil-helix domain containing 10
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of CHCHD10 mRNA
CTD
PMID:33854195
NCBI chr22:23,765,834...23,767,972
Ensembl chr22:23,765,834...23,767,972
G
CHEK2
checkpoint kinase 2
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of CHEK2 mRNA
CTD
PMID:33854195
NCBI chr22:28,687,743...28,741,834
Ensembl chr22:28,687,743...28,742,422
G
CHMP4A
charged multivesicular body protein 4A
decreases expression
EXP
azoxystrobin results in decreased expression of CHMP4A mRNA
CTD
PMID:33512557
NCBI chr14:24,209,615...24,213,488
Ensembl chr14:24,209,615...24,213,830
G
CHMP6
charged multivesicular body protein 6
decreases expression
EXP
azoxystrobin results in decreased expression of CHMP6 mRNA
CTD
PMID:33512557
NCBI chr17:80,991,841...81,000,133
Ensembl chr17:80,991,598...81,009,517
G
CHRNA4
cholinergic receptor nicotinic alpha 4 subunit
decreases expression
EXP
azoxystrobin results in decreased expression of CHRNA4 mRNA
CTD
PMID:33512557
NCBI chr20:63,343,223...63,361,349
Ensembl chr20:63,343,223...63,378,401
G
CIB1
calcium and integrin binding 1
increases expression
EXP
azoxystrobin results in increased expression of CIB1 mRNA
CTD
PMID:33512557
NCBI chr15:90,229,975...90,265,759
Ensembl chr15:90,229,975...90,234,047
G
CIRBP
cold inducible RNA binding protein
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of CIRBP mRNA
CTD
PMID:33854195
NCBI chr19:1,269,332...1,274,880
Ensembl chr19:1,259,384...1,274,880
G
CITED2
Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 2
decreases expression
EXP
azoxystrobin results in decreased expression of CITED2 mRNA
CTD
PMID:33512557
NCBI chr 6:139,371,807...139,374,648
Ensembl chr 6:139,371,807...139,374,648
G
CKS2
CDC28 protein kinase regulatory subunit 2
increases expression
EXP
azoxystrobin results in increased expression of CKS2 mRNA
CTD
PMID:33512557
NCBI chr 9:89,311,195...89,316,703
Ensembl chr 9:89,311,195...89,316,703
G
CLCF1
cardiotrophin like cytokine factor 1
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of CLCF1 mRNA
CTD
PMID:33854195
NCBI chr11:67,364,168...67,374,177
Ensembl chr11:67,364,168...67,374,177
G
CLK2
CDC like kinase 2
decreases expression
EXP
azoxystrobin results in decreased expression of CLK2 mRNA
CTD
PMID:33512557
NCBI chr 1:155,262,868...155,273,504
Ensembl chr 1:155,262,868...155,278,491
G
CLSTN1
calsyntenin 1
decreases expression
EXP
azoxystrobin results in decreased expression of CLSTN1 mRNA
CTD
PMID:33512557
NCBI chr 1:9,728,926...9,824,526
Ensembl chr 1:9,728,926...9,823,984
G
CLTB
clathrin light chain B
decreases expression
EXP
azoxystrobin results in decreased expression of CLTB mRNA
CTD
PMID:33512557
NCBI chr 5:176,392,455...176,416,569
Ensembl chr 5:176,392,501...176,416,539
G
CLU
clusterin
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of CLU mRNA
CTD
PMID:33854195
NCBI chr 8:27,596,917...27,614,700
Ensembl chr 8:27,596,917...27,614,700
G
CNDP2
carnosine dipeptidase 2
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of CNDP2 mRNA
CTD
PMID:33854195
NCBI chr18:74,496,363...74,523,454
Ensembl chr18:74,495,816...74,523,454
G
COA6
cytochrome c oxidase assembly factor 6
increases expression
EXP
azoxystrobin results in increased expression of COA6 mRNA
CTD
PMID:33512557
NCBI chr 1:234,373,456...234,385,080
Ensembl chr 1:234,373,456...234,385,080
G
COX6B1
cytochrome c oxidase subunit 6B1
increases expression
EXP
azoxystrobin results in increased expression of COX6B1 mRNA
CTD
PMID:33512557
NCBI chr19:35,648,323...35,658,782
Ensembl chr19:35,648,323...35,658,782
G
COX8A
cytochrome c oxidase subunit 8A
increases expression
EXP
azoxystrobin results in increased expression of COX8A mRNA
CTD
PMID:33512557
NCBI chr11:63,974,620...63,976,543
Ensembl chr11:63,974,620...63,976,543
G
CPT2
carnitine palmitoyltransferase 2
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of CPT2 mRNA
CTD
PMID:33854195
NCBI chr 1:53,196,824...53,214,197
Ensembl chr 1:53,196,792...53,214,197
G
CREBBP
CREB binding protein
decreases expression
EXP
azoxystrobin results in decreased expression of CREBBP mRNA
CTD
PMID:33512557
NCBI chr16:3,725,054...3,880,713
Ensembl chr16:3,725,054...3,880,713
G
CRY1
cryptochrome circadian regulator 1
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of CRY1 mRNA
CTD
PMID:33854195
NCBI chr12:106,991,364...107,093,549
Ensembl chr12:106,991,364...107,093,549
G
CSPP1
centrosome and spindle pole associated protein 1
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of CSPP1 mRNA
CTD
PMID:33854195
NCBI chr 8:67,064,368...67,196,614
Ensembl chr 8:67,062,417...67,196,778
G
CSRNP1
cysteine and serine rich nuclear protein 1
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of CSRNP1 mRNA
CTD
PMID:33854195
NCBI chr 3:39,141,855...39,154,641
Ensembl chr 3:39,141,855...39,154,562
G
CTH
cystathionine gamma-lyase
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of CTH gene
CTD
PMID:33854195
NCBI chr 1:70,411,268...70,439,851
Ensembl chr 1:70,411,218...70,439,851
G
CTNNAL1
catenin alpha like 1
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of CTNNAL1 mRNA
CTD
PMID:33854195
NCBI chr 9:108,942,577...109,013,499
Ensembl chr 9:108,942,569...109,013,522
G
CTSB
cathepsin B
decreases expression
EXP
azoxystrobin results in decreased expression of CTSB mRNA
CTD
PMID:33512557
NCBI chr 8:11,842,524...11,868,087
Ensembl chr 8:11,842,524...11,869,533
G
CUX2
cut like homeobox 2
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of CUX2 mRNA
CTD
PMID:33854195
NCBI chr12:111,034,165...111,350,554
Ensembl chr12:111,034,165...111,350,554
G
CXCR4
C-X-C motif chemokine receptor 4
decreases expression
EXP
azoxystrobin results in decreased expression of CXCR4 mRNA
CTD
PMID:33512557
NCBI chr 2:136,114,349...136,118,149
Ensembl chr 2:136,114,349...136,119,177
G
CYC1
cytochrome c1
increases expression
EXP
azoxystrobin results in increased expression of CYC1 mRNA
CTD
PMID:33512557
NCBI chr 8:144,095,076...144,097,525
Ensembl chr 8:144,095,039...144,097,525
G
CYCS
cytochrome c, somatic
decreases expression
EXP
azoxystrobin results in decreased expression of CYCS mRNA
CTD
PMID:33512557
NCBI chr 7:25,118,656...25,125,260
Ensembl chr 7:25,118,656...25,125,260
G
CYP1A1
cytochrome P450 family 1 subfamily A member 1
increases expression multiple interactions
EXP
azoxystrobin results in increased expression of CYP1A1 mRNA; azoxystrobin results in increased expression of CYP1A1 protein [cyproconazole co-treated with azoxystrobin] results in increased expression of CYP1A1 mRNA
CTD
PMID:21784029 PMID:29294346 PMID:32194361
NCBI chr15:74,719,542...74,725,528
Ensembl chr15:74,719,542...74,725,536
G
CYP1A2
cytochrome P450 family 1 subfamily A member 2
increases expression
EXP
azoxystrobin results in increased expression of CYP1A2 mRNA; azoxystrobin results in increased expression of CYP1A2 protein
CTD
PMID:21784029
NCBI chr15:74,748,845...74,756,607
Ensembl chr15:74,748,845...74,756,607
G
CYP26B1
cytochrome P450 family 26 subfamily B member 1
decreases expression
EXP
azoxystrobin results in decreased expression of CYP26B1 mRNA
CTD
PMID:33512557
NCBI chr 2:72,129,238...72,147,862
Ensembl chr 2:72,129,238...72,147,862
G
CYP2B6
cytochrome P450 family 2 subfamily B member 6
multiple interactions increases expression
EXP
[cyproconazole co-treated with azoxystrobin] results in increased expression of CYP2B6 protein azoxystrobin results in increased expression of CYP2B6 protein
CTD
PMID:29294346
NCBI chr19:40,991,282...41,018,398
Ensembl chr19:40,991,282...41,018,398
G
CYP2C19
cytochrome P450 family 2 subfamily C member 19
decreases expression
EXP
azoxystrobin results in decreased expression of CYP2C19 protein
CTD
PMID:32194361
NCBI chr10:94,762,681...94,855,547
Ensembl chr10:94,762,681...94,855,547
G
CYP3A4
cytochrome P450 family 3 subfamily A member 4
multiple interactions increases expression
EXP
[azoxystrobin co-treated with cyproconazole] results in increased expression of CYP3A4 protein; [cyproconazole co-treated with azoxystrobin] results in increased expression of CYP3A4 mRNA azoxystrobin results in increased expression of CYP3A4 mRNA
CTD
PMID:29294346
NCBI chr 7:99,756,967...99,784,184
Ensembl chr 7:99,756,960...99,784,248
G
CYP3A5
cytochrome P450 family 3 subfamily A member 5
increases expression
EXP
azoxystrobin results in increased expression of CYP3A5 mRNA
CTD
PMID:34642769
NCBI chr 7:99,648,194...99,679,996
Ensembl chr 7:99,648,194...99,679,996
G
CYP4A22
cytochrome P450 family 4 subfamily A member 22
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of CYP4A1 mRNA
CTD
PMID:33854195
NCBI chr 1:47,137,441...47,149,727
Ensembl chr 1:47,137,435...47,149,727
G
CYP4F12
cytochrome P450 family 4 subfamily F member 12
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of CYP4F1 mRNA
CTD
PMID:33854195
NCBI chr19:15,673,087...15,697,174
Ensembl chr19:15,673,018...15,697,174
G
CYP7A1
cytochrome P450 family 7 subfamily A member 1
decreases expression
EXP
azoxystrobin results in decreased expression of CYP7A1 mRNA; azoxystrobin results in decreased expression of CYP7A1 protein
CTD
PMID:32194361
NCBI chr 8:58,490,178...58,500,163
Ensembl chr 8:58,490,178...58,500,163
G
CYTIP
cytohesin 1 interacting protein
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of CYTIP mRNA
CTD
PMID:33854195
NCBI chr 2:157,414,619...157,444,089
Ensembl chr 2:157,414,619...157,488,961
G
DAAM1
dishevelled associated activator of morphogenesis 1
decreases expression
EXP
azoxystrobin results in decreased expression of DAAM1 mRNA
CTD
PMID:33512557
NCBI chr14:59,188,667...59,371,405
Ensembl chr14:59,188,646...59,371,405
G
DACH1
dachshund family transcription factor 1
decreases expression
EXP
azoxystrobin results in decreased expression of DACH1 mRNA
CTD
PMID:33512557
NCBI chr13:71,437,966...71,867,204
Ensembl chr13:71,437,966...71,867,204
G
DAD1
defender against cell death 1
increases expression
EXP
azoxystrobin results in increased expression of DAD1 mRNA
CTD
PMID:33512557
NCBI chr14:22,564,907...22,589,224
Ensembl chr14:22,564,907...22,589,224
G
DAXX
death domain associated protein
decreases expression
EXP
azoxystrobin results in decreased expression of DAXX mRNA
CTD
PMID:33512557
NCBI chr 6:33,318,558...33,322,959
Ensembl chr 6:33,318,558...33,323,016
G
DBNDD2
dysbindin domain containing 2
decreases expression
EXP
azoxystrobin results in decreased expression of DBNDD2 mRNA
CTD
PMID:33512557
NCBI chr20:45,405,993...45,410,610
Ensembl chr20:45,406,057...45,410,610
G
DBP
D-box binding PAR bZIP transcription factor
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of DBP mRNA
CTD
PMID:33854195
NCBI chr19:48,630,030...48,637,379
Ensembl chr19:48,630,030...48,637,379
G
DCLRE1C
DNA cross-link repair 1C
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of DCLRE1C mRNA
CTD
PMID:33854195
NCBI chr10:14,897,359...14,954,432
Ensembl chr10:14,897,359...14,954,432
G
DCX
doublecortin
decreases expression
EXP
azoxystrobin results in decreased expression of DCX mRNA
CTD
PMID:33512557
NCBI chr X:111,293,779...111,412,192
Ensembl chr X:111,293,779...111,412,429
G
DDIT3
DNA damage inducible transcript 3
increases expression
EXP
azoxystrobin results in increased expression of DDIT3 mRNA
CTD
PMID:33512557
NCBI chr12:57,516,588...57,520,517
Ensembl chr12:57,516,588...57,521,737
G
DDR1
discoidin domain receptor tyrosine kinase 1
decreases expression
EXP
azoxystrobin results in decreased expression of DDR1 mRNA
CTD
PMID:33512557
NCBI chr 6:30,880,970...30,900,156
Ensembl chr 6:30,876,421...30,900,156
G
DDX20
DEAD-box helicase 20
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of DDX20 mRNA
CTD
PMID:33854195
NCBI chr 1:111,755,901...111,768,000
Ensembl chr 1:111,754,832...111,775,602
G
DDX5
DEAD-box helicase 5
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of DDX5 mRNA
CTD
PMID:33854195
NCBI chr17:64,498,254...64,506,866
Ensembl chr17:64,498,254...64,508,199
G
DECR1
2,4-dienoyl-CoA reductase 1
increases expression
EXP
azoxystrobin results in increased expression of DECR1 mRNA
CTD
PMID:33512557
NCBI chr 8:90,001,477...90,053,633
Ensembl chr 8:90,001,405...90,053,633
G
DEPDC1
DEP domain containing 1
decreases expression
EXP
azoxystrobin results in decreased expression of DEPDC1 mRNA
CTD
PMID:33512557
NCBI chr 1:68,474,152...68,497,082
Ensembl chr 1:68,474,152...68,497,221
G
DEPDC1B
DEP domain containing 1B
increases expression
EXP
azoxystrobin results in increased expression of DEPDC1B mRNA
CTD
PMID:33512557
NCBI chr 5:60,596,912...60,700,166
Ensembl chr 5:60,596,912...60,700,190
G
DFFB
DNA fragmentation factor subunit beta
multiple interactions decreases expression
ISO EXP
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of DFFB mRNA azoxystrobin results in decreased expression of DFFB mRNA
CTD
PMID:33512557 PMID:33854195
NCBI chr 1:3,857,476...3,885,429
Ensembl chr 1:3,857,267...3,885,429
G
DLG2
discs large MAGUK scaffold protein 2
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of DLG2 gene
CTD
PMID:33854195
NCBI chr11:83,455,012...85,628,373
Ensembl chr11:83,455,012...85,628,335
G
DLL1
delta like canonical Notch ligand 1
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of DLL1 mRNA
CTD
PMID:33854195
NCBI chr 6:170,282,206...170,291,078
Ensembl chr 6:170,282,206...170,306,565
G
DMRT3
doublesex and mab-3 related transcription factor 3
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of DMRT3 gene
CTD
PMID:33854195
NCBI chr 9:976,655...991,732
Ensembl chr 9:976,655...991,732
G
DNAJB1
DnaJ heat shock protein family (Hsp40) member B1
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of DNAJB1 mRNA
CTD
PMID:33854195
NCBI chr19:14,514,769...14,560,391
Ensembl chr19:14,514,769...14,560,391
G
DNAJB4
DnaJ heat shock protein family (Hsp40) member B4
decreases expression
EXP
azoxystrobin results in decreased expression of DNAJB4 mRNA
CTD
PMID:33512557
NCBI chr 1:77,979,175...78,017,964
Ensembl chr 1:77,979,175...78,017,964
G
DNAJB9
DnaJ heat shock protein family (Hsp40) member B9
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of DNAJB9 mRNA
CTD
PMID:33854195
NCBI chr 7:108,569,874...108,574,850
Ensembl chr 7:108,569,867...108,574,850
G
DNTTIP2
deoxynucleotidyltransferase terminal interacting protein 2
decreases expression
EXP
azoxystrobin results in decreased expression of DNTTIP2 mRNA
CTD
PMID:33512557
NCBI chr 1:93,866,284...93,879,206
Ensembl chr 1:93,866,284...93,879,918
G
DPP4
dipeptidyl peptidase 4
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of DPP4 mRNA
CTD
PMID:33854195
NCBI chr 2:161,992,245...162,074,215
Ensembl chr 2:161,992,245...162,074,394
G
DPY30
dpy-30 histone methyltransferase complex regulatory subunit
increases expression
EXP
azoxystrobin results in increased expression of DPY30 mRNA
CTD
PMID:33512557
NCBI chr 2:32,011,649...32,039,835
Ensembl chr 2:31,867,809...32,039,805
G
DRD2
dopamine receptor D2
decreases expression
EXP
azoxystrobin results in decreased expression of DRD2 mRNA
CTD
PMID:33512557
NCBI chr11:113,409,605...113,475,398
Ensembl chr11:113,409,605...113,475,691
G
DUSP1
dual specificity phosphatase 1
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of DUSP1 mRNA
CTD
PMID:33854195
NCBI chr 5:172,768,096...172,771,195
Ensembl chr 5:172,768,096...172,771,195
G
DUSP11
dual specificity phosphatase 11
increases expression
EXP
azoxystrobin results in increased expression of DUSP11 mRNA
CTD
PMID:33512557
NCBI chr 2:73,762,213...73,780,149
Ensembl chr 2:73,761,782...73,780,132
G
DUSP5
dual specificity phosphatase 5
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of DUSP5 gene
CTD
PMID:33854195
NCBI chr10:110,497,907...110,511,533
Ensembl chr10:110,497,907...110,511,533
G
DUSP6
dual specificity phosphatase 6
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of DUSP6 mRNA
CTD
PMID:33854195
NCBI chr12:89,347,235...89,352,501
Ensembl chr12:89,347,235...89,352,501
G
DYNLL1
dynein light chain LC8-type 1
increases expression
EXP
azoxystrobin results in increased expression of DYNLL1 mRNA
CTD
PMID:33512557
NCBI chr12:120,469,842...120,498,493
Ensembl chr12:120,469,850...120,498,493
G
DZIP1L
DAZ interacting zinc finger protein 1 like
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of DZIP1L gene
CTD
PMID:33854195
NCBI chr 3:138,061,990...138,115,608
Ensembl chr 3:138,061,990...138,115,818
G
E2F1
E2F transcription factor 1
decreases expression
EXP
azoxystrobin results in decreased expression of E2F1 mRNA
CTD
PMID:33512557
NCBI chr20:33,675,477...33,686,385
Ensembl chr20:33,675,477...33,686,385
G
EED
embryonic ectoderm development
increases expression
EXP
azoxystrobin results in increased expression of EED mRNA
CTD
PMID:33512557
NCBI chr11:86,244,753...86,287,615
Ensembl chr11:86,201,212...86,278,813
G
EEF1B2
eukaryotic translation elongation factor 1 beta 2
increases expression
EXP
azoxystrobin results in increased expression of EEF1B2 mRNA
CTD
PMID:33512557
NCBI chr 2:206,159,609...206,162,928
Ensembl chr 2:206,159,585...206,162,928
G
EEF2K
eukaryotic elongation factor 2 kinase
decreases expression
EXP
azoxystrobin results in decreased expression of EEF2K mRNA
CTD
PMID:33512557
NCBI chr16:22,206,278...22,288,738
Ensembl chr16:22,206,278...22,288,738
G
EFNA1
ephrin A1
increases expression
EXP
azoxystrobin results in increased expression of EFNA1 mRNA
CTD
PMID:33512557
NCBI chr 1:155,127,876...155,134,899
Ensembl chr 1:155,127,876...155,134,899
G
EIF2S1
eukaryotic translation initiation factor 2 subunit alpha
decreases expression
EXP
azoxystrobin results in decreased expression of EIF2S1 mRNA
CTD
PMID:33512557
NCBI chr14:67,360,328...67,386,516
Ensembl chr14:67,360,328...67,386,516
G
EIF4B
eukaryotic translation initiation factor 4B
increases expression
EXP
azoxystrobin results in increased expression of EIF4B mRNA
CTD
PMID:33512557
NCBI chr12:53,006,456...53,042,215
Ensembl chr12:53,006,282...53,042,215
G
EIF4EBP1
eukaryotic translation initiation factor 4E binding protein 1
increases expression
EXP
azoxystrobin results in increased expression of EIF4EBP1 mRNA
CTD
PMID:33512557
NCBI chr 8:38,030,534...38,060,365
Ensembl chr 8:38,030,534...38,060,365
G
ELP1
elongator acetyltransferase complex subunit 1
decreases expression
EXP
azoxystrobin results in decreased expression of ELP1 mRNA
CTD
PMID:33512557
NCBI chr 9:108,867,517...108,934,124
Ensembl chr 9:108,866,898...108,934,328
G
EMILIN1
elastin microfibril interfacer 1
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of EMILIN1 mRNA
CTD
PMID:33854195
NCBI chr 2:27,078,615...27,086,403
Ensembl chr 2:27,078,615...27,086,403
G
EMX2
empty spiracles homeobox 2
decreases expression
EXP
azoxystrobin results in decreased expression of EMX2 mRNA
CTD
PMID:33512557
NCBI chr10:117,542,746...117,549,546
Ensembl chr10:117,542,445...117,549,546
G
ENO2
enolase 2
decreases expression
EXP
azoxystrobin results in decreased expression of ENO2 mRNA
CTD
PMID:33512557
NCBI chr12:6,914,580...6,923,697
Ensembl chr12:6,913,745...6,923,698
G
ENPP3
ectonucleotide pyrophosphatase/phosphodiesterase 3
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of ENPP3 mRNA
CTD
PMID:33854195
NCBI chr 6:131,637,302...131,747,410
Ensembl chr 6:131,628,442...131,747,418
G
EP300
E1A binding protein p300
decreases expression
EXP
azoxystrobin results in decreased expression of EP300 mRNA
CTD
PMID:33512557
NCBI chr22:41,092,592...41,180,077
Ensembl chr22:41,092,592...41,180,077
G
EPB41L3
erythrocyte membrane protein band 4.1 like 3
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of EPB41L3 gene
CTD
PMID:33854195
NCBI chr18:5,392,386...5,630,663
Ensembl chr18:5,392,381...5,630,700
G
EPM2AIP1
EPM2A interacting protein 1
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of EPM2AIP1 mRNA
CTD
PMID:33854195
NCBI chr 3:36,985,043...36,993,131
Ensembl chr 3:36,985,043...36,993,131
G
ERF
ETS2 repressor factor
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of ERF mRNA
CTD
PMID:33854195
NCBI chr19:42,247,569...42,255,128
Ensembl chr19:42,247,569...42,255,128
G
ESD
esterase D
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of ESD mRNA
CTD
PMID:33854195
NCBI chr13:46,771,256...46,797,700
Ensembl chr13:46,771,256...46,797,420
G
ETFB
electron transfer flavoprotein subunit beta
increases expression
EXP
azoxystrobin results in increased expression of ETFB mRNA
CTD
PMID:33512557
NCBI chr19:51,345,155...51,366,388
Ensembl chr19:51,345,169...51,366,388
G
ETNK1
ethanolamine kinase 1
decreases expression
EXP
azoxystrobin results in decreased expression of ETNK1 mRNA
CTD
PMID:33512557
NCBI chr12:22,625,171...22,690,665
Ensembl chr12:22,625,075...22,690,665
G
ETV1
ETS variant transcription factor 1
decreases expression
EXP
azoxystrobin results in decreased expression of ETV1 mRNA
CTD
PMID:33512557
NCBI chr 7:13,891,229...13,991,425
Ensembl chr 7:13,891,229...13,991,425
G
EVL
Enah/Vasp-like
decreases expression
EXP
azoxystrobin results in decreased expression of EVL mRNA
CTD
PMID:33512557
NCBI chr14:99,971,422...100,144,236
Ensembl chr14:99,971,449...100,144,236
G
EXOSC5
exosome component 5
decreases expression
EXP
azoxystrobin results in decreased expression of EXOSC5 mRNA
CTD
PMID:33512557
NCBI chr19:41,386,374...41,397,359
Ensembl chr19:41,386,371...41,397,362
G
EXOSC8
exosome component 8
increases expression
EXP
azoxystrobin results in increased expression of EXOSC8 mRNA
CTD
PMID:33512557
NCBI chr13:37,000,786...37,009,614
Ensembl chr13:36,998,816...37,025,881
G
FAM135A
family with sequence similarity 135 member A
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of FAM135A mRNA
CTD
PMID:33854195
NCBI chr 6:70,413,508...70,561,174
Ensembl chr 6:70,412,941...70,561,174
G
FAM13A
family with sequence similarity 13 member A
decreases expression
EXP
azoxystrobin results in decreased expression of FAM13A mRNA
CTD
PMID:33512557
NCBI chr 4:88,725,960...89,057,185
Ensembl chr 4:88,725,955...89,111,398
G
FAM177A1
family with sequence similarity 177 member A1
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of FAM177A1 gene
CTD
PMID:33854195
NCBI chr14:35,044,907...35,083,383
Ensembl chr14:35,045,117...35,116,630
G
FAM204A
family with sequence similarity 204 member A
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of FAM204A mRNA
CTD
PMID:33854195
NCBI chr10:118,297,925...118,342,324
Ensembl chr10:118,297,925...118,342,328
G
FAM53A
family with sequence similarity 53 member A
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of FAM53A gene
CTD
PMID:33854195
NCBI chr 4:1,574,062...1,686,017
Ensembl chr 4:1,617,915...1,684,313
G
FAM72A
family with sequence similarity 72 member A
increases expression
EXP
azoxystrobin results in increased expression of FAM72A mRNA
CTD
PMID:33512557
NCBI chr 1:206,186,179...206,205,773
Ensembl chr 1:206,186,179...206,204,414
G
FAM72C
family with sequence similarity 72 member C
increases expression
EXP
azoxystrobin results in increased expression of FAM72C mRNA
CTD
PMID:33512557
NCBI chr 1:143,955,287...143,973,564
Ensembl chr 1:143,955,287...143,971,986
G
FASN
fatty acid synthase
multiple interactions decreases expression
ISO EXP
[azoxystrobin co-treated with Dietary Fats] affects the expression of FASN mRNA azoxystrobin results in decreased expression of FASN mRNA
CTD
PMID:24726979 PMID:33512557
NCBI chr17:82,078,338...82,098,236
Ensembl chr17:82,078,338...82,098,294
G
FBXO7
F-box protein 7
decreases expression
EXP
azoxystrobin results in decreased expression of FBXO7 mRNA
CTD
PMID:33512557
NCBI chr22:32,474,811...32,498,829
Ensembl chr22:32,474,676...32,498,829
G
FDFT1
farnesyl-diphosphate farnesyltransferase 1
increases expression
EXP
azoxystrobin results in increased expression of FDFT1 mRNA
CTD
PMID:33512557
NCBI chr 8:11,795,582...11,839,309
Ensembl chr 8:11,795,573...11,839,395
G
FDPS
farnesyl diphosphate synthase
increases expression
EXP
azoxystrobin results in increased expression of FDPS mRNA
CTD
PMID:33512557
NCBI chr 1:155,308,866...155,320,665
Ensembl chr 1:155,308,748...155,320,666
G
FGF7P6
fibroblast growth factor 7 pseudogene 6
decreases expression
EXP
azoxystrobin results in decreased expression of FGF7P6 mRNA
CTD
PMID:33512557
NCBI chr 9:62,376,256...62,435,519
Ensembl chr 9:62,432,876...62,434,255
G
FICD
FIC domain protein adenylyltransferase
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of FICD mRNA
CTD
PMID:33854195
NCBI chr12:108,515,277...108,521,210
Ensembl chr12:108,515,277...108,525,837
G
FKBP4
FKBP prolyl isomerase 4
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of FKBP4 mRNA
CTD
PMID:33854195
NCBI chr12:2,794,970...2,805,423
Ensembl chr12:2,794,970...2,805,423
G
FKBP5
FKBP prolyl isomerase 5
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of FKBP5 gene
CTD
PMID:33854195
NCBI chr 6:35,573,590...35,728,583
Ensembl chr 6:35,573,585...35,728,583
G
FMN1
formin 1
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of FMN1 mRNA
CTD
PMID:33854195
NCBI chr15:32,765,544...33,194,714
Ensembl chr15:32,765,544...33,194,714
G
FOXO4
forkhead box O4
decreases expression
EXP
azoxystrobin results in decreased expression of FOXO4 mRNA
CTD
PMID:33512557
NCBI chr X:71,095,851...71,103,532
Ensembl chr X:71,095,851...71,103,532
G
FRMD4B
FERM domain containing 4B
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of FRMD4B mRNA
CTD
PMID:33854195
NCBI chr 3:69,168,782...69,542,586
Ensembl chr 3:69,168,782...69,542,583
G
FSD1
fibronectin type III and SPRY domain containing 1
decreases expression
EXP
azoxystrobin results in decreased expression of FSD1 mRNA
CTD
PMID:33512557
NCBI chr19:4,304,598...4,323,836
Ensembl chr19:4,304,598...4,323,843
G
FSTL1
follistatin like 1
decreases expression
EXP
azoxystrobin results in decreased expression of FSTL1 mRNA
CTD
PMID:33512557
NCBI chr 3:120,392,293...120,450,992
Ensembl chr 3:120,392,293...120,451,016
G
FTL
ferritin light chain
increases expression
EXP
azoxystrobin results in increased expression of FTL mRNA
CTD
PMID:33512557
NCBI chr19:48,965,309...48,966,879
Ensembl chr19:48,965,309...48,966,879
G
FZD6
frizzled class receptor 6
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of FZD6 mRNA
CTD
PMID:33854195
NCBI chr 8:103,298,494...103,332,866
Ensembl chr 8:103,298,433...103,332,866
G
G6PC1
glucose-6-phosphatase catalytic subunit 1
decreases expression
EXP
azoxystrobin results in decreased expression of G6PC1 mRNA
CTD
PMID:32194361
NCBI chr17:42,900,799...42,914,438
Ensembl chr17:42,900,797...42,914,438
G
G6PD
glucose-6-phosphate dehydrogenase
decreases expression
EXP
azoxystrobin results in decreased expression of G6PD mRNA
CTD
PMID:33512557
NCBI chr X:154,531,390...154,547,569
Ensembl chr X:154,517,825...154,547,572
G
GAA
alpha glucosidase
decreases expression
EXP
azoxystrobin results in decreased expression of GAA mRNA
CTD
PMID:33512557
NCBI chr17:80,101,581...80,119,881
Ensembl chr17:80,101,533...80,119,881
G
GADD45B
growth arrest and DNA damage inducible beta
decreases expression
EXP
azoxystrobin results in decreased expression of GADD45B mRNA
CTD
PMID:33512557
NCBI chr19:2,476,127...2,478,257
Ensembl chr19:2,476,122...2,478,259
G
GADD45G
growth arrest and DNA damage inducible gamma
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of GADD45G mRNA
CTD
PMID:33854195
NCBI chr 9:89,605,012...89,606,555
Ensembl chr 9:89,605,012...89,606,555
G
GAP43
growth associated protein 43
decreases expression
EXP
azoxystrobin results in decreased expression of GAP43 mRNA
CTD
PMID:33512557
NCBI chr 3:115,623,510...115,721,483
Ensembl chr 3:115,623,510...115,721,490
G
GATA2
GATA binding protein 2
increases expression
EXP
azoxystrobin results in increased expression of GATA2 mRNA
CTD
PMID:33512557
NCBI chr 3:128,479,422...128,493,201
Ensembl chr 3:128,479,427...128,493,201
G
GATD3
glutamine amidotransferase class 1 domain containing 3
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of GATD3A mRNA
CTD
PMID:33854195
NCBI chr21:44,133,683...44,145,711
Ensembl chr21:44,133,610...44,210,114
G
GCLM
glutamate-cysteine ligase modifier subunit
increases expression
EXP
azoxystrobin results in increased expression of GCLM mRNA
CTD
PMID:33512557
NCBI chr 1:93,885,199...93,909,430
Ensembl chr 1:93,885,199...93,909,456
G
GDF15
growth differentiation factor 15
multiple interactions increases expression
ISO EXP
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of GDF15 mRNA azoxystrobin results in increased expression of GDF15 mRNA
CTD
PMID:33512557 PMID:33854195
NCBI chr19:18,386,158...18,389,176
Ensembl chr19:18,374,731...18,389,176
G
GEN1
GEN1 Holliday junction 5' flap endonuclease
decreases expression
EXP
azoxystrobin results in decreased expression of GEN1 mRNA
CTD
PMID:33512557
NCBI chr 2:17,753,278...17,788,946
Ensembl chr 2:17,753,858...17,788,946
G
GET1
guided entry of tail-anchored proteins factor 1
increases expression
EXP
azoxystrobin results in increased expression of GET1 mRNA
CTD
PMID:33512557
NCBI chr21:39,380,326...39,428,528
Ensembl chr21:39,377,698...39,428,528
G
GIN1
gypsy retrotransposon integrase 1
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of GIN1 mRNA
CTD
PMID:33854195
NCBI chr 5:103,086,000...103,120,138
Ensembl chr 5:103,086,000...103,120,138
G
GIT2
GIT ArfGAP 2
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of GIT2 mRNA
CTD
PMID:33854195
NCBI chr12:109,929,804...110,000,164
Ensembl chr12:109,929,804...109,996,389
G
GJA1
gap junction protein alpha 1
increases expression
EXP
azoxystrobin results in increased expression of GJA1 mRNA
CTD
PMID:33512557
NCBI chr 6:121,435,646...121,449,727
Ensembl chr 6:121,435,595...121,449,727
G
GLB1
galactosidase beta 1
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of GLB1 mRNA
CTD
PMID:33854195
NCBI chr 3:32,961,108...33,097,146
Ensembl chr 3:32,996,609...33,097,202
G
GLI3
GLI family zinc finger 3
decreases expression
EXP
azoxystrobin results in decreased expression of GLI3 mRNA
CTD
PMID:33512557
NCBI chr 7:41,960,949...42,264,268
Ensembl chr 7:41,960,949...42,264,100
G
GLRX
glutaredoxin
decreases expression
EXP
azoxystrobin results in decreased expression of GLRX mRNA
CTD
PMID:33512557
NCBI chr 5:95,813,849...95,822,726
Ensembl chr 5:95,751,319...95,822,726
G
GMNN
geminin DNA replication inhibitor
increases expression
EXP
azoxystrobin results in increased expression of GMNN mRNA
CTD
PMID:33512557
NCBI chr 6:24,774,937...24,786,099
Ensembl chr 6:24,774,931...24,786,099
G
GNPDA2
glucosamine-6-phosphate deaminase 2
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of GNPDA2 mRNA
CTD
PMID:33854195
NCBI chr 4:44,701,795...44,726,556
Ensembl chr 4:44,682,200...44,726,588
G
GPC1
glypican 1
decreases expression
EXP
azoxystrobin results in decreased expression of GPC1 mRNA
CTD
PMID:33512557
NCBI chr 2:240,435,663...240,468,076
Ensembl chr 2:240,435,663...240,468,076
G
GPR89B
G protein-coupled receptor 89B
increases expression
EXP
azoxystrobin results in increased expression of GPR89B mRNA
CTD
PMID:33512557
NCBI chr 1:147,928,420...148,025,934
Ensembl chr 1:147,928,393...147,993,592 Ensembl chr 1:147,928,393...147,993,592 Ensembl chr 1:147,928,393...147,993,592
G
GPRASP3
G protein-coupled receptor associated sorting protein family member 3
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of GPRASP3 mRNA
CTD
PMID:33854195
NCBI chr X:102,720,743...102,753,540
Ensembl chr X:102,720,688...102,753,540
G
GRAMD1A
GRAM domain containing 1A
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of GRAMD1A mRNA
CTD
PMID:33854195
NCBI chr19:34,994,727...35,026,469
Ensembl chr19:34,994,784...35,026,471
G
GRIA1
glutamate ionotropic receptor AMPA type subunit 1
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of GRIA1 gene
CTD
PMID:33854195
NCBI chr 5:153,489,615...153,813,869
Ensembl chr 5:153,489,615...153,813,869
G
GRIA2
glutamate ionotropic receptor AMPA type subunit 2
decreases expression
EXP
azoxystrobin results in decreased expression of GRIA2 mRNA
CTD
PMID:33512557
NCBI chr 4:157,220,120...157,366,075
Ensembl chr 4:157,204,182...157,387,146
G
GRINA
glutamate ionotropic receptor NMDA type subunit associated protein 1
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of GRINA mRNA
CTD
PMID:33854195
NCBI chr 8:143,990,056...143,993,415
Ensembl chr 8:143,990,056...143,993,415
G
GSDMA
gasdermin A
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of GSDMA gene
CTD
PMID:33854195
NCBI chr17:39,963,004...39,977,768
Ensembl chr17:39,953,263...39,977,768
G
GSR
glutathione-disulfide reductase
increases expression
EXP
azoxystrobin results in increased expression of GSR mRNA
CTD
PMID:33512557
NCBI chr 8:30,678,066...30,727,846
Ensembl chr 8:30,678,066...30,727,846
G
GSTK1
glutathione S-transferase kappa 1
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of GSTK1 mRNA
CTD
PMID:33854195
NCBI chr 7:143,263,441...143,269,115
Ensembl chr 7:143,244,093...143,270,854
G
GUCY2C
guanylate cyclase 2C
decreases expression
EXP
azoxystrobin results in decreased expression of GUCY2C mRNA
CTD
PMID:33512557
NCBI chr12:14,612,632...14,696,599
Ensembl chr12:14,612,632...14,696,599
G
GUSBP15
GUSB pseudogene 15
decreases expression
EXP
azoxystrobin results in decreased expression of GUSBP15 mRNA
CTD
PMID:33512557
NCBI chr 5:70,481,043...70,585,722
Ensembl chr 5:70,516,387...70,555,266
G
HAPSTR2
HUWE1 associated protein modifying stress responses 2
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of HAPSTR2 gene
CTD
PMID:33854195
NCBI chr X:140,091,678...140,092,911
Ensembl chr X:140,091,678...140,092,911
G
HARS1
histidyl-tRNA synthetase 1
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of HARS1 mRNA
CTD
PMID:33854195
NCBI chr 5:140,673,905...140,691,370
Ensembl chr 5:140,673,035...140,691,537
G
HAUS1
HAUS augmin like complex subunit 1
increases expression
EXP
azoxystrobin results in increased expression of HAUS1 mRNA
CTD
PMID:33512557
NCBI chr18:46,104,385...46,128,333
Ensembl chr18:46,104,378...46,128,333
G
HDAC2
histone deacetylase 2
decreases expression
EXP
azoxystrobin results in decreased expression of HDAC2 mRNA
CTD
PMID:33512557
NCBI chr 6:113,933,028...113,971,148
Ensembl chr 6:113,933,028...114,011,308
G
HEBP1
heme binding protein 1
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of HEBP1 mRNA
CTD
PMID:33854195
NCBI chr12:12,974,870...13,000,265
Ensembl chr12:12,974,870...13,000,265
G
HES1
hes family bHLH transcription factor 1
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of HES1 mRNA
CTD
PMID:33854195
NCBI chr 3:194,136,148...194,138,732
Ensembl chr 3:194,136,148...194,138,732
G
HES5
hes family bHLH transcription factor 5
decreases expression
EXP
azoxystrobin results in decreased expression of HES5 mRNA
CTD
PMID:33512557
NCBI chr 1:2,528,745...2,530,263
Ensembl chr 1:2,528,745...2,530,263
G
HEXA
hexosaminidase subunit alpha
decreases expression
EXP
azoxystrobin results in decreased expression of HEXA mRNA
CTD
PMID:33512557
NCBI chr15:72,340,924...72,376,014
Ensembl chr15:72,340,924...72,376,420
G
HK1
hexokinase 1
decreases expression
EXP
azoxystrobin results in decreased expression of HK1 mRNA
CTD
PMID:33512557
NCBI chr10:69,270,000...69,401,882
Ensembl chr10:69,269,984...69,401,884
G
HMMR
hyaluronan mediated motility receptor
increases expression
EXP
azoxystrobin results in increased expression of HMMR mRNA
CTD
PMID:33512557
NCBI chr 5:163,460,632...163,491,941
Ensembl chr 5:163,460,203...163,491,941
G
HMOX1
heme oxygenase 1
increases expression
EXP
azoxystrobin results in increased expression of HMOX1 mRNA
CTD
PMID:33512557
NCBI chr22:35,381,096...35,394,207
Ensembl chr22:35,380,361...35,394,214
G
HNRNPM
heterogeneous nuclear ribonucleoprotein M
decreases expression
EXP
azoxystrobin results in decreased expression of HNRNPM mRNA
CTD
PMID:33512557
NCBI chr19:8,444,975...8,489,114
Ensembl chr19:8,444,767...8,489,114
G
HS3ST3B1
heparan sulfate-glucosamine 3-sulfotransferase 3B1
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of HS3ST3B1 mRNA
CTD
PMID:33854195
NCBI chr17:14,301,081...14,349,404
Ensembl chr17:14,301,081...14,349,404
G
HSD11B2
hydroxysteroid 11-beta dehydrogenase 2
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of HSD11B2 mRNA
CTD
PMID:33854195
NCBI chr16:67,429,801...67,437,553
Ensembl chr16:67,430,652...67,437,553
G
HSD17B10
hydroxysteroid 17-beta dehydrogenase 10
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of HSD17B10 mRNA
CTD
PMID:33854195
NCBI chr X:53,431,258...53,434,376
Ensembl chr X:53,431,258...53,434,370
G
HSD17B11
hydroxysteroid 17-beta dehydrogenase 11
increases expression
EXP
azoxystrobin results in increased expression of HSD17B11 mRNA
CTD
PMID:33512557
NCBI chr 4:87,336,515...87,391,188
Ensembl chr 4:87,336,515...87,391,188
G
HSD17B2
hydroxysteroid 17-beta dehydrogenase 2
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of HSD17B2 mRNA
CTD
PMID:33854195
NCBI chr16:82,035,253...82,098,534
Ensembl chr16:82,035,004...82,098,534
G
HSP90AA1
heat shock protein 90 alpha family class A member 1
increases expression
EXP
azoxystrobin results in increased expression of HSP90AA1 mRNA
CTD
PMID:33512557
NCBI chr14:102,080,742...102,139,749
Ensembl chr14:102,080,742...102,139,699
G
HSP90B1
heat shock protein 90 beta family member 1
increases expression
EXP
azoxystrobin results in increased expression of HSP90B1 mRNA
CTD
PMID:33512557
NCBI chr12:103,930,410...103,947,926
Ensembl chr12:103,930,107...103,953,931
G
HSPA1B
heat shock protein family A (Hsp70) member 1B
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of HSPA1B mRNA
CTD
PMID:33854195
NCBI chr 6:31,827,738...31,830,254
Ensembl chr 6:31,827,738...31,830,254
G
HSPA2
heat shock protein family A (Hsp70) member 2
decreases expression
EXP
azoxystrobin results in decreased expression of HSPA2 mRNA
CTD
PMID:33512557
NCBI chr14:64,535,905...64,543,237
Ensembl chr14:64,535,905...64,546,173
G
HSPA8
heat shock protein family A (Hsp70) member 8
increases expression
EXP
azoxystrobin results in increased expression of HSPA8 mRNA
CTD
PMID:33512557
NCBI chr11:123,057,489...123,062,462
Ensembl chr11:123,057,489...123,063,230
G
HSPB1
heat shock protein family B (small) member 1
increases expression
EXP
azoxystrobin results in increased expression of HSPB1 mRNA
CTD
PMID:33512557
NCBI chr 7:76,302,673...76,304,292
Ensembl chr 7:76,302,673...76,304,295
G
HSPBP1
HSPA (Hsp70) binding protein 1
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of HSPBP1 mRNA
CTD
PMID:33854195
NCBI chr19:55,262,223...55,280,383
Ensembl chr19:55,262,223...55,280,381
G
HSPD1
heat shock protein family D (Hsp60) member 1
increases expression
EXP
azoxystrobin results in increased expression of HSPD1 mRNA
CTD
PMID:33512557
NCBI chr 2:197,486,584...197,500,274
Ensembl chr 2:197,486,584...197,516,737
G
HTATSF1
HIV-1 Tat specific factor 1
decreases expression
EXP
azoxystrobin results in decreased expression of HTATSF1 mRNA
CTD
PMID:33512557
NCBI chr X:136,497,229...136,512,346
Ensembl chr X:136,497,079...136,512,346
G
IARS2
isoleucyl-tRNA synthetase 2, mitochondrial
increases expression
EXP
azoxystrobin results in increased expression of IARS2 mRNA
CTD
PMID:33512557
NCBI chr 1:220,094,132...220,148,041
Ensembl chr 1:220,094,132...220,148,041
G
ID1
inhibitor of DNA binding 1
decreases expression
EXP
azoxystrobin results in decreased expression of ID1 mRNA
CTD
PMID:33512557
NCBI chr20:31,605,289...31,606,510
Ensembl chr20:31,605,283...31,606,515
G
IDI1
isopentenyl-diphosphate delta isomerase 1
increases expression
EXP
azoxystrobin results in increased expression of IDI1 mRNA
CTD
PMID:33512557
NCBI chr10:1,039,152...1,056,704
Ensembl chr10:1,039,152...1,049,119
G
IER2
immediate early response 2
decreases expression
EXP
azoxystrobin results in decreased expression of IER2 mRNA
CTD
PMID:33512557
NCBI chr19:13,150,411...13,154,911
Ensembl chr19:13,150,411...13,154,911
G
IER3
immediate early response 3
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of IER3 mRNA
CTD
PMID:33854195
NCBI chr 6:30,743,199...30,744,547
Ensembl chr 6:30,743,199...30,744,548
G
IFI44L
interferon induced protein 44 like
increases expression
EXP
azoxystrobin results in increased expression of IFI44L mRNA
CTD
PMID:33512557
NCBI chr 1:78,620,448...78,646,145
Ensembl chr 1:78,619,902...78,646,145
G
IFITM2
interferon induced transmembrane protein 2
decreases expression
EXP
azoxystrobin results in decreased expression of IFITM2 mRNA
CTD
PMID:33512557
NCBI chr11:307,816...309,395
Ensembl chr11:303,655...309,397
G
IFITM3
interferon induced transmembrane protein 3
decreases expression
EXP
azoxystrobin results in decreased expression of IFITM3 mRNA
CTD
PMID:33512557
NCBI chr11:319,676...320,860
Ensembl chr11:319,676...329,475
G
IGF2R
insulin like growth factor 2 receptor
decreases expression
EXP
azoxystrobin results in decreased expression of IGF2R mRNA
CTD
PMID:33512557
NCBI chr 6:159,969,082...160,111,504
Ensembl chr 6:159,969,082...160,113,507
G
IGFBP1
insulin like growth factor binding protein 1
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of IGFBP1 mRNA
CTD
PMID:33854195
NCBI chr 7:45,888,488...45,893,660
Ensembl chr 7:45,888,360...45,893,660
G
IGFBP2
insulin like growth factor binding protein 2
decreases expression
EXP
azoxystrobin results in decreased expression of IGFBP2 mRNA
CTD
PMID:33512557
NCBI chr 2:216,632,828...216,664,436
Ensembl chr 2:216,632,828...216,664,436
G
IGFBP4
insulin like growth factor binding protein 4
decreases expression
EXP
azoxystrobin results in decreased expression of IGFBP4 mRNA
CTD
PMID:33512557
NCBI chr17:40,443,450...40,457,725
Ensembl chr17:40,443,450...40,457,725
G
IKZF1
IKAROS family zinc finger 1
decreases expression
EXP
azoxystrobin results in decreased expression of IKZF1 mRNA
CTD
PMID:33512557
NCBI chr 7:50,303,455...50,405,101
Ensembl chr 7:50,304,068...50,405,101
G
ILF2
interleukin enhancer binding factor 2
increases expression
EXP
azoxystrobin results in increased expression of ILF2 mRNA
CTD
PMID:33512557
NCBI chr 1:153,661,788...153,670,993
Ensembl chr 1:153,661,788...153,671,028
G
ILK
integrin linked kinase
decreases expression
EXP
azoxystrobin results in decreased expression of ILK mRNA
CTD
PMID:33512557
NCBI chr11:6,603,774...6,610,870
Ensembl chr11:6,603,708...6,610,874
G
INA
internexin neuronal intermediate filament protein alpha
decreases expression
EXP
azoxystrobin results in decreased expression of INA mRNA
CTD
PMID:33512557
NCBI chr10:103,277,138...103,290,346
Ensembl chr10:103,277,138...103,290,346
G
INHBE
inhibin subunit beta E
decreases expression
EXP
azoxystrobin results in decreased expression of INHBE mRNA
CTD
PMID:33512557
NCBI chr12:57,455,307...57,458,025
Ensembl chr12:57,452,323...57,459,280
G
INPP5F
inositol polyphosphate-5-phosphatase F
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of INPP5F mRNA
CTD
PMID:33854195
NCBI chr10:119,726,050...119,829,147
Ensembl chr10:119,726,042...119,829,147
G
INSIG1
insulin induced gene 1
affects expression
EXP
azoxystrobin affects the expression of INSIG1 mRNA
CTD
PMID:33512557
NCBI chr 7:155,297,878...155,310,235
Ensembl chr 7:155,297,776...155,310,235
G
IQCB1
IQ motif containing B1
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of IQCB1 mRNA
CTD
PMID:33854195
NCBI chr 3:121,769,761...121,835,060
Ensembl chr 3:121,769,761...121,835,079
G
IRF2BP2
interferon regulatory factor 2 binding protein 2
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of IRF2BP2 mRNA
CTD
PMID:33854195
NCBI chr 1:234,604,269...234,610,178
Ensembl chr 1:234,604,269...234,610,178
G
ITPRIP
inositol 1,4,5-trisphosphate receptor interacting protein
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of ITPRIP mRNA
CTD
PMID:33854195
NCBI chr10:104,309,700...104,338,465
Ensembl chr10:104,309,698...104,338,465
G
JUNB
JunB proto-oncogene, AP-1 transcription factor subunit
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of JUNB mRNA
CTD
PMID:33854195
NCBI chr19:12,791,486...12,793,315
Ensembl chr19:12,791,486...12,793,315
G
KATNIP
katanin interacting protein
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of KATNIP gene
CTD
PMID:33854195
NCBI chr16:27,550,144...27,780,344
Ensembl chr16:27,550,133...27,780,344
G
KDM3A
lysine demethylase 3A
decreases expression
EXP
azoxystrobin results in decreased expression of KDM3A mRNA
CTD
PMID:33512557
NCBI chr 2:86,437,044...86,492,716
Ensembl chr 2:86,440,647...86,492,716
G
KHDC4
KH domain containing 4, pre-mRNA splicing factor
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of KHDC4 mRNA
CTD
PMID:33854195
NCBI chr 1:155,913,045...155,934,413
Ensembl chr 1:155,913,045...155,934,413
G
KIF11
kinesin family member 11
increases expression
EXP
azoxystrobin results in increased expression of KIF11 mRNA
CTD
PMID:33512557
NCBI chr10:92,593,130...92,655,395
Ensembl chr10:92,574,105...92,655,395
G
KIF14
kinesin family member 14
increases expression
EXP
azoxystrobin results in increased expression of KIF14 mRNA
CTD
PMID:33512557
NCBI chr 1:200,551,497...200,620,751
Ensembl chr 1:200,551,497...200,620,751
G
KIF15
kinesin family member 15
increases expression
EXP
azoxystrobin results in increased expression of KIF15 mRNA
CTD
PMID:33512557
NCBI chr 3:44,761,794...44,868,687
Ensembl chr 3:44,761,721...44,873,376
G
KIF20A
kinesin family member 20A
increases expression
EXP
azoxystrobin results in increased expression of KIF20A mRNA
CTD
PMID:33512557
NCBI chr 5:138,179,112...138,187,723
Ensembl chr 5:138,178,719...138,187,723
G
KIF2C
kinesin family member 2C
increases expression
EXP
azoxystrobin results in increased expression of KIF2C mRNA
CTD
PMID:33512557
NCBI chr 1:44,739,837...44,767,767
Ensembl chr 1:44,739,818...44,767,767
G
KIF5C
kinesin family member 5C
decreases expression
EXP
azoxystrobin results in decreased expression of KIF5C mRNA
CTD
PMID:33512557
NCBI chr 2:148,875,227...149,026,759
Ensembl chr 2:148,875,227...149,026,759
G
KLF10
KLF transcription factor 10
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of KLF10 mRNA
CTD
PMID:33854195
NCBI chr 8:102,648,784...102,655,725
Ensembl chr 8:102,648,784...102,655,725
G
KLF2
KLF transcription factor 2
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of KLF2 mRNA
CTD
PMID:33854195
NCBI chr19:16,324,826...16,328,685
Ensembl chr19:16,324,826...16,328,685
G
KLHL10
kelch like family member 10
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of KLHL10 gene
CTD
PMID:33854195
NCBI chr17:41,835,685...41,848,384
Ensembl chr17:41,835,685...41,848,384
G
KRT18
keratin 18
decreases expression
EXP
azoxystrobin results in decreased expression of KRT18 mRNA
CTD
PMID:33512557
NCBI chr12:52,948,855...52,952,906
Ensembl chr12:52,948,871...52,952,906
G
KTN1
kinectin 1
increases expression
EXP
azoxystrobin results in increased expression of KTN1 mRNA
CTD
PMID:33512557
NCBI chr14:55,580,207...55,684,584
Ensembl chr14:55,559,072...55,701,526
G
L1CAM
L1 cell adhesion molecule
decreases expression
EXP
azoxystrobin results in decreased expression of L1CAM mRNA
CTD
PMID:33512557
NCBI chr X:153,861,514...153,886,173
Ensembl chr X:153,861,514...153,886,173
G
LAGE3
L antigen family member 3
increases expression
EXP
azoxystrobin results in increased expression of LAGE3 mRNA
CTD
PMID:33512557
NCBI chr X:154,477,775...154,479,281
Ensembl chr X:154,477,775...154,479,281
G
LAMP1
lysosomal associated membrane protein 1
decreases expression
EXP
azoxystrobin results in decreased expression of LAMP1 mRNA
CTD
PMID:33512557
NCBI chr13:113,297,239...113,323,672
Ensembl chr13:113,297,239...113,323,672
G
LDHA
lactate dehydrogenase A
increases expression
EXP
azoxystrobin results in increased expression of LDHA mRNA
CTD
PMID:33512557
NCBI chr11:18,394,563...18,408,425
Ensembl chr11:18,394,560...18,408,425
G
LDLR
low density lipoprotein receptor
affects expression
EXP
azoxystrobin affects the expression of LDLR mRNA
CTD
PMID:33512557
NCBI chr19:11,089,463...11,133,820
Ensembl chr19:11,089,418...11,133,820
G
LEP
leptin
multiple interactions
ISO
[azoxystrobin co-treated with Dietary Fats] affects the expression of LEP protein
CTD
PMID:24726979
NCBI chr 7:128,241,278...128,257,629
Ensembl chr 7:128,241,278...128,257,629
G
LGALSL
galectin like
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of LGALSL mRNA
CTD
PMID:33854195
NCBI chr 2:64,454,162...64,461,381
Ensembl chr 2:64,453,969...64,461,381
G
LHX2
LIM homeobox 2
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of LHX2 gene
CTD
PMID:33854195
NCBI chr 9:124,011,768...124,033,301
Ensembl chr 9:124,001,670...124,033,301
G
LILRB3
leukocyte immunoglobulin like receptor B3
multiple interactions decreases expression
ISO EXP
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of LILRB3 mRNA azoxystrobin results in decreased expression of LILRB3 mRNA
CTD
PMID:33512557 PMID:33854195
NCBI chr19:54,216,278...54,223,007
Ensembl chr19:54,216,278...54,223,506
G
LITAF
lipopolysaccharide induced TNF factor
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of LITAF mRNA
CTD
PMID:33854195
NCBI chr16:11,547,722...11,640,317
Ensembl chr16:11,547,722...11,636,381
G
LMNA
lamin A/C
decreases expression
EXP
azoxystrobin results in decreased expression of LMNA mRNA
CTD
PMID:33512557
NCBI chr 1:156,082,573...156,140,081
Ensembl chr 1:156,082,573...156,140,081
G
LMOD1
leiomodin 1
decreases expression
EXP
azoxystrobin results in decreased expression of LMOD1 mRNA
CTD
PMID:33512557
NCBI chr 1:201,896,456...201,946,548
Ensembl chr 1:201,896,456...201,946,548
G
LNX2
ligand of numb-protein X 2
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of LNX2 mRNA
CTD
PMID:33854195
NCBI chr13:27,545,913...27,621,107
Ensembl chr13:27,545,913...27,620,529
G
LOXL1
lysyl oxidase like 1
decreases expression
EXP
azoxystrobin results in decreased expression of LOXL1 mRNA
CTD
PMID:33512557
NCBI chr15:73,926,462...73,952,136
Ensembl chr15:73,925,989...73,952,137
G
LOXL3
lysyl oxidase like 3
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of LOXL3 gene
CTD
PMID:33854195
NCBI chr 2:74,532,258...74,555,702
Ensembl chr 2:74,532,258...74,555,690
G
LPAR2
lysophosphatidic acid receptor 2
decreases expression
EXP
azoxystrobin results in decreased expression of LPAR2 mRNA
CTD
PMID:33512557
NCBI chr19:19,623,655...19,628,220
Ensembl chr19:19,623,655...19,628,930
G
LPCAT1
lysophosphatidylcholine acyltransferase 1
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of LPCAT1 gene
CTD
PMID:33854195
NCBI chr 5:1,461,427...1,523,960
Ensembl chr 5:1,456,480...1,523,962
G
LPGAT1
lysophosphatidylglycerol acyltransferase 1
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of LPGAT1 gene
CTD
PMID:33854195
NCBI chr 1:211,743,457...211,830,763
Ensembl chr 1:211,743,457...211,830,763
G
LPIN3
lipin 3
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of LPIN3 mRNA
CTD
PMID:33854195
NCBI chr20:41,340,821...41,360,582
Ensembl chr20:41,340,821...41,360,582
G
LRP1
LDL receptor related protein 1
decreases expression
EXP
azoxystrobin results in decreased expression of LRP1 mRNA
CTD
PMID:33512557
NCBI chr12:57,128,483...57,213,361
Ensembl chr12:57,128,483...57,213,361
G
LSM5
LSM5 homolog, U6 small nuclear RNA and mRNA degradation associated
increases expression
EXP
azoxystrobin results in increased expression of LSM5 mRNA
CTD
PMID:33512557
NCBI chr 7:32,485,338...32,495,283
Ensembl chr 7:32,485,338...32,495,283
G
LSS
lanosterol synthase
affects expression
EXP
azoxystrobin affects the expression of LSS mRNA
CTD
PMID:33512557
NCBI chr21:46,188,446...46,228,774
Ensembl chr21:46,188,141...46,228,824
G
LTA4H
leukotriene A4 hydrolase
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of LTA4H mRNA
CTD
PMID:33854195
NCBI chr12:96,000,753...96,043,520
Ensembl chr12:96,000,753...96,043,520
G
LURAP1L
leucine rich adaptor protein 1 like
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of LURAP1L gene
CTD
PMID:33854195
NCBI chr 9:12,775,020...12,823,060
Ensembl chr 9:12,775,020...12,823,060
G
LYAR
Ly1 antibody reactive
decreases expression
EXP
azoxystrobin results in decreased expression of LYAR mRNA
CTD
PMID:33512557
NCBI chr 4:4,267,701...4,290,154
Ensembl chr 4:4,267,701...4,290,154
G
MAFF
MAF bZIP transcription factor F
decreases expression
EXP
azoxystrobin results in decreased expression of MAFF mRNA
CTD
PMID:33512557
NCBI chr22:38,201,994...38,216,511
Ensembl chr22:38,200,767...38,216,507
G
MAFG
MAF bZIP transcription factor G
decreases expression
EXP
azoxystrobin results in decreased expression of MAFG mRNA
CTD
PMID:33512557
NCBI chr17:81,918,270...81,931,244
Ensembl chr17:81,918,270...81,927,735
G
MALAT1
metastasis associated lung adenocarcinoma transcript 1
decreases expression
EXP
azoxystrobin results in decreased expression of MALAT1 mRNA
CTD
PMID:33512557
NCBI chr11:65,497,738...65,506,516
Ensembl chr11:65,497,640...65,508,073
G
MAP1B
microtubule associated protein 1B
decreases expression
EXP
azoxystrobin results in decreased expression of MAP1B mRNA
CTD
PMID:33512557
NCBI chr 5:72,107,475...72,209,565
Ensembl chr 5:72,107,234...72,209,565
G
MAP2
microtubule associated protein 2
decreases expression
EXP
azoxystrobin results in decreased expression of MAP2 mRNA
CTD
PMID:33512557
NCBI chr 2:209,424,047...209,734,112
Ensembl chr 2:209,424,047...209,734,147
G
MAP6
microtubule associated protein 6
decreases expression
EXP
azoxystrobin results in decreased expression of MAP6 mRNA
CTD
PMID:33512557
NCBI chr11:75,586,918...75,669,038
Ensembl chr11:75,586,918...75,669,038
G
MAPKAPK2
MAPK activated protein kinase 2
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of MAPKAPK2 mRNA
CTD
PMID:33854195
NCBI chr 1:206,684,905...206,734,281
Ensembl chr 1:206,684,905...206,734,281
G
MAPRE3
microtubule associated protein RP/EB family member 3
decreases expression
EXP
azoxystrobin results in decreased expression of MAPRE3 mRNA
CTD
PMID:33512557
NCBI chr 2:26,970,637...27,027,219
Ensembl chr 2:26,970,637...27,027,219
G
MARF1
meiosis regulator and mRNA stability factor 1
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of MARF1 mRNA
CTD
PMID:33854195
NCBI chr16:15,594,387...15,643,154
Ensembl chr16:15,594,387...15,643,154
G
MAT2A
methionine adenosyltransferase 2A
decreases expression
EXP
azoxystrobin results in decreased expression of MAT2A mRNA
CTD
PMID:33512557
NCBI chr 2:85,539,168...85,545,281
Ensembl chr 2:85,539,168...85,545,281
G
MCM4
minichromosome maintenance complex component 4
increases expression
EXP
azoxystrobin results in increased expression of MCM4 mRNA
CTD
PMID:33512557
NCBI chr 8:47,960,941...47,978,160
Ensembl chr 8:47,960,185...47,978,160
G
MDH2
malate dehydrogenase 2
increases expression
EXP
azoxystrobin results in increased expression of MDH2 mRNA
CTD
PMID:33512557
NCBI chr 7:76,048,106...76,067,508
Ensembl chr 7:76,048,051...76,067,508
G
MDK
midkine
increases expression
EXP
azoxystrobin results in increased expression of MDK mRNA
CTD
PMID:33512557
NCBI chr11:46,380,784...46,383,837
Ensembl chr11:46,380,756...46,383,837
G
MDM2
MDM2 proto-oncogene
increases expression
EXP
azoxystrobin results in increased expression of MDM2 protein
CTD
PMID:32339800
NCBI chr12:68,808,172...68,850,686
Ensembl chr12:68,808,177...68,845,544
G
ME1
malic enzyme 1
increases expression
EXP
azoxystrobin results in increased expression of ME1 mRNA
CTD
PMID:33512557
NCBI chr 6:83,210,402...83,431,051
Ensembl chr 6:83,210,402...83,431,051
G
MED12L
mediator complex subunit 12L
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of MED12L mRNA
CTD
PMID:33854195
NCBI chr 3:151,085,664...151,436,653
Ensembl chr 3:151,085,286...151,437,072
G
METTL14
methyltransferase 14, N6-adenosine-methyltransferase non-catalytic subunit
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of METTL14 mRNA
CTD
PMID:33854195
NCBI chr 4:118,685,392...118,715,430
Ensembl chr 4:118,685,392...118,715,433
G
MEX3B
mex-3 RNA binding family member B
decreases expression
EXP
azoxystrobin results in decreased expression of MEX3B mRNA
CTD
PMID:33512557
NCBI chr15:82,041,778...82,046,018
Ensembl chr15:82,041,778...82,046,119
G
MFAP5
microfibril associated protein 5
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of MFAP5 gene
CTD
PMID:33854195
NCBI chr12:8,645,943...8,662,826
Ensembl chr12:8,637,346...8,662,888
G
MIF
macrophage migration inhibitory factor
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of MIF mRNA
CTD
PMID:33854195
NCBI chr22:23,894,383...23,895,223
Ensembl chr22:23,894,383...23,895,227
G
MIR122
microRNA 122
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of MIR122 mRNA
CTD
PMID:34626815
NCBI chr18:58,451,074...58,451,158
Ensembl chr18:58,451,074...58,451,158
G
MIR130A
microRNA 130a
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of MIR130A mRNA
CTD
PMID:34626815
NCBI chr11:57,641,198...57,641,286
Ensembl chr11:57,641,198...57,641,286
G
MIR146A
microRNA 146a
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of MIR146A mRNA
CTD
PMID:34626815
NCBI chr 5:160,485,352...160,485,450
Ensembl chr 5:160,485,352...160,485,450
G
MIR22
microRNA 22
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of MIR22 mRNA
CTD
PMID:34626815
NCBI chr17:1,713,903...1,713,987
Ensembl chr17:1,713,903...1,713,987
G
MIR32
microRNA 32
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of MIR32 mRNA
CTD
PMID:34626815
NCBI chr 9:109,046,229...109,046,298
Ensembl chr 9:109,046,229...109,046,298
G
MIR33A
microRNA 33a
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of MIR33 mRNA
CTD
PMID:34626815
NCBI chr22:41,900,944...41,901,012
Ensembl chr22:41,900,944...41,901,012
G
MIR486-1
microRNA 486-1
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of MIR486 mRNA
CTD
PMID:34626815
NCBI chr 8:41,660,441...41,660,508
Ensembl chr 8:41,660,441...41,660,508
G
MLLT11
MLLT11 transcription factor 7 cofactor
decreases expression
EXP
azoxystrobin results in decreased expression of MLLT11 mRNA
CTD
PMID:33512557
NCBI chr 1:151,060,397...151,069,544
Ensembl chr 1:151,060,397...151,069,544
G
MLYCD
malonyl-CoA decarboxylase
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of MLYCD mRNA
CTD
PMID:33854195
NCBI chr16:83,899,115...83,927,031
Ensembl chr16:83,899,115...83,951,445
G
MMP2
matrix metallopeptidase 2
decreases expression
EXP
azoxystrobin results in decreased expression of MMP2 mRNA
CTD
PMID:33512557
NCBI chr16:55,478,830...55,506,691
Ensembl chr16:55,389,700...55,506,691
G
MOCS2
molybdenum cofactor synthesis 2
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of MOCS2 mRNA
CTD
PMID:33854195
NCBI chr 5:53,095,679...53,109,757
Ensembl chr 5:53,095,679...53,110,063
G
MORC3
MORC family CW-type zinc finger 3
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of MORC3 mRNA
CTD
PMID:33854195
NCBI chr21:36,320,197...36,376,632
Ensembl chr21:36,320,189...36,386,148
G
MORF4L2
mortality factor 4 like 2
increases expression
EXP
azoxystrobin results in increased expression of MORF4L2 mRNA
CTD
PMID:33512557
NCBI chr X:103,675,498...103,688,047
Ensembl chr X:103,675,496...103,688,158
G
MRE11
MRE11 homolog, double strand break repair nuclease
decreases expression
EXP
azoxystrobin results in decreased expression of MRE11 mRNA
CTD
PMID:33512557
NCBI chr11:94,415,570...94,512,412
Ensembl chr11:94,415,570...94,493,885
G
MRGBP
MRG domain binding protein
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of MRGBP mRNA
CTD
PMID:33854195
NCBI chr20:62,796,473...62,801,729
Ensembl chr20:62,796,473...62,801,729
G
MRNIP
MRN complex interacting protein
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of MRNIP mRNA
CTD
PMID:33854195
NCBI chr 5:179,837,276...179,858,817
Ensembl chr 5:179,835,133...179,862,173
G
MRPL3
mitochondrial ribosomal protein L3
increases expression
EXP
azoxystrobin results in increased expression of MRPL3 mRNA
CTD
PMID:33512557
NCBI chr 3:131,462,212...131,502,971
Ensembl chr 3:131,462,212...131,502,983
G
MRPL37
mitochondrial ribosomal protein L37
increases expression
EXP
azoxystrobin results in increased expression of MRPL37 mRNA
CTD
PMID:33512557
NCBI chr 1:54,200,167...54,225,489
Ensembl chr 1:54,184,041...54,225,464
G
MRPL44
mitochondrial ribosomal protein L44
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of MRPL44 mRNA
CTD
PMID:33854195
NCBI chr 2:223,950,854...223,967,714
Ensembl chr 2:223,957,463...223,967,714
G
MRPS17
mitochondrial ribosomal protein S17
increases expression
EXP
azoxystrobin results in increased expression of MRPS17 mRNA
CTD
PMID:33512557
NCBI chr 7:55,951,877...55,956,500
Ensembl chr 7:55,951,877...55,956,500
G
MRPS18B
mitochondrial ribosomal protein S18B
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of MRPS18B mRNA
CTD
PMID:33854195
NCBI chr 6:30,617,840...30,626,392
Ensembl chr 6:30,617,840...30,626,395
G
MSH2
mutS homolog 2
increases expression
EXP
azoxystrobin results in increased expression of MSH2 mRNA
CTD
PMID:33512557
NCBI chr 2:47,403,067...47,709,830
Ensembl chr 2:47,403,067...47,663,146
G
MT-ATP6
mitochondrially encoded ATP synthase membrane subunit 6
decreases expression
EXP
azoxystrobin results in decreased expression of ATP6 protein
CTD
PMID:32339800
NCBI chr MT:8,527...9,207
Ensembl chr MT:8,527...9,207
G
MT-CYB
mitochondrially encoded cytochrome b
decreases expression
EXP
azoxystrobin results in decreased expression of CYTB protein
CTD
PMID:32339800
NCBI chr MT:14,747...15,887
Ensembl chr MT:14,747...15,887
G
MT-ND6
mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 6
decreases expression
EXP
azoxystrobin results in decreased expression of ND6 mRNA
CTD
PMID:33512557
NCBI chr MT:14,149...14,673
Ensembl chr MT:14,149...14,673
G
MTA1
metastasis associated 1
decreases expression
EXP
azoxystrobin results in decreased expression of MTA1 mRNA
CTD
PMID:33512557
NCBI chr14:105,419,827...105,470,729
Ensembl chr14:105,419,820...105,470,729
G
MTARC1
mitochondrial amidoxime reducing component 1
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of MTARC1 mRNA
CTD
PMID:33854195
NCBI chr 1:220,786,913...220,819,659
Ensembl chr 1:220,786,352...220,819,659
G
MTHFD2
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase
increases expression
EXP
azoxystrobin results in increased expression of MTHFD2 mRNA
CTD
PMID:33512557
NCBI chr 2:74,198,615...74,217,565
Ensembl chr 2:74,186,172...74,217,565
G
MYBL1
MYB proto-oncogene like 1
decreases expression
EXP
azoxystrobin results in decreased expression of MYBL1 mRNA
CTD
PMID:33512557
NCBI chr 8:66,562,175...66,613,218
Ensembl chr 8:66,562,175...66,614,247
G
MYL4
myosin light chain 4
decreases expression
EXP
azoxystrobin results in decreased expression of MYL4 mRNA
CTD
PMID:33512557
NCBI chr17:47,189,433...47,227,650
Ensembl chr17:47,200,446...47,223,679
G
MYO10
myosin X
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of MYO10 mRNA
CTD
PMID:33854195
NCBI chr 5:16,661,907...16,936,288
Ensembl chr 5:16,661,907...16,936,288
G
N4BP2L2
NEDD4 binding protein 2 like 2
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of N4BP2L2 mRNA
CTD
PMID:33854195
NCBI chr13:32,432,485...32,538,868
Ensembl chr13:32,432,417...32,538,885
G
NAE1
NEDD8 activating enzyme E1 subunit 1
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of NAE1 mRNA
CTD
PMID:33854195
NCBI chr16:66,802,878...66,830,976
Ensembl chr16:66,802,875...66,873,256
G
NAMPT
nicotinamide phosphoribosyltransferase
increases expression
EXP
azoxystrobin results in increased expression of NAMPT mRNA
CTD
PMID:33512557
NCBI chr 7:106,248,298...106,285,888
Ensembl chr 7:106,248,298...106,285,966
G
NCAM1
neural cell adhesion molecule 1
decreases expression
EXP
azoxystrobin results in decreased expression of NCAM1 mRNA
CTD
PMID:33512557
NCBI chr11:112,961,420...113,278,436
Ensembl chr11:112,961,275...113,278,436
G
NCAN
neurocan
decreases expression
EXP
azoxystrobin results in decreased expression of NCAN mRNA
CTD
PMID:33512557
NCBI chr19:19,211,958...19,252,233
Ensembl chr19:19,211,958...19,252,233
G
NDRG1
N-myc downstream regulated 1
decreases expression
EXP
azoxystrobin results in decreased expression of NDRG1 mRNA
CTD
PMID:33512557
NCBI chr 8:133,237,175...133,297,252
Ensembl chr 8:133,237,175...133,302,022
G
NDUFA13
NADH:ubiquinone oxidoreductase subunit A13
increases expression
EXP
azoxystrobin results in increased expression of NDUFA13 mRNA
CTD
PMID:33512557
NCBI chr19:19,516,225...19,528,198
Ensembl chr19:19,515,736...19,529,054
G
NDUFA4
NDUFA4 mitochondrial complex associated
increases expression
EXP
azoxystrobin results in increased expression of NDUFA4 mRNA
CTD
PMID:33512557
NCBI chr 7:10,931,943...10,940,153
Ensembl chr 7:10,931,943...10,940,153
G
NDUFB11
NADH:ubiquinone oxidoreductase subunit B11
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of NDUFB11 gene
CTD
PMID:33854195
NCBI chr X:47,142,216...47,145,491
Ensembl chr X:47,142,071...47,145,466
G
NDUFB3
NADH:ubiquinone oxidoreductase subunit B3
increases expression
EXP
azoxystrobin results in increased expression of NDUFB3 mRNA
CTD
PMID:33512557
NCBI chr 2:201,072,001...201,085,750
Ensembl chr 2:201,071,433...201,085,750
G
NDUFV2
NADH:ubiquinone oxidoreductase core subunit V2
increases expression
EXP
azoxystrobin results in increased expression of NDUFV2 mRNA
CTD
PMID:33512557
NCBI chr18:9,102,699...9,134,341
Ensembl chr18:9,102,630...9,134,345
G
NDUFV3
NADH:ubiquinone oxidoreductase subunit V3
increases expression
EXP
azoxystrobin results in increased expression of NDUFV3 mRNA
CTD
PMID:33512557
NCBI chr21:42,893,309...42,913,299
Ensembl chr21:42,879,644...42,913,304
G
NEFL
neurofilament light chain
decreases expression
EXP
azoxystrobin results in decreased expression of NEFL mRNA
CTD
PMID:33512557
NCBI chr 8:24,950,955...24,956,612
Ensembl chr 8:24,950,955...24,956,721
G
NEK2
NIMA related kinase 2
increases expression
EXP
azoxystrobin results in increased expression of NEK2 mRNA
CTD
PMID:33512557
NCBI chr 1:211,658,256...211,675,621
Ensembl chr 1:211,658,657...211,675,630
G
NENF
neudesin neurotrophic factor
increases expression
EXP
azoxystrobin results in increased expression of NENF mRNA
CTD
PMID:33512557
NCBI chr 1:212,432,920...212,446,379
Ensembl chr 1:212,432,920...212,446,379
G
NFATC4
nuclear factor of activated T cells 4
decreases expression
EXP
azoxystrobin results in decreased expression of NFATC4 mRNA
CTD
PMID:33512557
NCBI chr14:24,366,911...24,379,604
Ensembl chr14:24,365,673...24,379,604
G
NFE2
nuclear factor, erythroid 2
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of NFE2 mRNA
CTD
PMID:33854195
NCBI chr12:54,292,111...54,301,015
Ensembl chr12:54,292,111...54,301,015
G
NFIL3
nuclear factor, interleukin 3 regulated
multiple interactions decreases expression
ISO EXP
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of NFIL3 mRNA azoxystrobin results in decreased expression of NFIL3 mRNA
CTD
PMID:33512557 PMID:33854195
NCBI chr 9:91,409,045...91,483,497
Ensembl chr 9:91,409,045...91,423,832
G
NFKBIB
NFKB inhibitor beta
decreases expression
EXP
azoxystrobin results in decreased expression of NFKBIB mRNA
CTD
PMID:33512557
NCBI chr19:38,899,666...38,908,889
Ensembl chr19:38,899,700...38,908,893
G
NHLH1
nescient helix-loop-helix 1
decreases expression
EXP
azoxystrobin results in decreased expression of NHLH1 mRNA
CTD
PMID:33512557
NCBI chr 1:160,367,071...160,372,846
Ensembl chr 1:160,367,071...160,372,846
G
NIPSNAP3A
nipsnap homolog 3A
increases expression
EXP
azoxystrobin results in increased expression of NIPSNAP3A mRNA
CTD
PMID:33512557
NCBI chr 9:104,747,683...104,760,120
Ensembl chr 9:104,747,683...104,760,120
G
NOS3
nitric oxide synthase 3
increases expression
EXP
azoxystrobin results in increased expression of NOS3 mRNA
CTD
PMID:34642769
NCBI chr 7:150,991,017...151,014,588
Ensembl chr 7:150,991,017...151,014,588
G
NOTCH1
notch receptor 1
decreases expression
EXP
azoxystrobin results in decreased expression of NOTCH1 mRNA
CTD
PMID:33512557
NCBI chr 9:136,494,433...136,546,048
Ensembl chr 9:136,494,433...136,546,048
G
NOTCH3
notch receptor 3
decreases expression
EXP
azoxystrobin results in decreased expression of NOTCH3 mRNA
CTD
PMID:33512557
NCBI chr19:15,159,038...15,200,995
Ensembl chr19:15,159,038...15,200,995
G
NPDC1
neural proliferation, differentiation and control 1
decreases expression
EXP
azoxystrobin results in decreased expression of NPDC1 mRNA
CTD
PMID:33512557
NCBI chr 9:137,039,463...137,046,177
Ensembl chr 9:137,039,463...137,046,179
G
NPEPL1
aminopeptidase like 1
decreases expression
EXP
azoxystrobin results in decreased expression of NPEPL1 mRNA
CTD
PMID:33512557
NCBI chr20:58,689,131...58,715,844
Ensembl chr20:58,689,131...58,719,238
G
NQO1
NAD(P)H quinone dehydrogenase 1
increases expression
EXP
azoxystrobin results in increased expression of NQO1 mRNA
CTD
PMID:33512557
NCBI chr16:69,709,401...69,726,560
Ensembl chr16:69,706,996...69,726,668
G
NR0B2
nuclear receptor subfamily 0 group B member 2
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of NR0B2 mRNA
CTD
PMID:33854195
NCBI chr 1:26,911,489...26,913,975
Ensembl chr 1:26,911,489...26,913,975
G
NR1D1
nuclear receptor subfamily 1 group D member 1
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of NR1D1 mRNA
CTD
PMID:33854195
NCBI chr17:40,092,793...40,100,589
Ensembl chr17:40,092,793...40,100,589
G
NR1D2
nuclear receptor subfamily 1 group D member 2
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of NR1D2 mRNA
CTD
PMID:33854195
NCBI chr 3:23,945,286...23,980,617
Ensembl chr 3:23,945,286...23,980,617
G
NR1I2
nuclear receptor subfamily 1 group I member 2
multiple interactions
EXP ISO
azoxystrobin binds to and results in increased activity of NR1I2 protein
CTD
PMID:33049310
NCBI chr 3:119,782,101...119,818,487
Ensembl chr 3:119,780,484...119,818,487
G
NR3C1
nuclear receptor subfamily 3 group C member 1
increases expression
EXP
azoxystrobin results in increased expression of NR3C1 mRNA
CTD
PMID:33512557
NCBI chr 5:143,277,931...143,435,512
Ensembl chr 5:143,277,931...143,435,512
G
NR5A1
nuclear receptor subfamily 5 group A member 1
decreases expression
EXP
azoxystrobin results in decreased expression of NR5A1 mRNA
CTD
PMID:33512557
NCBI chr 9:124,481,236...124,507,399
Ensembl chr 9:124,481,236...124,507,420
G
NRCAM
neuronal cell adhesion molecule
decreases expression
EXP
azoxystrobin results in decreased expression of NRCAM mRNA
CTD
PMID:33512557
NCBI chr 7:108,147,649...108,456,720
Ensembl chr 7:108,147,623...108,456,717
G
NRG1
neuregulin 1
decreases expression
EXP
azoxystrobin results in decreased expression of NRG1 mRNA
CTD
PMID:33512557
NCBI chr 8:31,639,245...32,774,046
Ensembl chr 8:31,639,222...32,855,666
G
NUCKS1
nuclear casein kinase and cyclin dependent kinase substrate 1
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of NUCKS1 mRNA
CTD
PMID:33854195
NCBI chr 1:205,712,822...205,750,182
Ensembl chr 1:205,712,822...205,750,182
G
NUDCD3
NudC domain containing 3
decreases expression
EXP
azoxystrobin results in decreased expression of NUDCD3 mRNA
CTD
PMID:33512557
NCBI chr 7:44,379,119...44,490,658
Ensembl chr 7:44,379,119...44,490,658
G
NUSAP1
nucleolar and spindle associated protein 1
decreases expression
EXP
azoxystrobin results in decreased expression of NUSAP1 mRNA
CTD
PMID:33512557
NCBI chr15:41,332,881...41,381,046
Ensembl chr15:41,320,794...41,381,050
G
OIP5
Opa interacting protein 5
increases expression
EXP
azoxystrobin results in increased expression of OIP5 mRNA
CTD
PMID:33512557
NCBI chr15:41,309,273...41,332,591
Ensembl chr15:41,309,273...41,332,591
G
OLFML2B
olfactomedin like 2B
decreases expression
EXP
azoxystrobin results in decreased expression of OLFML2B mRNA
CTD
PMID:33512557
NCBI chr 1:161,983,192...162,023,869
Ensembl chr 1:161,983,192...162,023,869
G
OPLAH
5-oxoprolinase, ATP-hydrolysing
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of OPLAH mRNA
CTD
PMID:33854195
NCBI chr 8:144,050,322...144,063,961
Ensembl chr 8:144,051,266...144,063,965
G
ORAI3
ORAI calcium release-activated calcium modulator 3
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of ORAI3 gene
CTD
PMID:33854195
NCBI chr16:30,949,068...30,954,938
Ensembl chr16:30,949,068...30,956,461
G
ORC3
origin recognition complex subunit 3
decreases expression
EXP
azoxystrobin results in decreased expression of ORC3 mRNA
CTD
PMID:33512557
NCBI chr 6:87,590,135...87,677,823
Ensembl chr 6:87,590,067...87,667,453
G
P2RX3
purinergic receptor P2X 3
decreases expression
EXP
azoxystrobin results in decreased expression of P2RX3 mRNA
CTD
PMID:33512557
NCBI chr11:57,335,950...57,372,396
Ensembl chr11:57,338,352...57,372,396
G
PABIR1
PP2A Aalpha (PPP2R1A) and B55A (PPP2R2A) interacting phosphatase regulator 1
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of PABIR1 gene
CTD
PMID:33854195
NCBI chr 9:68,780,065...68,785,566
Ensembl chr 9:68,780,065...68,785,566
G
PAPSS1
3'-phosphoadenosine 5'-phosphosulfate synthase 1
increases expression
EXP
azoxystrobin results in increased expression of PAPSS1 mRNA
CTD
PMID:33512557
NCBI chr 4:107,613,666...107,720,234
Ensembl chr 4:107,590,276...107,720,234
G
PARPBP
PARP1 binding protein
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of PARPBP gene
CTD
PMID:33854195
NCBI chr12:102,120,183...102,197,520
Ensembl chr12:102,120,183...102,197,520
G
PCDHA9
protocadherin alpha 9
decreases expression
EXP
azoxystrobin results in decreased expression of PCDHA9 mRNA
CTD
PMID:33512557
NCBI chr 5:140,847,772...141,012,347
Ensembl chr 5:140,847,772...141,012,347
G
PCMT1
protein-L-isoaspartate (D-aspartate) O-methyltransferase
increases expression
EXP
azoxystrobin results in increased expression of PCMT1 mRNA
CTD
PMID:33512557
NCBI chr 6:149,749,695...149,811,421
Ensembl chr 6:149,749,444...149,811,420
G
PCNA
proliferating cell nuclear antigen
increases expression
EXP
azoxystrobin results in increased expression of PCNA mRNA
CTD
PMID:33512557
NCBI chr20:5,114,953...5,126,622
Ensembl chr20:5,114,953...5,126,626
G
PDCD6IP
programmed cell death 6 interacting protein
decreases expression
EXP
azoxystrobin results in decreased expression of PDCD6IP mRNA
CTD
PMID:33512557
NCBI chr 3:33,798,630...33,869,703
Ensembl chr 3:33,798,571...33,869,707
G
PDK4
pyruvate dehydrogenase kinase 4
decreases expression
EXP
azoxystrobin results in decreased expression of PDK4 mRNA
CTD
PMID:33512557
NCBI chr 7:95,583,499...95,596,516
Ensembl chr 7:95,583,499...95,596,516
G
PDLIM1
PDZ and LIM domain 1
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of PDLIM1 mRNA
CTD
PMID:33854195
NCBI chr10:95,237,572...95,291,003
Ensembl chr10:95,237,572...95,291,012
G
PDP1
pyruvate dehydrogenase phosphatase catalytic subunit 1
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of PDP1 mRNA
CTD
PMID:33854195
NCBI chr 8:93,916,923...93,926,068
Ensembl chr 8:93,857,807...93,926,068
G
PDZD2
PDZ domain containing 2
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of PDZD2 gene
CTD
PMID:33854195
NCBI chr 5:31,639,131...32,110,932
Ensembl chr 5:31,639,131...32,110,932
G
PEG10
paternally expressed 10
decreases expression
EXP
azoxystrobin results in decreased expression of PEG10 mRNA
CTD
PMID:33512557
NCBI chr 7:94,656,325...94,669,695
Ensembl chr 7:94,656,325...94,669,695
G
PER1
period circadian regulator 1
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of PER1 mRNA
CTD
PMID:33854195
NCBI chr17:8,140,472...8,152,404
Ensembl chr17:8,140,472...8,156,506
G
PER3
period circadian regulator 3
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of PER3 mRNA
CTD
PMID:33854195
NCBI chr 1:7,784,291...7,845,177
Ensembl chr 1:7,784,291...7,845,177
G
PGA5
pepsinogen A5
increases expression
EXP
azoxystrobin results in increased expression of PGA5 mRNA
CTD
PMID:33512557
NCBI chr11:61,241,175...61,251,444
Ensembl chr11:61,241,175...61,251,444
G
PGF
placental growth factor
decreases expression
EXP
azoxystrobin results in decreased expression of PGF mRNA
CTD
PMID:33512557
NCBI chr14:74,941,830...74,955,764
Ensembl chr14:74,941,834...74,955,626
G
PGK1
phosphoglycerate kinase 1
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of PGK1 mRNA
CTD
PMID:33854195
NCBI chr X:78,104,248...78,129,295
Ensembl chr X:77,910,739...78,129,295
G
PHGDH
phosphoglycerate dehydrogenase
increases expression
EXP
azoxystrobin results in increased expression of PHGDH mRNA
CTD
PMID:33512557
NCBI chr 1:119,711,934...119,744,215
Ensembl chr 1:119,648,411...119,744,218
G
PHLDA1
pleckstrin homology like domain family A member 1
decreases expression
EXP
azoxystrobin results in decreased expression of PHLDA1 mRNA
CTD
PMID:33512557
NCBI chr12:76,025,447...76,031,776
Ensembl chr12:76,025,447...76,031,776
G
PI4KA
phosphatidylinositol 4-kinase alpha
decreases expression
EXP
azoxystrobin results in decreased expression of PI4KA mRNA
CTD
PMID:33512557
NCBI chr22:20,707,691...20,858,811
Ensembl chr22:20,707,691...20,859,417
G
PIAS3
protein inhibitor of activated STAT 3
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of PIAS3 mRNA
CTD
PMID:33854195
NCBI chr 1:145,848,522...145,859,081
Ensembl chr 1:145,848,522...145,859,836
G
PIGP
phosphatidylinositol glycan anchor biosynthesis class P
increases expression
EXP
azoxystrobin results in increased expression of PIGP mRNA
CTD
PMID:33512557
NCBI chr21:37,065,364...37,073,071
Ensembl chr21:37,062,846...37,073,170
G
PINK1
PTEN induced kinase 1
decreases expression
EXP
azoxystrobin results in decreased expression of PINK1 mRNA
CTD
PMID:33512557
NCBI chr 1:20,633,458...20,651,511
Ensembl chr 1:20,633,458...20,651,511
G
PIP4K2B
phosphatidylinositol-5-phosphate 4-kinase type 2 beta
decreases expression
EXP
azoxystrobin results in decreased expression of PIP4K2B mRNA
CTD
PMID:33512557
NCBI chr17:38,765,691...38,799,556
Ensembl chr17:38,765,691...38,800,126
G
PIP4P1
phosphatidylinositol-4,5-bisphosphate 4-phosphatase 1
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of PIP4P1 mRNA
CTD
PMID:33854195
NCBI chr14:20,457,681...20,461,434
Ensembl chr14:20,457,681...20,461,465
G
PITPNA
phosphatidylinositol transfer protein alpha
decreases expression
EXP
azoxystrobin results in decreased expression of PITPNA mRNA
CTD
PMID:33512557
NCBI chr17:1,517,718...1,562,792
Ensembl chr17:1,517,718...1,562,792
G
PLEKHG5
pleckstrin homology and RhoGEF domain containing G5
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of PLEKHG5 mRNA
CTD
PMID:33854195
NCBI chr 1:6,467,122...6,520,092
Ensembl chr 1:6,467,122...6,520,074
G
PLK2
polo like kinase 2
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of PLK2 mRNA
CTD
PMID:33854195
NCBI chr 5:58,453,982...58,460,086
Ensembl chr 5:58,453,982...58,460,139
G
PLPP4
phospholipid phosphatase 4
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of PLPP4 gene
CTD
PMID:33854195
NCBI chr10:120,456,954...120,592,065
Ensembl chr10:120,457,227...120,592,065
G
PLXDC2
plexin domain containing 2
decreases expression
EXP
azoxystrobin results in decreased expression of PLXDC2 mRNA
CTD
PMID:33512557
NCBI chr10:19,816,432...20,289,856
Ensembl chr10:19,816,239...20,289,856
G
PMM2
phosphomannomutase 2
decreases expression
EXP
azoxystrobin results in decreased expression of PMM2 mRNA
CTD
PMID:33512557
NCBI chr16:8,797,839...8,849,325
Ensembl chr16:8,788,823...8,862,534
G
PMVK
phosphomevalonate kinase
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of PMVK mRNA
CTD
PMID:33854195
NCBI chr 1:154,924,740...154,942,658
Ensembl chr 1:154,924,740...154,936,719
G
PNKD
PNKD metallo-beta-lactamase domain containing
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of PNKD mRNA
CTD
PMID:33854195
NCBI chr 2:218,270,519...218,346,793
Ensembl chr 2:218,269,651...218,346,793
G
PNKP
polynucleotide kinase 3'-phosphatase
decreases expression
EXP
azoxystrobin results in decreased expression of PNKP mRNA
CTD
PMID:33512557
NCBI chr19:49,861,204...49,867,576
Ensembl chr19:49,859,882...49,878,351
G
PNRC1
proline rich nuclear receptor coactivator 1
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of PNRC1 mRNA
CTD
PMID:33854195
NCBI chr 6:89,080,751...89,085,160
Ensembl chr 6:89,080,751...89,085,160
G
POLB
DNA polymerase beta
increases expression
EXP
azoxystrobin results in increased expression of POLB mRNA
CTD
PMID:33512557
NCBI chr 8:42,338,494...42,371,808
Ensembl chr 8:42,338,454...42,371,808
G
POR
cytochrome p450 oxidoreductase
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of POR gene
CTD
PMID:33854195
NCBI chr 7:75,915,155...75,986,855
Ensembl chr 7:75,899,200...75,986,855
G
POU4F1
POU class 4 homeobox 1
decreases expression
EXP
azoxystrobin results in decreased expression of POU4F1 mRNA
CTD
PMID:33512557
NCBI chr13:78,598,362...78,603,552
Ensembl chr13:78,598,362...78,603,552
G
PPA1
inorganic pyrophosphatase 1
increases expression
EXP
azoxystrobin results in increased expression of PPA1 mRNA
CTD
PMID:33512557
NCBI chr10:70,202,835...70,233,429
Ensembl chr10:70,202,835...70,233,911
G
PPARD
peroxisome proliferator activated receptor delta
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of PPARD mRNA
CTD
PMID:33854195
NCBI chr 6:35,342,558...35,428,178
Ensembl chr 6:35,342,558...35,428,191
G
PPIL1
peptidylprolyl isomerase like 1
decreases expression
EXP
azoxystrobin results in decreased expression of PPIL1 mRNA
CTD
PMID:33512557
NCBI chr 6:36,854,829...36,874,803
Ensembl chr 6:36,854,827...36,874,803
G
PPP1R15A
protein phosphatase 1 regulatory subunit 15A
decreases expression
EXP
azoxystrobin results in decreased expression of PPP1R15A mRNA
CTD
PMID:33512557
NCBI chr19:48,872,421...48,876,058
Ensembl chr19:48,872,212...48,876,059
G
PRDM15
PR/SET domain 15
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of PRDM15 mRNA
CTD
PMID:33854195
NCBI chr21:41,798,225...41,879,344
Ensembl chr21:41,798,225...41,879,482
G
PRDX1
peroxiredoxin 1
increases expression
EXP
azoxystrobin results in increased expression of PRDX1 mRNA
CTD
PMID:33512557
NCBI chr 1:45,511,051...45,522,890
Ensembl chr 1:45,510,914...45,542,732
G
PRDX2
peroxiredoxin 2
increases expression
EXP
azoxystrobin results in increased expression of PRDX2 mRNA
CTD
PMID:33512557
NCBI chr19:12,796,823...12,801,800
Ensembl chr19:12,796,820...12,801,800
G
PRELID2
PRELI domain containing 2
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of PRELID2 mRNA
CTD
PMID:33854195
NCBI chr 5:145,228,985...145,835,342
Ensembl chr 5:145,471,799...145,835,369
G
PRELP
proline and arginine rich end leucine rich repeat protein
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of PRELP mRNA
CTD
PMID:33854195
NCBI chr 1:203,475,806...203,491,352
Ensembl chr 1:203,475,806...203,491,352
G
PRKAG1
protein kinase AMP-activated non-catalytic subunit gamma 1
decreases expression
EXP
azoxystrobin results in decreased expression of PRKAG1 mRNA
CTD
PMID:33512557
NCBI chr12:49,002,274...49,018,776
Ensembl chr12:49,002,274...49,018,807
G
PRKAR1A
protein kinase cAMP-dependent type I regulatory subunit alpha
decreases expression
EXP
azoxystrobin results in decreased expression of PRKAR1A mRNA
CTD
PMID:33512557
NCBI chr17:68,413,623...68,551,316
Ensembl chr17:68,511,780...68,551,319
G
PRKN
parkin RBR E3 ubiquitin protein ligase
decreases expression
EXP
azoxystrobin results in decreased expression of PRKN mRNA
CTD
PMID:33512557
NCBI chr 6:161,347,417...162,727,766
Ensembl chr 6:161,347,417...162,727,775
G
PROSER2
proline and serine rich 2
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of PROSER2 mRNA
CTD
PMID:33854195
NCBI chr10:11,823,356...11,872,277
Ensembl chr10:11,823,339...11,872,277
G
PRPF39
pre-mRNA processing factor 39
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of PRPF39 mRNA
CTD
PMID:33854195
NCBI chr14:45,084,116...45,116,282
Ensembl chr14:45,084,107...45,116,282
G
PRR11
proline rich 11
increases expression
EXP
azoxystrobin results in increased expression of PRR11 mRNA
CTD
PMID:33512557
NCBI chr17:59,155,746...59,206,709
Ensembl chr17:59,155,732...59,206,709
G
PRR7
proline rich 7, synaptic
decreases expression
EXP
azoxystrobin results in decreased expression of PRR7 mRNA
CTD
PMID:33512557
NCBI chr 5:177,445,995...177,456,286
Ensembl chr 5:177,446,445...177,456,286
G
PSAT1
phosphoserine aminotransferase 1
increases expression
EXP
azoxystrobin results in increased expression of PSAT1 mRNA
CTD
PMID:33512557
NCBI chr 9:78,297,125...78,330,093
Ensembl chr 9:78,297,125...78,330,093
G
PSENEN
presenilin enhancer, gamma-secretase subunit
increases expression
EXP
azoxystrobin results in increased expression of PSENEN mRNA
CTD
PMID:33512557
NCBI chr19:35,745,651...35,747,519
Ensembl chr19:35,745,600...35,747,519
G
PSIP1
PC4 and SRSF1 interacting protein 1
decreases expression
EXP
azoxystrobin results in decreased expression of PSIP1 mRNA
CTD
PMID:33512557
NCBI chr 9:15,464,066...15,510,970
Ensembl chr 9:15,464,066...15,510,995
G
PSMC2
proteasome 26S subunit, ATPase 2
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of PSMC2 mRNA
CTD
PMID:33854195
NCBI chr 7:103,347,524...103,369,395
Ensembl chr 7:103,328,570...103,370,346
G
PSMC4
proteasome 26S subunit, ATPase 4
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of PSMC4 mRNA
CTD
PMID:33854195
NCBI chr19:39,971,165...39,981,764
Ensembl chr19:39,971,165...39,981,764
G
PSMC5
proteasome 26S subunit, ATPase 5
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of PSMC5 mRNA
CTD
PMID:33854195
NCBI chr17:63,827,431...63,832,019
Ensembl chr17:63,827,152...63,832,026
G
PSMD2
proteasome 26S subunit ubiquitin receptor, non-ATPase 2
decreases expression
EXP
azoxystrobin results in decreased expression of PSMD2 mRNA
CTD
PMID:33512557
NCBI chr 3:184,299,241...184,309,050
Ensembl chr 3:184,299,198...184,309,050
G
PTK2B
protein tyrosine kinase 2 beta
decreases expression
EXP
azoxystrobin results in decreased expression of PTK2B mRNA
CTD
PMID:33512557
NCBI chr 8:27,310,506...27,459,391
Ensembl chr 8:27,311,482...27,459,391
G
PTPA
protein phosphatase 2 phosphatase activator
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of PTPA mRNA
CTD
PMID:33854195
NCBI chr 9:129,110,950...129,148,946
Ensembl chr 9:129,110,950...129,148,946
G
PTPRF
protein tyrosine phosphatase receptor type F
decreases expression
EXP
azoxystrobin results in decreased expression of PTPRF mRNA
CTD
PMID:33512557
NCBI chr 1:43,522,051...43,623,666
Ensembl chr 1:43,525,187...43,623,666
G
PUS1
pseudouridine synthase 1
decreases expression
EXP
azoxystrobin results in decreased expression of PUS1 mRNA
CTD
PMID:33512557
NCBI chr12:131,929,276...131,945,896
Ensembl chr12:131,929,200...131,945,896
G
PUS10
pseudouridine synthase 10
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of PUS10 mRNA
CTD
PMID:33854195
NCBI chr 2:60,940,223...61,018,259
Ensembl chr 2:60,940,222...61,018,259
G
PUS7
pseudouridine synthase 7
decreases expression
EXP
azoxystrobin results in decreased expression of PUS7 mRNA
CTD
PMID:33512557
NCBI chr 7:105,456,501...105,522,271
Ensembl chr 7:105,439,661...105,522,271
G
RAB11FIP2
RAB11 family interacting protein 2
increases expression
EXP
azoxystrobin results in increased expression of RAB11FIP2 mRNA
CTD
PMID:33512557
NCBI chr10:118,004,916...118,046,941
Ensembl chr10:118,004,916...118,046,941
G
RAB31
RAB31, member RAS oncogene family
decreases expression
EXP
azoxystrobin results in decreased expression of RAB31 mRNA
CTD
PMID:33512557
NCBI chr18:9,708,301...9,862,551
Ensembl chr18:9,708,275...9,862,551
G
RABEP1
rabaptin, RAB GTPase binding effector protein 1
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of RABEP1 mRNA
CTD
PMID:33854195
NCBI chr17:5,282,284...5,386,340
Ensembl chr17:5,282,265...5,386,340
G
RABL2B
RAB, member of RAS oncogene family like 2B
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of RABL2 mRNA
CTD
PMID:33854195
NCBI chr22:50,767,506...50,783,636
Ensembl chr22:50,767,501...50,783,667
G
RAMAC
RNA guanine-7 methyltransferase activating subunit
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of RAMAC gene
CTD
PMID:33854195
NCBI chr15:82,986,210...82,991,057
Ensembl chr15:82,986,210...82,991,057
G
RANGAP1
Ran GTPase activating protein 1
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of RANGAP1 mRNA
CTD
PMID:33854195
NCBI chr22:41,244,779...41,302,369
Ensembl chr22:41,244,779...41,286,187
G
RARS1
arginyl-tRNA synthetase 1
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of RARS1 mRNA
CTD
PMID:33854195
NCBI chr 5:168,486,471...168,519,301
Ensembl chr 5:168,486,451...168,519,301
G
RBM14
RNA binding motif protein 14
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of RBM14 mRNA
CTD
PMID:33854195
NCBI chr11:66,616,630...66,629,934
Ensembl chr11:66,616,626...66,629,934
G
RBM3
RNA binding motif protein 3
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of RBM3 mRNA
CTD
PMID:33854195
NCBI chr X:48,574,484...48,581,162
Ensembl chr X:48,574,449...48,581,162
G
RBPMS
RNA binding protein, mRNA processing factor
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of RBPMS gene
CTD
PMID:33854195
NCBI chr 8:30,384,541...30,572,256
Ensembl chr 8:30,384,511...30,572,256
G
RESF1
retroelement silencing factor 1
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of RESF1 mRNA
CTD
PMID:33854195
NCBI chr12:31,959,415...31,993,107
Ensembl chr12:31,959,370...31,993,107
G
REV1
REV1 DNA directed polymerase
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of REV1 mRNA
CTD
PMID:33854195
NCBI chr 2:99,400,477...99,490,202
Ensembl chr 2:99,400,475...99,490,035
G
RFX7
regulatory factor X7
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of RFX7 mRNA
CTD
PMID:33854195
NCBI chr15:56,087,280...56,245,082
Ensembl chr15:56,087,280...56,245,082
G
RGCC
regulator of cell cycle
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of RGCC gene
CTD
PMID:33854195
NCBI chr13:41,457,550...41,470,871
Ensembl chr13:41,457,550...41,470,871
G
RGS16
regulator of G protein signaling 16
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of RGS16 mRNA
CTD
PMID:33854195
NCBI chr 1:182,598,623...182,604,389
Ensembl chr 1:182,598,623...182,604,389
G
RHOBTB3
Rho related BTB domain containing 3
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of RHOBTB3 mRNA
CTD
PMID:33854195
NCBI chr 5:95,717,624...95,796,361
Ensembl chr 5:95,713,522...95,824,383
G
RNASE10
ribonuclease A family member 10 (inactive)
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of RNASE10 gene
CTD
PMID:33854195
NCBI chr14:20,504,233...20,513,884
Ensembl chr14:20,505,537...20,513,884
G
RND3
Rho family GTPase 3
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of RND3 gene; [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of RND3 mRNA
CTD
PMID:33854195
NCBI chr 2:150,468,193...150,487,695
Ensembl chr 2:150,468,195...150,539,011
G
RORC
RAR related orphan receptor C
increases activity multiple interactions
EXP ISO
azoxystrobin results in increased activity of RORC protein [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of RORC mRNA
CTD
PMID:20143881 PMID:33854195
NCBI chr 1:151,806,071...151,831,802
Ensembl chr 1:151,806,071...151,831,845
G
RPAP3
RNA polymerase II associated protein 3
decreases expression
EXP
azoxystrobin results in decreased expression of RPAP3 mRNA
CTD
PMID:33512557
NCBI chr12:47,661,249...47,706,030
Ensembl chr12:47,661,249...47,706,030
G
RPL11
ribosomal protein L11
increases expression
EXP
azoxystrobin results in increased expression of RPL11 mRNA
CTD
PMID:33512557
NCBI chr 1:23,691,779...23,696,835
Ensembl chr 1:23,691,742...23,696,835
G
RPL13A
ribosomal protein L13a
increases expression
EXP
azoxystrobin results in increased expression of RPL13A mRNA
CTD
PMID:33512557
NCBI chr19:49,487,608...49,492,308
Ensembl chr19:49,487,510...49,493,057
G
RPL17
ribosomal protein L17
increases expression
EXP
azoxystrobin results in increased expression of RPL17 mRNA
CTD
PMID:33512557
NCBI chr18:49,488,481...49,492,465
Ensembl chr18:49,488,453...49,492,508
G
RPL19
ribosomal protein L19
increases expression
EXP
azoxystrobin results in increased expression of RPL19 mRNA
CTD
PMID:33512557
NCBI chr17:39,200,283...39,204,732
Ensembl chr17:39,200,283...39,204,840
G
RPL22
ribosomal protein L22
increases expression
EXP
azoxystrobin results in increased expression of RPL22 mRNA
CTD
PMID:33512557
NCBI chr 1:6,185,020...6,199,595
Ensembl chr 1:6,185,020...6,209,389
G
RPL26
ribosomal protein L26
increases expression
EXP
azoxystrobin results in increased expression of RPL26 mRNA
CTD
PMID:33512557
NCBI chr17:8,377,516...8,383,193
Ensembl chr17:8,377,516...8,383,213
G
RPL32
ribosomal protein L32
increases expression
EXP
azoxystrobin results in increased expression of RPL32 mRNA
CTD
PMID:33512557
NCBI chr 3:12,834,485...12,841,582
Ensembl chr 3:12,834,485...12,841,582
G
RPL36
ribosomal protein L36
increases expression
EXP
azoxystrobin results in increased expression of RPL36 mRNA
CTD
PMID:33512557
NCBI chr19:5,690,295...5,691,875
Ensembl chr19:5,674,947...5,691,875
G
RPL36AL
ribosomal protein L36a like
increases expression
EXP
azoxystrobin results in increased expression of RPL36AL mRNA
CTD
PMID:33512557
NCBI chr14:49,618,530...49,620,626
Ensembl chr14:49,618,530...49,620,626
G
RPL4
ribosomal protein L4
increases expression
EXP
azoxystrobin results in increased expression of RPL4 mRNA
CTD
PMID:33512557
NCBI chr15:66,498,015...66,504,855
Ensembl chr15:66,498,015...66,524,532
G
RPL6
ribosomal protein L6
increases expression
EXP
azoxystrobin results in increased expression of RPL6 mRNA
CTD
PMID:33512557
NCBI chr12:112,405,181...112,418,835
Ensembl chr12:112,405,189...112,418,838
G
RPL8
ribosomal protein L8
increases expression
EXP
azoxystrobin results in increased expression of RPL8 mRNA
CTD
PMID:33512557
NCBI chr 8:144,789,769...144,792,390
Ensembl chr 8:144,789,765...144,792,587
G
RPL9
ribosomal protein L9
increases expression
EXP
azoxystrobin results in increased expression of RPL9 mRNA
CTD
PMID:33512557
NCBI chr 4:39,454,124...39,458,922
Ensembl chr 4:39,452,587...39,458,931
G
RPS13
ribosomal protein S13
increases expression
EXP
azoxystrobin results in increased expression of RPS13 mRNA
CTD
PMID:33512557
NCBI chr11:17,074,388...17,077,667
Ensembl chr11:17,074,388...17,077,715
G
RPS18
ribosomal protein S18
increases expression
EXP
azoxystrobin results in increased expression of RPS18 mRNA
CTD
PMID:33512557
NCBI chr 6:33,272,075...33,276,511
Ensembl chr 6:33,272,075...33,276,511
G
RPS2
ribosomal protein S2
increases expression
EXP
azoxystrobin results in increased expression of RPS2 mRNA
CTD
PMID:33512557
NCBI chr16:1,962,058...1,964,826
Ensembl chr16:1,962,058...1,964,841
G
RPS20
ribosomal protein S20
increases expression
EXP
azoxystrobin results in increased expression of RPS20 mRNA
CTD
PMID:33512557
NCBI chr 8:56,067,254...56,074,506
Ensembl chr 8:56,067,254...56,074,510
G
RPS25
ribosomal protein S25
increases expression
EXP
azoxystrobin results in increased expression of RPS25 mRNA
CTD
PMID:33512557
NCBI chr11:119,015,717...119,018,343
Ensembl chr11:119,015,712...119,018,691
G
RPS27A
ribosomal protein S27a
increases expression
EXP
azoxystrobin results in increased expression of RPS27A mRNA
CTD
PMID:33512557
NCBI chr 2:55,231,903...55,235,853
Ensembl chr 2:55,231,903...55,235,853
G
RPS27L
ribosomal protein S27 like
increases expression
EXP
azoxystrobin results in increased expression of RPS27L mRNA
CTD
PMID:33512557
NCBI chr15:63,148,249...63,157,477
Ensembl chr15:63,125,872...63,158,021
G
RPS5
ribosomal protein S5
increases expression
EXP
azoxystrobin results in increased expression of RPS5 mRNA
CTD
PMID:33512557
NCBI chr19:58,387,269...58,394,804
Ensembl chr19:58,386,400...58,394,806
G
RPS6
ribosomal protein S6
increases expression
EXP
azoxystrobin results in increased expression of RPS6 mRNA
CTD
PMID:33512557
NCBI chr 9:19,375,715...19,380,236
Ensembl chr 9:19,375,715...19,380,236
G
RPS7
ribosomal protein S7
increases expression
EXP
azoxystrobin results in increased expression of RPS7 mRNA
CTD
PMID:33512557
NCBI chr 2:3,575,260...3,580,920
Ensembl chr 2:3,575,260...3,580,920
G
RRP12
ribosomal RNA processing 12 homolog
decreases expression
EXP
azoxystrobin results in decreased expression of RRP12 mRNA
CTD
PMID:33512557
NCBI chr10:97,356,357...97,401,370
Ensembl chr10:97,356,358...97,426,076
G
RUVBL1
RuvB like AAA ATPase 1
increases expression
EXP
azoxystrobin results in increased expression of RUVBL1 mRNA
CTD
PMID:33512557
NCBI chr 3:128,064,785...128,153,914
Ensembl chr 3:128,064,778...128,153,914
G
RXYLT1
ribitol xylosyltransferase 1
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of RXYLT1 gene
CTD
PMID:33854195
NCBI chr12:63,779,909...63,809,562
Ensembl chr12:63,779,833...63,809,792
G
S100A4
S100 calcium binding protein A4
increases expression
EXP
azoxystrobin results in increased expression of S100A4 mRNA
CTD
PMID:33512557
NCBI chr 1:153,543,621...153,545,806
Ensembl chr 1:153,543,613...153,550,136
G
S100P
S100 calcium binding protein P
increases expression
EXP
azoxystrobin results in increased expression of S100P mRNA
CTD
PMID:32194361
NCBI chr 4:6,693,878...6,697,170
Ensembl chr 4:6,693,878...6,697,170
G
SALL4
spalt like transcription factor 4
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of SALL4 gene
CTD
PMID:33854195
NCBI chr20:51,782,331...51,802,521
Ensembl chr20:51,782,331...51,802,521
G
SARDH
sarcosine dehydrogenase
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of SARDH mRNA
CTD
PMID:33854195
NCBI chr 9:133,659,418...133,739,955
Ensembl chr 9:133,663,560...133,739,955
G
SATB1
SATB homeobox 1
decreases expression
EXP
azoxystrobin results in decreased expression of SATB1 mRNA
CTD
PMID:33512557
NCBI chr 3:18,345,377...18,445,592
Ensembl chr 3:18,345,377...18,445,621
G
SCNN1A
sodium channel epithelial 1 subunit alpha
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of SCNN1A mRNA
CTD
PMID:33854195
NCBI chr12:6,346,847...6,377,359
Ensembl chr12:6,346,843...6,377,730
G
SCRN1
secernin 1
decreases expression
EXP
azoxystrobin results in decreased expression of SCRN1 mRNA
CTD
PMID:33512557
NCBI chr 7:29,920,103...29,990,289
Ensembl chr 7:29,920,104...29,990,289
G
SDHB
succinate dehydrogenase complex iron sulfur subunit B
increases expression
EXP
azoxystrobin results in increased expression of SDHB mRNA
CTD
PMID:33512557
NCBI chr 1:17,018,722...17,054,032
Ensembl chr 1:17,018,664...17,054,032
G
SDK2
sidekick cell adhesion molecule 2
decreases expression
EXP
azoxystrobin results in decreased expression of SDK2 mRNA
CTD
PMID:33512557
NCBI chr17:73,334,384...73,644,445
Ensembl chr17:73,334,384...73,644,445
G
SDR42E1
short chain dehydrogenase/reductase family 42E, member 1
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of SDR42E1 mRNA
CTD
PMID:33854195
NCBI chr16:81,988,855...82,011,470
Ensembl chr16:81,988,855...82,011,481
G
SEC11A
SEC11 homolog A, signal peptidase complex subunit
increases expression
EXP
azoxystrobin results in increased expression of SEC11A mRNA
CTD
PMID:33512557
NCBI chr15:84,669,544...84,716,139
Ensembl chr15:84,669,538...84,716,460
G
SEMA4B
semaphorin 4B
decreases expression
EXP
azoxystrobin results in decreased expression of SEMA4B mRNA
CTD
PMID:33512557
NCBI chr15:90,184,920...90,229,661
Ensembl chr15:90,160,604...90,229,679
G
SEMA6D
semaphorin 6D
decreases expression
EXP
azoxystrobin results in decreased expression of SEMA6D mRNA
CTD
PMID:33512557
NCBI chr15:47,184,089...47,774,228
Ensembl chr15:47,184,101...47,774,228
G
SERPINA1
serpin family A member 1
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of SERPINA1 mRNA
CTD
PMID:33854195
NCBI chr14:94,376,747...94,390,635
Ensembl chr14:94,376,747...94,390,693
G
SESN2
sestrin 2
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of SESN2 mRNA
CTD
PMID:33854195
NCBI chr 1:28,259,518...28,282,491
Ensembl chr 1:28,259,518...28,282,491
G
SETD6
SET domain containing 6, protein lysine methyltransferase
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of SETD6 mRNA
CTD
PMID:33854195
NCBI chr16:58,515,479...58,523,842
Ensembl chr16:58,515,479...58,523,842
G
SFRP2
secreted frizzled related protein 2
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of SFRP2 gene
CTD
PMID:33854195
NCBI chr 4:153,780,591...153,789,083
Ensembl chr 4:153,780,591...153,789,083
G
SGK2
serum/glucocorticoid regulated kinase 2
affects expression
EXP
azoxystrobin affects the expression of SGK2 mRNA
CTD
PMID:33512557
NCBI chr20:43,559,027...43,585,627
Ensembl chr20:43,558,968...43,588,237
G
SH3BP2
SH3 domain binding protein 2
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of SH3BP2 mRNA
CTD
PMID:33854195
NCBI chr 4:2,793,085...2,841,096
Ensembl chr 4:2,793,071...2,841,098
G
SHC1
SHC adaptor protein 1
decreases expression
EXP
azoxystrobin results in decreased expression of SHC1 mRNA
CTD
PMID:33512557
NCBI chr 1:154,962,298...154,974,376
Ensembl chr 1:154,962,298...154,974,395
G
SIGIRR
single Ig and TIR domain containing
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of SIGIRR mRNA
CTD
PMID:33854195
NCBI chr11:405,716...417,397
Ensembl chr11:405,716...417,455
G
SIK2
salt inducible kinase 2
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of SIK2 mRNA
CTD
PMID:33854195
NCBI chr11:111,602,449...111,730,855
Ensembl chr11:111,602,449...111,730,855
G
SLC11A2
solute carrier family 11 member 2
decreases expression
EXP
azoxystrobin results in decreased expression of SLC11A2 mRNA
CTD
PMID:33512557
NCBI chr12:50,952,263...51,028,886
Ensembl chr12:50,979,401...51,028,566
G
SLC12A6
solute carrier family 12 member 6
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of SLC12A6 mRNA
CTD
PMID:33854195
NCBI chr15:34,229,784...34,338,057
Ensembl chr15:34,229,784...34,338,060
G
SLC17A6
solute carrier family 17 member 6
decreases expression
EXP
azoxystrobin results in decreased expression of SLC17A6 mRNA
CTD
PMID:33512557
NCBI chr11:22,338,381...22,379,503
Ensembl chr11:22,338,381...22,379,503
G
SLC1A2
solute carrier family 1 member 2
decreases expression
EXP
azoxystrobin results in decreased expression of SLC1A2 mRNA
CTD
PMID:33512557
NCBI chr11:35,251,205...35,420,507
Ensembl chr11:35,251,205...35,420,063
G
SLC20A1
solute carrier family 20 member 1
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of SLC20A1 mRNA
CTD
PMID:33854195
NCBI chr 2:112,645,939...112,663,825
Ensembl chr 2:112,645,939...112,663,825
G
SLC25A39
solute carrier family 25 member 39
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of SLC25A39 mRNA
CTD
PMID:33854195
NCBI chr17:44,319,628...44,324,823
Ensembl chr17:44,319,625...44,324,870
G
SLC25A4
solute carrier family 25 member 4
increases expression
EXP
azoxystrobin results in increased expression of SLC25A4 mRNA
CTD
PMID:33512557
NCBI chr 4:185,143,266...185,150,382
Ensembl chr 4:185,143,266...185,150,382
G
SLC25A5
solute carrier family 25 member 5
increases expression
EXP
azoxystrobin results in increased expression of SLC25A5 mRNA
CTD
PMID:33512557
NCBI chr X:119,468,444...119,471,396
Ensembl chr X:119,468,422...119,471,396
G
SLC25A6
solute carrier family 25 member 6
increases expression
EXP
azoxystrobin results in increased expression of SLC25A6 mRNA
CTD
PMID:33512557
NCBI chr X:1,386,152...1,392,113 NCBI chr Y:1,386,152...1,392,113
Ensembl chr X:1,386,152...1,392,113 Ensembl chr Y:1,386,152...1,392,113
G
SLC26A6
solute carrier family 26 member 6
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of SLC26A6 mRNA
CTD
PMID:33854195
NCBI chr 3:48,625,723...48,635,461
Ensembl chr 3:48,625,723...48,635,493
G
SLC37A2
solute carrier family 37 member 2
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of SLC37A2 mRNA
CTD
PMID:33854195
NCBI chr11:125,063,305...125,090,516
Ensembl chr11:125,063,302...125,090,516
G
SLC3A2
solute carrier family 3 member 2
decreases expression
EXP
azoxystrobin results in decreased expression of SLC3A2 mRNA
CTD
PMID:33512557
NCBI chr11:62,856,109...62,888,860
Ensembl chr11:62,856,004...62,888,880
G
SLC7A5
solute carrier family 7 member 5
affects expression
EXP
azoxystrobin affects the expression of SLC7A5 mRNA
CTD
PMID:33512557
NCBI chr16:87,830,023...87,869,507
Ensembl chr16:87,830,023...87,869,507
G
SLK
STE20 like kinase
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of SLK gene
CTD
PMID:33854195
NCBI chr10:103,967,140...104,029,233
Ensembl chr10:103,967,140...104,029,233
G
SMAD3
SMAD family member 3
decreases expression
EXP
azoxystrobin results in decreased expression of SMAD3 mRNA
CTD
PMID:33512557
NCBI chr15:67,065,602...67,195,169
Ensembl chr15:67,063,763...67,195,173
G
SMAD7
SMAD family member 7
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of SMAD7 mRNA
CTD
PMID:33854195
NCBI chr18:48,919,853...48,950,965
Ensembl chr18:48,919,853...48,950,965
G
SMPX
small muscle protein X-linked
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of SMPX gene
CTD
PMID:33854195
NCBI chr X:21,705,978...21,758,116
Ensembl chr X:21,705,978...21,758,116
G
SNCA
synuclein alpha
increases expression
EXP
azoxystrobin results in increased expression of SNCA mRNA
CTD
PMID:33512557
NCBI chr 4:89,724,099...89,838,304
Ensembl chr 4:89,700,345...89,838,315
G
SNRNP200
small nuclear ribonucleoprotein U5 subunit 200
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of SNRNP200 mRNA
CTD
PMID:33854195
NCBI chr 2:96,274,338...96,305,546
Ensembl chr 2:96,274,338...96,321,271
G
SNX13
sorting nexin 13
decreases expression
EXP
azoxystrobin results in decreased expression of SNX13 mRNA
CTD
PMID:33512557
NCBI chr 7:17,790,761...17,940,494
Ensembl chr 7:17,790,761...17,940,501
G
SNX4
sorting nexin 4
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of SNX4 mRNA
CTD
PMID:33854195
NCBI chr 3:125,446,650...125,520,202
Ensembl chr 3:125,446,650...125,520,202
G
SOCS2
suppressor of cytokine signaling 2
decreases expression
EXP
azoxystrobin results in decreased expression of SOCS2 mRNA
CTD
PMID:33512557
NCBI chr12:93,569,969...93,626,236
Ensembl chr12:93,569,814...93,583,487
G
SOCS3
suppressor of cytokine signaling 3
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of SOCS3 mRNA
CTD
PMID:33854195
NCBI chr17:78,356,778...78,360,925
Ensembl chr17:78,356,778...78,360,077
G
SOD3
superoxide dismutase 3
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of SOD3 mRNA
CTD
PMID:33854195
NCBI chr 4:24,795,573...24,800,842
Ensembl chr 4:24,789,912...24,800,842
G
SOHLH1
spermatogenesis and oogenesis specific basic helix-loop-helix 1
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of SOHLH1 gene
CTD
PMID:33854195
NCBI chr 9:135,693,407...135,702,112
Ensembl chr 9:135,693,407...135,704,498
G
SOX9
SRY-box transcription factor 9
decreases expression
EXP
azoxystrobin results in decreased expression of SOX9 mRNA
CTD
PMID:33512557
NCBI chr17:72,121,020...72,126,416
Ensembl chr17:72,121,020...72,126,416
G
SPAG1
sperm associated antigen 1
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of SPAG1 mRNA
CTD
PMID:33854195
NCBI chr 8:100,158,038...100,241,904
Ensembl chr 8:100,157,906...100,259,278
G
SPAG5
sperm associated antigen 5
increases expression
EXP
azoxystrobin results in increased expression of SPAG5 mRNA
CTD
PMID:33512557
NCBI chr17:28,577,574...28,599,025
Ensembl chr17:28,577,565...28,599,025
G
SPDEF
SAM pointed domain containing ETS transcription factor
decreases expression
EXP
azoxystrobin results in decreased expression of SPDEF mRNA
CTD
PMID:33512557
NCBI chr 6:34,537,802...34,556,329
Ensembl chr 6:34,537,802...34,556,333
G
SPRED2
sprouty related EVH1 domain containing 2
decreases expression
EXP
azoxystrobin results in decreased expression of SPRED2 mRNA
CTD
PMID:33512557
NCBI chr 2:65,307,175...65,432,599
Ensembl chr 2:65,310,851...65,432,637
G
SRD5A1
steroid 5 alpha-reductase 1
decreases expression
EXP
azoxystrobin results in decreased expression of SRD5A1 mRNA
CTD
PMID:33512557
NCBI chr 5:6,633,440...6,674,386
Ensembl chr 5:6,633,290...6,676,539
G
SRD5A2
steroid 5 alpha-reductase 2
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of SRD5A2 gene
CTD
PMID:33854195
NCBI chr 2:31,522,480...31,663,009
Ensembl chr 2:31,522,480...31,580,938
G
SREBF1
sterol regulatory element binding transcription factor 1
multiple interactions
ISO
[azoxystrobin co-treated with Dietary Fats] affects the expression of SREBF1 mRNA
CTD
PMID:24726979
NCBI chr17:17,811,334...17,836,986
Ensembl chr17:17,810,399...17,837,002
G
SRM
spermidine synthase
increases expression
EXP
azoxystrobin results in increased expression of SRM mRNA
CTD
PMID:33512557
NCBI chr 1:11,054,589...11,060,018
Ensembl chr 1:11,054,584...11,060,020
G
SRP72
signal recognition particle 72
increases expression
EXP
azoxystrobin results in increased expression of SRP72 mRNA
CTD
PMID:33512557
NCBI chr 4:56,467,617...56,503,681
Ensembl chr 4:56,467,617...56,503,681
G
SRRM2
serine/arginine repetitive matrix 2
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of SRRM2 mRNA
CTD
PMID:33854195
NCBI chr16:2,752,638...2,771,412
Ensembl chr16:2,752,626...2,772,538
G
SRSF2
serine and arginine rich splicing factor 2
increases expression
EXP
azoxystrobin results in increased expression of SRSF2 mRNA
CTD
PMID:33512557
NCBI chr17:76,734,115...76,737,411
Ensembl chr17:76,734,115...76,737,333
G
SRSF5
serine and arginine rich splicing factor 5
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of SRSF5 mRNA
CTD
PMID:33854195
NCBI chr14:69,767,142...69,772,005
Ensembl chr14:69,726,900...69,772,005
G
STARD9
StAR related lipid transfer domain containing 9
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of STARD9 mRNA
CTD
PMID:33854195
NCBI chr15:42,575,606...42,720,998
Ensembl chr15:42,575,606...42,720,998
G
STAT4
signal transducer and activator of transcription 4
decreases expression
EXP
azoxystrobin results in decreased expression of STAT4 mRNA
CTD
PMID:33512557
NCBI chr 2:191,029,576...191,151,596
Ensembl chr 2:191,029,576...191,151,596
G
STK10
serine/threonine kinase 10
decreases expression
EXP
azoxystrobin results in decreased expression of STK10 mRNA
CTD
PMID:33512557
NCBI chr 5:172,042,079...172,188,224
Ensembl chr 5:172,042,079...172,188,224
G
STK25
serine/threonine kinase 25
decreases expression
EXP
azoxystrobin results in decreased expression of STK25 mRNA
CTD
PMID:33512557
NCBI chr 2:241,492,670...241,509,572
Ensembl chr 2:241,492,670...241,509,730
G
STMN1
stathmin 1
increases expression
EXP
azoxystrobin results in increased expression of STMN1 mRNA
CTD
PMID:33512557
NCBI chr 1:25,884,179...25,906,880
Ensembl chr 1:25,884,181...25,906,991
G
SUSD2
sushi domain containing 2
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of SUSD2 mRNA
CTD
PMID:33854195
NCBI chr22:24,181,487...24,189,106
Ensembl chr22:24,181,487...24,189,106
G
SUV39H1
SUV39H1 histone lysine methyltransferase
decreases expression
EXP
azoxystrobin results in decreased expression of SUV39H1 mRNA
CTD
PMID:33512557
NCBI chr X:48,695,554...48,709,016
Ensembl chr X:48,695,554...48,709,016
G
SYMPK
symplekin scaffold protein
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of SYMPK mRNA
CTD
PMID:33854195
NCBI chr19:45,815,410...45,863,147
Ensembl chr19:45,815,410...45,863,194
G
SYNGR3
synaptogyrin 3
decreases expression
EXP
azoxystrobin results in decreased expression of SYNGR3 mRNA
CTD
PMID:33512557
NCBI chr16:1,989,970...1,994,275
Ensembl chr16:1,989,660...1,994,275
G
TACC3
transforming acidic coiled-coil containing protein 3
increases expression
EXP
azoxystrobin results in increased expression of TACC3 mRNA
CTD
PMID:33512557
NCBI chr 4:1,721,521...1,745,171
Ensembl chr 4:1,712,858...1,745,171
G
TAGLN
transgelin
increases expression
EXP
azoxystrobin results in increased expression of TAGLN mRNA
CTD
PMID:33512557
NCBI chr11:117,199,294...117,207,465
Ensembl chr11:117,199,370...117,207,464
G
TAT
tyrosine aminotransferase
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of TAT mRNA
CTD
PMID:33854195
NCBI chr16:71,565,660...71,577,092
Ensembl chr16:71,565,660...71,577,092
G
TBC1D4
TBC1 domain family member 4
multiple interactions
ISO
[azoxystrobin co-treated with Dietary Fats] affects the phosphorylation of TBC1D4 protein
CTD
PMID:24726979
NCBI chr13:75,283,503...75,482,169
Ensembl chr13:75,283,503...75,482,169
G
TCEAL4
transcription elongation factor A like 4
decreases expression
EXP
azoxystrobin results in decreased expression of TCEAL4 mRNA
CTD
PMID:33512557
NCBI chr X:103,576,231...103,587,729
Ensembl chr X:103,576,231...103,587,729
G
TCEAL9
transcription elongation factor A like 9
increases expression
EXP
azoxystrobin results in increased expression of TCEAL9 mRNA
CTD
PMID:33512557
NCBI chr X:103,356,506...103,358,462
Ensembl chr X:103,356,489...103,358,462
G
TDP2
tyrosyl-DNA phosphodiesterase 2
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of TDP2 mRNA
CTD
PMID:33854195
NCBI chr 6:24,649,979...24,666,899
Ensembl chr 6:24,649,979...24,666,930
G
TEAD2
TEA domain transcription factor 2
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of TEAD2 mRNA
CTD
PMID:33854195
NCBI chr19:49,340,595...49,362,416
Ensembl chr19:49,340,595...49,362,457
G
TECR
trans-2,3-enoyl-CoA reductase
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of TECR mRNA
CTD
PMID:33854195
NCBI chr19:14,527,726...14,565,980
Ensembl chr19:14,517,085...14,565,980
G
TERF2IP
TERF2 interacting protein
decreases expression
EXP
azoxystrobin results in decreased expression of TERF2IP mRNA
CTD
PMID:33512557
NCBI chr16:75,647,773...75,657,432
Ensembl chr16:75,647,773...75,761,872
G
TERT
telomerase reverse transcriptase
decreases expression
EXP
azoxystrobin results in decreased expression of TERT mRNA
CTD
PMID:33512557
NCBI chr 5:1,253,167...1,295,068
Ensembl chr 5:1,253,147...1,295,068
G
TGDS
TDP-glucose 4,6-dehydratase
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of TGDS mRNA
CTD
PMID:33854195
NCBI chr13:94,574,054...94,596,273
Ensembl chr13:94,574,054...94,596,242
G
TGFB1
transforming growth factor beta 1
increases expression
EXP
azoxystrobin results in increased expression of TGFB1 mRNA
CTD
PMID:33512557
NCBI chr19:41,330,323...41,353,922
Ensembl chr19:41,301,587...41,353,922
G
TGFB3
transforming growth factor beta 3
decreases expression
EXP
azoxystrobin results in decreased expression of TGFB3 mRNA
CTD
PMID:33512557
NCBI chr14:75,958,097...75,983,011
Ensembl chr14:75,958,097...75,983,011
G
TGFBI
transforming growth factor beta induced
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of TGFBI mRNA
CTD
PMID:33854195
NCBI chr 5:136,028,988...136,063,818
Ensembl chr 5:136,028,988...136,063,818
G
TGFBR2
transforming growth factor beta receptor 2
decreases expression
EXP
azoxystrobin results in decreased expression of TGFBR2 mRNA
CTD
PMID:33512557
NCBI chr 3:30,606,356...30,694,142
Ensembl chr 3:30,606,601...30,694,142
G
TIMMDC1
translocase of inner mitochondrial membrane domain containing 1
increases expression
EXP
azoxystrobin results in increased expression of TIMMDC1 mRNA
CTD
PMID:33512557
NCBI chr 3:119,498,547...119,525,090
Ensembl chr 3:119,498,547...119,525,090
G
TJAP1
tight junction associated protein 1
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of TJAP1 mRNA
CTD
PMID:33854195
NCBI chr 6:43,477,570...43,506,554
Ensembl chr 6:43,477,523...43,506,556
G
TKT
transketolase
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of TKT mRNA
CTD
PMID:33854195
NCBI chr 3:53,224,712...53,256,022
Ensembl chr 3:53,224,712...53,256,052
G
TM7SF3
transmembrane 7 superfamily member 3
increases expression
EXP
azoxystrobin results in increased expression of TM7SF3 mRNA
CTD
PMID:33512557
NCBI chr12:26,971,579...27,014,384
Ensembl chr12:26,971,579...27,014,434
G
TMBIM6
transmembrane BAX inhibitor motif containing 6
multiple interactions increases expression
ISO EXP
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of TMBIM6 mRNA azoxystrobin results in increased expression of TMBIM6 mRNA
CTD
PMID:33512557 PMID:33854195
NCBI chr12:49,741,557...49,764,934
Ensembl chr12:49,707,725...49,764,934
G
TMEM185A
transmembrane protein 185A
decreases expression
EXP
azoxystrobin results in decreased expression of TMEM185A mRNA
CTD
PMID:33512557
NCBI chr X:149,596,556...149,631,792
Ensembl chr X:149,596,556...149,631,912
G
TMEM268
transmembrane protein 268
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of TMEM268 mRNA
CTD
PMID:33854195
NCBI chr 9:114,603,904...114,646,422
Ensembl chr 9:114,611,206...114,646,422
G
TMEM65
transmembrane protein 65
decreases expression
EXP
azoxystrobin results in decreased expression of TMEM65 mRNA
CTD
PMID:33512557
NCBI chr 8:124,306,189...124,372,701
Ensembl chr 8:124,306,189...124,372,701
G
TMEM97
transmembrane protein 97
increases expression
EXP
azoxystrobin results in increased expression of TMEM97 mRNA
CTD
PMID:33512557
NCBI chr17:28,319,200...28,328,685
Ensembl chr17:28,319,200...28,328,685
G
TMT1B
thiol methyltransferase 1B
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of METTL7B mRNA
CTD
PMID:33854195
NCBI chr12:55,681,736...55,684,611
Ensembl chr12:55,681,736...55,684,611
G
TNC
tenascin C
decreases expression
EXP
azoxystrobin results in decreased expression of TNC mRNA
CTD
PMID:33512557
NCBI chr 9:115,019,575...115,118,157
Ensembl chr 9:115,019,575...115,118,207
G
TNF
tumor necrosis factor
multiple interactions
ISO
Acetylcysteine inhibits the reaction [azoxystrobin inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein]]; azoxystrobin inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein]
CTD
PMID:33226166
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
G
TNFAIP2
TNF alpha induced protein 2
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of TNFAIP2 mRNA
CTD
PMID:33854195
NCBI chr14:103,121,469...103,137,439
Ensembl chr14:103,121,476...103,137,439
G
TNFRSF10B
TNF receptor superfamily member 10b
increases expression
EXP
azoxystrobin results in increased expression of TNFRSF10B mRNA
CTD
PMID:33512557
NCBI chr 8:23,020,133...23,069,031
Ensembl chr 8:23,020,133...23,069,031
G
TNIP1
TNFAIP3 interacting protein 1
decreases expression
EXP
azoxystrobin results in decreased expression of TNIP1 mRNA
CTD
PMID:33512557
NCBI chr 5:151,029,943...151,087,685
Ensembl chr 5:151,029,945...151,093,577
G
TOR3A
torsin family 3 member A
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of TOR3A mRNA
CTD
PMID:33854195
NCBI chr 1:179,082,070...179,095,996
Ensembl chr 1:179,082,070...179,098,023
G
TPM1
tropomyosin 1
decreases expression
EXP
azoxystrobin results in decreased expression of TPM1 mRNA
CTD
PMID:33512557
NCBI chr15:63,042,747...63,071,915
Ensembl chr15:63,042,620...63,071,915
G
TPX2
TPX2 microtubule nucleation factor
increases expression
EXP
azoxystrobin results in increased expression of TPX2 mRNA
CTD
PMID:33512557
NCBI chr20:31,739,290...31,801,800
Ensembl chr20:31,739,271...31,801,805
G
TRAF3IP2
TRAF3 interacting protein 2
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of TRAF3IP2 mRNA
CTD
PMID:33854195
NCBI chr 6:111,555,381...111,605,878
Ensembl chr 6:111,555,381...111,606,906
G
TRAFD1
TRAF-type zinc finger domain containing 1
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of TRAFD1 mRNA
CTD
PMID:33854195
NCBI chr12:112,125,560...112,153,604
Ensembl chr12:112,125,538...112,153,604
G
TRIB3
tribbles pseudokinase 3
increases expression
EXP
azoxystrobin results in increased expression of TRIB3 mRNA
CTD
PMID:33512557
NCBI chr20:380,760...397,559
Ensembl chr20:362,835...397,559
G
TRIM13
tripartite motif containing 13
decreases expression
EXP
azoxystrobin results in decreased expression of TRIM13 mRNA
CTD
PMID:33512557
NCBI chr13:49,997,042...50,018,467
Ensembl chr13:49,995,888...50,020,481
G
TRIM34
tripartite motif containing 34
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of TRIM34 mRNA
CTD
PMID:33854195
NCBI chr11:5,619,944...5,644,398
Ensembl chr11:5,619,764...5,644,398
G
TRPV1
transient receptor potential cation channel subfamily V member 1
decreases expression
EXP
azoxystrobin results in decreased expression of TRPV1 mRNA
CTD
PMID:33512557
NCBI chr17:3,565,446...3,609,411
Ensembl chr17:3,565,444...3,609,411
G
TSC22D3
TSC22 domain family member 3
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of TSC22D3 mRNA
CTD
PMID:33854195
NCBI chr X:107,713,221...107,775,988
Ensembl chr X:107,713,221...107,777,342
G
TSPAN3
tetraspanin 3
decreases expression
EXP
azoxystrobin results in decreased expression of TSPAN3 mRNA
CTD
PMID:33512557
NCBI chr15:77,041,404...77,071,109
Ensembl chr15:77,041,404...77,083,984
G
TST
thiosulfate sulfurtransferase
decreases expression
EXP
azoxystrobin results in decreased expression of TST mRNA
CTD
PMID:33512557
NCBI chr22:37,010,859...37,020,183
Ensembl chr22:37,010,859...37,020,183
G
TUBA1B
tubulin alpha 1b
increases expression
EXP
azoxystrobin results in increased expression of TUBA1B mRNA
CTD
PMID:33512557
NCBI chr12:49,127,782...49,131,395
Ensembl chr12:49,127,782...49,131,397
G
TUBB2A
tubulin beta 2A class IIa
decreases expression
EXP
azoxystrobin results in decreased expression of TUBB2A mRNA
CTD
PMID:33512557
NCBI chr 6:3,153,666...3,157,544
Ensembl chr 6:3,153,497...3,157,544
G
TUBB2B
tubulin beta 2B class IIb
decreases expression
EXP
azoxystrobin results in decreased expression of TUBB2B mRNA
CTD
PMID:33512557
NCBI chr 6:3,224,277...3,227,653
Ensembl chr 6:3,223,324...3,231,730
G
TXNIP
thioredoxin interacting protein
decreases expression
EXP
azoxystrobin results in decreased expression of TXNIP mRNA
CTD
PMID:33512557
NCBI chr 1:145,992,435...145,996,579
Ensembl chr 1:145,992,435...145,996,579
G
TYMS
thymidylate synthetase
affects expression
EXP
azoxystrobin affects the expression of TYMS mRNA
CTD
PMID:33512557
NCBI chr18:657,653...673,578
Ensembl chr18:657,653...673,578
G
UBA3
ubiquitin like modifier activating enzyme 3
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of UBA3 mRNA
CTD
PMID:33854195
NCBI chr 3:69,054,730...69,080,373
Ensembl chr 3:69,054,730...69,080,408
G
UBB
ubiquitin B
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of UBB mRNA
CTD
PMID:33854195
NCBI chr17:16,380,779...16,382,745
Ensembl chr17:16,380,798...16,382,745
G
UBC
ubiquitin C
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of UBC mRNA
CTD
PMID:33854195
NCBI chr12:124,911,646...124,914,650
Ensembl chr12:124,911,604...124,917,368
G
UBE2C
ubiquitin conjugating enzyme E2 C
increases expression
EXP
azoxystrobin results in increased expression of UBE2C mRNA
CTD
PMID:33512557
NCBI chr20:45,812,644...45,816,952
Ensembl chr20:45,812,576...45,816,957
G
UCHL1
ubiquitin C-terminal hydrolase L1
decreases expression
EXP
azoxystrobin results in decreased expression of UCHL1 mRNA
CTD
PMID:33512557
NCBI chr 4:41,256,928...41,268,455
Ensembl chr 4:41,256,413...41,268,455
G
UCKL1
uridine-cytidine kinase 1 like 1
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of UCKL1 mRNA
CTD
PMID:33854195
NCBI chr20:63,939,829...63,956,416
Ensembl chr20:63,939,829...63,956,416
G
UHRF1
ubiquitin like with PHD and ring finger domains 1
decreases expression
EXP
azoxystrobin results in decreased expression of UHRF1 mRNA
CTD
PMID:33512557
NCBI chr19:4,903,080...4,962,154
Ensembl chr19:4,903,080...4,962,154
G
UNC45A
unc-45 myosin chaperone A
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of UNC45A mRNA
CTD
PMID:33854195
NCBI chr15:90,930,180...90,954,093
Ensembl chr15:90,930,180...90,954,093
G
USP2
ubiquitin specific peptidase 2
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of USP2 mRNA
CTD
PMID:33854195
NCBI chr11:119,355,215...119,381,690
Ensembl chr11:119,355,215...119,381,711
G
USP40
ubiquitin specific peptidase 40
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of USP40 mRNA
CTD
PMID:33854195
NCBI chr 2:233,475,526...233,566,782
Ensembl chr 2:233,475,526...233,566,782
G
USP7
ubiquitin specific peptidase 7
decreases expression
EXP
azoxystrobin results in decreased expression of USP7 mRNA
CTD
PMID:33512557
NCBI chr16:8,892,097...8,963,906
Ensembl chr16:8,892,097...8,975,328
G
VDAC1
voltage dependent anion channel 1
increases expression
EXP
azoxystrobin results in increased expression of VDAC1 mRNA
CTD
PMID:33512557
NCBI chr 5:133,971,871...134,114,540
Ensembl chr 5:133,971,871...134,004,975
G
VEGFA
vascular endothelial growth factor A
multiple interactions affects expression
ISO EXP
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of VEGFA mRNA azoxystrobin affects the expression of VEGFA mRNA
CTD
PMID:33512557 PMID:33854195
NCBI chr 6:43,770,211...43,786,487
Ensembl chr 6:43,770,184...43,786,487
G
VEGFD
vascular endothelial growth factor D
decreases expression
EXP
azoxystrobin results in decreased expression of VEGFD mRNA
CTD
PMID:33512557
NCBI chr X:15,345,596...15,384,413
Ensembl chr X:15,345,596...15,384,413
G
VIM
vimentin
increases expression
EXP
azoxystrobin results in increased expression of VIM mRNA
CTD
PMID:33512557
NCBI chr10:17,228,241...17,237,593
Ensembl chr10:17,228,241...17,237,593
G
VNN3P
vanin 3, pseudogene
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of VNN3 mRNA
CTD
PMID:33854195
NCBI chr 6:132,722,787...132,734,765
Ensembl chr 6:132,722,784...132,736,935 Ensembl chr 6:132,722,784...132,736,935
G
VTN
vitronectin
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of VTN mRNA
CTD
PMID:33854195
NCBI chr17:28,367,284...28,370,307
Ensembl chr17:28,367,284...28,373,091
G
WDR11
WD repeat domain 11
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of WDR11 gene
CTD
PMID:33854195
NCBI chr10:120,851,362...120,909,524
Ensembl chr10:120,851,305...120,909,524
G
WDR3
WD repeat domain 3
decreases expression
EXP
azoxystrobin results in decreased expression of WDR3 mRNA
CTD
PMID:33512557
NCBI chr 1:117,929,739...117,966,543
Ensembl chr 1:117,929,720...117,966,543
G
WDTC1
WD and tetratricopeptide repeats 1
decreases expression
EXP
azoxystrobin results in decreased expression of WDTC1 mRNA
CTD
PMID:33512557
NCBI chr 1:27,234,441...27,308,636
Ensembl chr 1:27,234,632...27,308,636
G
WEE1
WEE1 G2 checkpoint kinase
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of WEE1 mRNA
CTD
PMID:33854195
NCBI chr11:9,573,670...9,589,985
Ensembl chr11:9,573,670...9,593,457
G
WFDC9
WAP four-disulfide core domain 9
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of WFDC9 gene
CTD
PMID:33854195
NCBI chr20:45,607,939...45,631,284
Ensembl chr20:45,607,939...45,631,284
G
WNT5A
Wnt family member 5A
decreases expression
EXP
azoxystrobin results in decreased expression of WNT5A mRNA
CTD
PMID:33512557
NCBI chr 3:55,465,715...55,505,263
Ensembl chr 3:55,465,715...55,490,539
G
YOD1
YOD1 deubiquitinase
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of YOD1 gene
CTD
PMID:33854195
NCBI chr 1:207,043,849...207,053,116
Ensembl chr 1:207,043,849...207,052,980
G
YWHAB
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein beta
decreases expression
EXP
azoxystrobin results in decreased expression of YWHAB mRNA
CTD
PMID:33512557
NCBI chr20:44,885,705...44,908,532
Ensembl chr20:44,885,702...44,908,532
G
ZDHHC16
zinc finger DHHC-type palmitoyltransferase 16
decreases expression
EXP
azoxystrobin results in decreased expression of ZDHHC16 mRNA
CTD
PMID:33512557
NCBI chr10:97,446,175...97,457,370
Ensembl chr10:97,446,170...97,457,370
G
ZFAND2A
zinc finger AN1-type containing 2A
increases expression
EXP
azoxystrobin results in increased expression of ZFAND2A mRNA
CTD
PMID:33512557
NCBI chr 7:1,148,850...1,160,196
Ensembl chr 7:1,152,071...1,160,759
G
ZFC3H1
zinc finger C3H1-type containing
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of ZFC3H1 mRNA
CTD
PMID:33854195
NCBI chr12:71,609,599...71,663,848
Ensembl chr12:71,609,599...71,667,725
G
ZFP36L2
ZFP36 ring finger protein like 2
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of ZFP36L2 mRNA
CTD
PMID:33854195
NCBI chr 2:43,222,402...43,226,606
Ensembl chr 2:43,222,402...43,226,606
G
ZMYM3
zinc finger MYM-type containing 3
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of ZMYM3 mRNA
CTD
PMID:33854195
NCBI chr X:71,239,624...71,255,290
Ensembl chr X:71,239,624...71,255,146
G
ZMYM6
zinc finger MYM-type containing 6
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of ZMYM6 mRNA
CTD
PMID:33854195
NCBI chr 1:34,986,165...35,031,945
Ensembl chr 1:34,986,165...35,031,945
G
ZNF22
zinc finger protein 22
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of ZFP422 mRNA
CTD
PMID:33854195
NCBI chr10:45,000,923...45,005,326
Ensembl chr10:45,000,923...45,005,326
G
ZNF280D
zinc finger protein 280D
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of ZFP280D mRNA
CTD
PMID:33854195
NCBI chr15:56,630,176...56,733,509
Ensembl chr15:56,630,176...56,734,086
G
ZNF586
zinc finger protein 586
decreases expression
EXP
azoxystrobin results in decreased expression of ZNF586 mRNA
CTD
PMID:33512557
NCBI chr19:57,769,676...57,780,616
Ensembl chr19:57,769,655...57,819,939
G
ZNF587
zinc finger protein 587
decreases expression
EXP
azoxystrobin results in decreased expression of ZNF587 mRNA
CTD
PMID:33512557
NCBI chr19:57,849,859...57,865,117
Ensembl chr19:57,849,859...57,865,117
G
ZNF589
zinc finger protein 589
decreases expression
EXP
azoxystrobin results in decreased expression of ZNF589 mRNA
CTD
PMID:33512557
NCBI chr 3:48,241,104...48,270,990
Ensembl chr 3:48,241,100...48,299,253
G
ZNF598
zinc finger protein 598, E3 ubiquitin ligase
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of ZFP598 mRNA
CTD
PMID:33854195
NCBI chr16:1,997,654...2,009,821
Ensembl chr16:1,997,654...2,009,821
G
ZRANB2
zinc finger RANBP2-type containing 2
multiple interactions
ISO
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of ZRANB2 mRNA
CTD
PMID:33854195
NCBI chr 1:71,063,291...71,081,035
Ensembl chr 1:71,063,291...71,081,289
G
AHI1
Abelson helper integration site 1
increases expression
EXP
Homoharringtonine results in increased expression of AHI1 protein alternative form
CTD
PMID:19379585
NCBI chr 6:135,283,532...135,497,740
Ensembl chr 6:135,283,407...135,498,434
G
AKT1
AKT serine/threonine kinase 1
decreases phosphorylation
EXP
Homoharringtonine results in decreased phosphorylation of AKT1 protein
CTD
PMID:31726078
NCBI chr14:104,769,349...104,795,748
Ensembl chr14:104,769,349...104,795,751
G
BAD
BCL2 associated agonist of cell death
increases expression
EXP
Homoharringtonine results in increased expression of BAD protein
CTD
PMID:31726078
NCBI chr11:64,269,828...64,284,704
Ensembl chr11:64,269,830...64,284,704
G
BAX
BCL2 associated X, apoptosis regulator
increases expression
EXP
Homoharringtonine results in increased expression of BAX protein
CTD
PMID:31726078
NCBI chr19:48,954,875...48,961,798
Ensembl chr19:48,954,815...48,961,798
G
BCL2
BCL2 apoptosis regulator
decreases expression
EXP
Homoharringtonine results in decreased expression of BCL2 protein
CTD
PMID:23980369 PMID:31726078
NCBI chr18:63,123,346...63,320,090
Ensembl chr18:63,123,346...63,320,128
G
CASP3
caspase 3
increases expression increases cleavage
EXP
Homoharringtonine results in increased expression of CASP3 protein Homoharringtonine results in increased cleavage of CASP3 protein
CTD
PMID:23980369 PMID:31726078
NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062
G
CASP7
caspase 7
increases cleavage
EXP
Homoharringtonine results in increased cleavage of CASP7 protein
CTD
PMID:31726078
NCBI chr10:113,679,194...113,730,909
Ensembl chr10:113,679,162...113,730,907
G
CASP9
caspase 9
increases expression increases cleavage
EXP
Homoharringtonine results in increased expression of CASP9 protein Homoharringtonine results in increased cleavage of CASP9 protein
CTD
PMID:23980369 PMID:31726078
NCBI chr 1:15,491,401...15,524,912
Ensembl chr 1:15,490,832...15,526,534
G
CCNA2
cyclin A2
decreases expression
EXP
Homoharringtonine results in decreased expression of CCNA2 protein
CTD
PMID:31726078
NCBI chr 4:121,816,444...121,823,883
Ensembl chr 4:121,816,444...121,823,883
G
CCNB1
cyclin B1
decreases expression
EXP
Homoharringtonine results in decreased expression of CCNB1 protein
CTD
PMID:31726078
NCBI chr 5:69,167,150...69,178,245
Ensembl chr 5:69,167,135...69,178,245
G
CCNE1
cyclin E1
increases expression
EXP
Homoharringtonine results in increased expression of CCNE1 protein
CTD
PMID:31726078
NCBI chr19:29,811,991...29,824,312
Ensembl chr19:29,811,991...29,824,312
G
CD34
CD34 molecule
decreases expression multiple interactions
EXP
Homoharringtonine results in decreased expression of CD34 mRNA Arsenic Trioxide promotes the reaction [Homoharringtonine results in decreased expression of CD34 mRNA]
CTD
PMID:31307525
NCBI chr 1:207,880,972...207,911,125
Ensembl chr 1:207,880,972...207,911,402
G
CD38
CD38 molecule
multiple interactions increases expression
EXP
[Arsenic Trioxide co-treated with Homoharringtonine] results in increased expression of CD38 mRNA Homoharringtonine results in increased expression of CD38 mRNA
CTD
PMID:31307525
NCBI chr 4:15,778,328...15,853,232
Ensembl chr 4:15,778,275...15,853,232
G
CD96
CD96 molecule
multiple interactions
EXP
[Arsenic Trioxide co-treated with Homoharringtonine] results in decreased expression of CD96 mRNA
CTD
PMID:31307525
NCBI chr 3:111,542,197...111,665,996
Ensembl chr 3:111,292,719...111,665,750
G
CDK1
cyclin dependent kinase 1
increases expression
EXP
Homoharringtonine results in increased expression of CDK1 protein
CTD
PMID:31726078
NCBI chr10:60,778,331...60,794,852
Ensembl chr10:60,778,331...60,794,852
G
CDK2
cyclin dependent kinase 2
increases expression
EXP
Homoharringtonine results in increased expression of CDK2 protein
CTD
PMID:31726078
NCBI chr12:55,966,830...55,972,789
Ensembl chr12:55,966,781...55,972,789
G
CHUK
component of inhibitor of nuclear factor kappa B kinase complex
increases phosphorylation multiple interactions
EXP
Homoharringtonine results in increased phosphorylation of CHUK protein Arsenic Trioxide inhibits the reaction [Homoharringtonine results in increased phosphorylation of CHUK protein]; crenigacestat inhibits the reaction [Homoharringtonine results in increased phosphorylation of CHUK protein]
CTD
PMID:31307525
NCBI chr10:100,186,319...100,229,596
Ensembl chr10:100,188,300...100,229,596
G
EPHB4
EPH receptor B4
decreases expression multiple interactions
EXP
Homoharringtonine results in decreased expression of EPHB4 protein benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Homoharringtonine results in decreased expression of EPHB4 protein]
CTD
PMID:31726078
NCBI chr 7:100,802,565...100,827,523
Ensembl chr 7:100,802,565...100,827,523
G
MAPK1
mitogen-activated protein kinase 1
decreases phosphorylation
EXP
Homoharringtonine results in decreased phosphorylation of MAPK1 protein
CTD
PMID:31726078
NCBI chr22:21,759,657...21,867,680
Ensembl chr22:21,759,657...21,867,680
G
MAPK3
mitogen-activated protein kinase 3
decreases phosphorylation
EXP
Homoharringtonine results in decreased phosphorylation of MAPK3 protein
CTD
PMID:31726078
NCBI chr16:30,114,105...30,123,220
Ensembl chr16:30,114,105...30,123,506
G
MCL1
MCL1 apoptosis regulator, BCL2 family member
decreases expression
EXP
Homoharringtonine results in decreased expression of MCL1 protein
CTD
PMID:23980369 PMID:31726078
NCBI chr 1:150,574,558...150,579,610
Ensembl chr 1:150,560,895...150,579,738
G
MKI67
marker of proliferation Ki-67
decreases expression
EXP
Homoharringtonine results in decreased expression of MKI67 protein
CTD
PMID:31726078
NCBI chr10:128,096,659...128,126,423
Ensembl chr10:128,096,659...128,126,423
G
MTOR
mechanistic target of rapamycin kinase
decreases phosphorylation
EXP
Homoharringtonine results in decreased phosphorylation of MTOR protein
CTD
PMID:31726078
NCBI chr 1:11,106,535...11,262,551
Ensembl chr 1:11,106,535...11,262,556
G
NFKB2
nuclear factor kappa B subunit 2
multiple interactions increases expression
EXP
Arsenic Trioxide inhibits the reaction [Homoharringtonine results in increased expression of NFKB2 protein]
CTD
PMID:31307525
NCBI chr10:102,394,110...102,402,529
Ensembl chr10:102,394,110...102,402,524
G
NOTCH1
notch receptor 1
multiple interactions increases expression
EXP
Arsenic Trioxide inhibits the reaction [Homoharringtonine results in increased expression of NOTCH1 protein]
CTD
PMID:31307525
NCBI chr 9:136,494,433...136,546,048
Ensembl chr 9:136,494,433...136,546,048
G
NOTCH2
notch receptor 2
multiple interactions
EXP
[Arsenic Trioxide co-treated with Homoharringtonine] results in decreased expression of NOTCH2 protein
CTD
PMID:31307525
NCBI chr 1:119,911,553...120,069,662
Ensembl chr 1:119,911,553...120,100,779
G
PIK3CA
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha
decreases expression
EXP
Homoharringtonine results in decreased expression of PIK3CA protein
CTD
PMID:31726078
NCBI chr 3:179,148,126...179,240,093
Ensembl chr 3:179,148,114...179,240,093
G
PTEN
phosphatase and tensin homolog
increases expression
EXP
Homoharringtonine results in increased expression of PTEN protein
CTD
PMID:31726078
NCBI chr10:87,863,625...87,971,930
Ensembl chr10:87,862,638...87,971,930
G
RELA
RELA proto-oncogene, NF-kB subunit
multiple interactions increases expression
EXP
[Arsenic Trioxide co-treated with Homoharringtonine] results in decreased expression of RELA protein; crenigacestat inhibits the reaction [Homoharringtonine results in increased expression of RELA protein]
CTD
PMID:31307525
NCBI chr11:65,653,601...65,663,857
Ensembl chr11:65,653,599...65,663,090
G
RELB
RELB proto-oncogene, NF-kB subunit
multiple interactions increases expression
EXP
Arsenic Trioxide inhibits the reaction [Homoharringtonine results in increased expression of RELB protein]
CTD
PMID:31307525
NCBI chr19:45,001,464...45,038,192
Ensembl chr19:45,001,461...45,038,192
G
TP53
tumor protein p53
increases expression multiple interactions
EXP
Homoharringtonine results in increased expression of TP53 protein [Arsenic Trioxide co-treated with Homoharringtonine] results in increased expression of TP53 protein; crenigacestat inhibits the reaction [Homoharringtonine results in increased expression of TP53 protein]
CTD
PMID:31307525
NCBI chr17:7,668,421...7,687,490
Ensembl chr17:7,661,779...7,687,538
G
TYR
tyrosinase
increases expression
ISO
Homoharringtonine results in increased expression of TYR mRNA
CTD
PMID:21071833
NCBI chr11:89,177,875...89,295,759
Ensembl chr11:89,177,875...89,295,759
G
AARS1
alanyl-tRNA synthetase 1
decreases expression
EXP
picoxystrobin results in decreased expression of AARS1 mRNA
CTD
PMID:33512557
NCBI chr16:70,252,298...70,289,506
Ensembl chr16:70,251,983...70,289,707
G
ABCA1
ATP binding cassette subfamily A member 1
decreases expression
EXP
picoxystrobin results in decreased expression of ABCA1 mRNA
CTD
PMID:33512557
NCBI chr 9:104,781,006...104,928,155
Ensembl chr 9:104,781,006...104,928,155
G
ABCC4
ATP binding cassette subfamily C member 4 (PEL blood group)
increases expression
EXP
picoxystrobin results in increased expression of ABCC4 mRNA
CTD
PMID:33512557
NCBI chr13:95,019,835...95,301,451
Ensembl chr13:95,019,835...95,301,475
G
ABCC5
ATP binding cassette subfamily C member 5
decreases expression
EXP
picoxystrobin results in decreased expression of ABCC5 mRNA
CTD
PMID:33512557
NCBI chr 3:183,919,934...184,017,884
Ensembl chr 3:183,919,934...184,017,939
G
ABHD6
abhydrolase domain containing 6, acylglycerol lipase
decreases expression
EXP
picoxystrobin results in decreased expression of ABHD6 mRNA
CTD
PMID:33512557
NCBI chr 3:58,237,792...58,294,734
Ensembl chr 3:58,237,532...58,295,693
G
ACADM
acyl-CoA dehydrogenase medium chain
increases expression
EXP
picoxystrobin results in increased expression of ACADM mRNA
CTD
PMID:33512557
NCBI chr 1:75,724,709...75,763,679
Ensembl chr 1:75,724,431...75,787,575
G
ACADVL
acyl-CoA dehydrogenase very long chain
decreases expression
EXP
picoxystrobin results in decreased expression of ACADVL mRNA
CTD
PMID:33512557
NCBI chr17:7,217,125...7,225,266
Ensembl chr17:7,217,125...7,225,266
G
ACAT1
acetyl-CoA acetyltransferase 1
increases expression
EXP
picoxystrobin results in increased expression of ACAT1 mRNA
CTD
PMID:33512557
NCBI chr11:108,116,705...108,147,603
Ensembl chr11:108,116,695...108,147,603
G
ACAT2
acetyl-CoA acetyltransferase 2
increases expression
EXP
picoxystrobin results in increased expression of ACAT2 mRNA
CTD
PMID:33512557
NCBI chr 6:159,762,045...159,779,112
Ensembl chr 6:159,762,045...159,779,112
G
ACLY
ATP citrate lyase
increases expression
EXP
picoxystrobin results in increased expression of ACLY mRNA
CTD
PMID:33512557
NCBI chr17:41,866,917...41,930,545
Ensembl chr17:41,866,917...41,930,542
G
ACTL6A
actin like 6A
increases expression
EXP
picoxystrobin results in increased expression of ACTL6A mRNA
CTD
PMID:33512557
NCBI chr 3:179,562,926...179,588,407
Ensembl chr 3:179,562,886...179,588,407
G
ACTN1
actinin alpha 1
decreases expression
EXP
picoxystrobin results in decreased expression of ACTN1 mRNA
CTD
PMID:33512557
NCBI chr14:68,874,128...68,979,302
Ensembl chr14:68,874,128...68,979,440
G
ADAM10
ADAM metallopeptidase domain 10
decreases expression
EXP
picoxystrobin results in decreased expression of ADAM10 mRNA
CTD
PMID:33512557
NCBI chr15:58,588,809...58,749,707
Ensembl chr15:58,588,809...58,749,791
G
ADAM12
ADAM metallopeptidase domain 12
decreases expression
EXP
picoxystrobin results in decreased expression of ADAM12 mRNA
CTD
PMID:33512557
NCBI chr10:126,012,391...126,388,477
Ensembl chr10:126,012,381...126,388,477
G
ADAM8
ADAM metallopeptidase domain 8
decreases expression
EXP
picoxystrobin results in decreased expression of ADAM8 mRNA
CTD
PMID:33512557
NCBI chr10:133,262,423...133,276,868
Ensembl chr10:133,262,420...133,276,868
G
ADH5
alcohol dehydrogenase 5 (class III), chi polypeptide
increases expression
EXP
picoxystrobin results in increased expression of ADH5 mRNA
CTD
PMID:33512557
NCBI chr 4:99,070,978...99,088,788
Ensembl chr 4:99,070,978...99,088,801
G
ADI1
acireductone dioxygenase 1
increases expression
EXP
picoxystrobin results in increased expression of ADI1 mRNA
CTD
PMID:33512557
NCBI chr 2:3,497,366...3,519,531
Ensembl chr 2:3,497,366...3,519,531
G
ADO
2-aminoethanethiol dioxygenase
increases expression
EXP
picoxystrobin results in increased expression of ADO mRNA
CTD
PMID:33512557
NCBI chr10:62,804,720...62,808,479
Ensembl chr10:62,804,720...62,808,479
G
AHCY
adenosylhomocysteinase
increases expression
EXP
picoxystrobin results in increased expression of AHCY mRNA
CTD
PMID:33512557
NCBI chr20:34,231,981...34,311,836
Ensembl chr20:34,280,268...34,311,802
G
AHSA1
activator of HSP90 ATPase activity 1
increases expression
EXP
picoxystrobin results in increased expression of AHSA1 mRNA
CTD
PMID:33512557
NCBI chr14:77,457,867...77,469,472
Ensembl chr14:77,457,870...77,469,472
G
AIFM1
apoptosis inducing factor mitochondria associated 1
increases expression
EXP
picoxystrobin results in increased expression of AIFM1 mRNA
CTD
PMID:33512557
NCBI chr X:130,129,362...130,165,841
Ensembl chr X:130,124,666...130,165,879
G
AKAP8
A-kinase anchoring protein 8
decreases expression
EXP
picoxystrobin results in decreased expression of AKAP8 mRNA
CTD
PMID:33512557
NCBI chr19:15,353,385...15,379,787
Ensembl chr19:15,353,385...15,379,815
G
AKR1B1
aldo-keto reductase family 1 member B
decreases expression
EXP
picoxystrobin results in decreased expression of AKR1B1 mRNA
CTD
PMID:33512557
NCBI chr 7:134,442,350...134,459,239
Ensembl chr 7:134,442,356...134,459,284
G
AKR1B10
aldo-keto reductase family 1 member B10
decreases expression
EXP
picoxystrobin results in decreased expression of AKR1B10 mRNA
CTD
PMID:33512557
NCBI chr 7:134,527,567...134,541,412
Ensembl chr 7:134,527,567...134,541,412
G
AKR1C3
aldo-keto reductase family 1 member C3
increases expression
EXP
picoxystrobin results in increased expression of AKR1C3 mRNA
CTD
PMID:33512557
NCBI chr10:5,048,781...5,107,686
Ensembl chr10:5,035,354...5,107,686
G
AKR7A2
aldo-keto reductase family 7 member A2
decreases expression
EXP
picoxystrobin results in decreased expression of AKR7A2 mRNA
CTD
PMID:33512557
NCBI chr 1:19,302,708...19,312,146
Ensembl chr 1:19,303,965...19,312,144
G
AKT1
AKT serine/threonine kinase 1
decreases expression
EXP
picoxystrobin results in decreased expression of AKT1 mRNA
CTD
PMID:33512557
NCBI chr14:104,769,349...104,795,748
Ensembl chr14:104,769,349...104,795,751
G
ALDH2
aldehyde dehydrogenase 2 family member
decreases expression
EXP
picoxystrobin results in decreased expression of ALDH2 mRNA
CTD
PMID:33512557
NCBI chr12:111,766,933...111,817,532
Ensembl chr12:111,766,887...111,817,532
G
ALDH3A2
aldehyde dehydrogenase 3 family member A2
increases expression
EXP
picoxystrobin results in increased expression of ALDH3A2 mRNA
CTD
PMID:33512557
NCBI chr17:19,648,136...19,677,596
Ensembl chr17:19,648,136...19,685,760
G
ALDH9A1
aldehyde dehydrogenase 9 family member A1
decreases expression
EXP
picoxystrobin results in decreased expression of ALDH9A1 mRNA
CTD
PMID:33512557
NCBI chr 1:165,662,216...165,698,562
Ensembl chr 1:165,662,216...165,698,562
G
ALDOC
aldolase, fructose-bisphosphate C
increases expression
EXP
picoxystrobin results in increased expression of ALDOC mRNA
CTD
PMID:33512557
NCBI chr17:28,573,120...28,576,895
Ensembl chr17:28,573,115...28,576,948
G
ALG8
ALG8 alpha-1,3-glucosyltransferase
increases expression
EXP
picoxystrobin results in increased expression of ALG8 mRNA
CTD
PMID:33512557
NCBI chr11:78,100,946...78,139,626
Ensembl chr11:78,095,244...78,139,660
G
AMDHD2
amidohydrolase domain containing 2
decreases expression
EXP
picoxystrobin results in decreased expression of AMDHD2 mRNA
CTD
PMID:33512557
NCBI chr16:2,520,371...2,531,417
Ensembl chr16:2,520,357...2,531,422
G
AMER1
APC membrane recruitment protein 1
decreases expression
EXP
picoxystrobin results in decreased expression of AMER1 mRNA
CTD
PMID:33512557
NCBI chr X:64,185,117...64,205,708
Ensembl chr X:64,185,117...64,205,708
G
ANKRD10
ankyrin repeat domain 10
decreases expression
EXP
picoxystrobin results in decreased expression of ANKRD10 mRNA
CTD
PMID:33512557
NCBI chr13:110,878,540...110,915,069
Ensembl chr13:110,878,540...110,915,069
G
ANKRD20A13P
ankyrin repeat domain 20 family member A13, pseudogene
decreases expression
EXP
picoxystrobin results in decreased expression of ANKRD20A13P mRNA
CTD
PMID:33512557
G
ANLN
anillin, actin binding protein
increases expression
EXP
picoxystrobin results in increased expression of ANLN mRNA
CTD
PMID:33512557
NCBI chr 7:36,389,862...36,453,791
Ensembl chr 7:36,389,821...36,453,791
G
ANO10
anoctamin 10
decreases expression
EXP
picoxystrobin results in decreased expression of ANO10 mRNA
CTD
PMID:33512557
NCBI chr 3:43,365,848...43,691,594
Ensembl chr 3:43,354,859...43,691,594
G
ANXA2
annexin A2
decreases expression
EXP
picoxystrobin results in decreased expression of ANXA2 mRNA
CTD
PMID:33512557
NCBI chr15:60,347,151...60,397,986
Ensembl chr15:60,347,134...60,402,883
G
ANXA5
annexin A5
increases expression
EXP
picoxystrobin results in increased expression of ANXA5 mRNA
CTD
PMID:33512557
NCBI chr 4:121,667,946...121,696,980
Ensembl chr 4:121,667,946...121,696,995
G
ANXA7
annexin A7
increases expression
EXP
picoxystrobin results in increased expression of ANXA7 mRNA
CTD
PMID:33512557
NCBI chr10:73,375,101...73,414,058
Ensembl chr10:73,375,101...73,414,076
G
ANXA8L1
annexin A8 like 1
decreases expression
EXP
picoxystrobin results in decreased expression of ANXA8L1 mRNA
CTD
PMID:33512557
NCBI chr10:46,375,776...46,391,778
Ensembl chr10:46,375,627...46,391,784
G
AP3M1
adaptor related protein complex 3 subunit mu 1
decreases expression
EXP
picoxystrobin results in decreased expression of AP3M1 mRNA
CTD
PMID:33512557
NCBI chr10:74,120,255...74,150,828
Ensembl chr10:74,120,255...74,150,842
G
APBB2
amyloid beta precursor protein binding family B member 2
increases expression
EXP
picoxystrobin results in increased expression of APBB2 mRNA
CTD
PMID:33512557
NCBI chr 4:40,810,027...41,214,542
Ensembl chr 4:40,810,027...41,216,714
G
APLP1
amyloid beta precursor like protein 1
decreases expression
EXP
picoxystrobin results in decreased expression of APLP1 mRNA
CTD
PMID:33512557
NCBI chr19:35,868,574...35,879,792
Ensembl chr19:35,867,899...35,879,792
G
ARF4
ADP ribosylation factor 4
increases expression
EXP
picoxystrobin results in increased expression of ARF4 mRNA
CTD
PMID:33512557
NCBI chr 3:57,571,363...57,597,344
Ensembl chr 3:57,571,363...57,598,220
G
ARHGEF2
Rho/Rac guanine nucleotide exchange factor 2
decreases expression
EXP
picoxystrobin results in decreased expression of ARHGEF2 mRNA
CTD
PMID:33512557
NCBI chr 1:155,946,854...155,979,617
Ensembl chr 1:155,946,851...156,007,070
G
ARID4A
AT-rich interaction domain 4A
decreases expression
EXP
picoxystrobin results in decreased expression of ARID4A mRNA
CTD
PMID:33512557
NCBI chr14:58,298,555...58,373,876
Ensembl chr14:58,298,504...58,373,887
G
ARRDC4
arrestin domain containing 4
decreases expression
EXP
picoxystrobin results in decreased expression of ARRDC4 mRNA
CTD
PMID:33512557
NCBI chr15:97,960,703...97,973,833
Ensembl chr15:97,960,703...97,973,833
G
ASAH1
N-acylsphingosine amidohydrolase 1
increases expression
EXP
picoxystrobin results in increased expression of ASAH1 mRNA
CTD
PMID:33512557
NCBI chr 8:18,055,992...18,084,961
Ensembl chr 8:18,055,992...18,084,998
G
ASNS
asparagine synthetase (glutamine-hydrolyzing)
increases expression
EXP
picoxystrobin results in increased expression of ASNS mRNA
CTD
PMID:33512557
NCBI chr 7:97,851,677...97,928,441
Ensembl chr 7:97,851,677...97,872,542
G
ASS1
argininosuccinate synthase 1
increases expression
EXP
picoxystrobin results in increased expression of ASS1 mRNA
CTD
PMID:33512557
NCBI chr 9:130,444,707...130,501,274
Ensembl chr 9:130,444,961...130,501,274
G
ATF4
activating transcription factor 4
increases expression
EXP
picoxystrobin results in increased expression of ATF4 mRNA
CTD
PMID:33512557
NCBI chr22:39,520,559...39,522,686
Ensembl chr22:39,519,695...39,522,683
G
ATF5
activating transcription factor 5
decreases expression
EXP
picoxystrobin results in decreased expression of ATF5 mRNA
CTD
PMID:33512557
NCBI chr19:49,928,906...49,933,935
Ensembl chr19:49,928,702...49,933,935
G
ATP11C
ATPase phospholipid transporting 11C
decreases expression
EXP
picoxystrobin results in decreased expression of ATP11C mRNA
CTD
PMID:33512557
NCBI chr X:139,726,348...139,936,903
Ensembl chr X:139,726,346...139,945,276
G
ATP1A1
ATPase Na+/K+ transporting subunit alpha 1
increases expression
EXP
picoxystrobin results in increased expression of ATP1A1 mRNA
CTD
PMID:33512557
NCBI chr 1:116,373,244...116,404,774
Ensembl chr 1:116,372,668...116,410,261
G
ATP1B1
ATPase Na+/K+ transporting subunit beta 1
decreases expression
EXP
picoxystrobin results in decreased expression of ATP1B1 mRNA
CTD
PMID:33512557
NCBI chr 1:169,106,690...169,132,719
Ensembl chr 1:169,105,697...169,310,992
G
ATP2C1
ATPase secretory pathway Ca2+ transporting 1
decreases expression
EXP
picoxystrobin results in decreased expression of ATP2C1 mRNA
CTD
PMID:33512557
NCBI chr 3:130,850,595...131,016,712
Ensembl chr 3:130,850,595...131,016,712
G
ATP5F1C
ATP synthase F1 subunit gamma
decreases expression
EXP
picoxystrobin results in decreased expression of ATP5F1C mRNA
CTD
PMID:33512557
NCBI chr10:7,788,177...7,807,801
Ensembl chr10:7,788,147...7,807,815
G
ATP6V1B2
ATPase H+ transporting V1 subunit B2
decreases expression
EXP
picoxystrobin results in decreased expression of ATP6V1B2 mRNA
CTD
PMID:33512557
NCBI chr 8:20,197,381...20,221,696
Ensembl chr 8:20,197,381...20,226,819
G
ATP6V1D
ATPase H+ transporting V1 subunit D
increases expression
EXP
picoxystrobin results in increased expression of ATP6V1D mRNA
CTD
PMID:33512557
NCBI chr14:67,337,872...67,359,804
Ensembl chr14:67,294,371...67,360,265
G
AURKB
aurora kinase B
increases expression
EXP
picoxystrobin results in increased expression of AURKB mRNA
CTD
PMID:33512557
NCBI chr17:8,204,731...8,210,575
Ensembl chr17:8,204,733...8,210,600
G
B2M
beta-2-microglobulin
increases expression
EXP
picoxystrobin results in increased expression of B2M mRNA
CTD
PMID:33512557
NCBI chr15:44,711,517...44,718,145
Ensembl chr15:44,711,358...44,718,851
G
B3GALT6
beta-1,3-galactosyltransferase 6
decreases expression
EXP
picoxystrobin results in decreased expression of B3GALT6 mRNA
CTD
PMID:33512557
NCBI chr 1:1,232,237...1,235,041
Ensembl chr 1:1,232,237...1,235,041
G
BAAT
bile acid-CoA:amino acid N-acyltransferase
decreases expression
EXP
picoxystrobin results in decreased expression of BAAT mRNA
CTD
PMID:33512557
NCBI chr 9:101,360,417...101,385,006
Ensembl chr 9:101,354,182...101,385,400
G
BANF1
BAF nuclear assembly factor 1
increases expression
EXP
picoxystrobin results in increased expression of BANF1 mRNA
CTD
PMID:33512557
NCBI chr11:66,002,079...66,004,149
Ensembl chr11:66,002,228...66,004,149
G
BCL2
BCL2 apoptosis regulator
decreases expression
EXP
picoxystrobin results in decreased expression of BCL2 mRNA
CTD
PMID:33512557
NCBI chr18:63,123,346...63,320,090
Ensembl chr18:63,123,346...63,320,128
G
BCL2L1
BCL2 like 1
decreases expression
EXP
picoxystrobin results in decreased expression of BCL2L1 mRNA
CTD
PMID:33512557
NCBI chr20:31,664,452...31,723,963
Ensembl chr20:31,664,452...31,723,989
G
BCL2L11
BCL2 like 11
decreases expression
EXP
picoxystrobin results in decreased expression of BCL2L11 mRNA
CTD
PMID:33512557
NCBI chr 2:111,120,914...111,168,445
Ensembl chr 2:111,119,378...111,168,444
G
BCL2L13
BCL2 like 13
decreases expression
EXP
picoxystrobin results in decreased expression of BCL2L13 mRNA
CTD
PMID:33512557
NCBI chr22:17,628,877...17,730,855
Ensembl chr22:17,628,855...17,730,855
G
BCL2L2
BCL2 like 2
decreases expression
EXP
picoxystrobin results in decreased expression of BCL2L2 mRNA
CTD
PMID:33512557
NCBI chr14:23,306,833...23,311,751
Ensembl chr14:23,298,790...23,311,751
G
BCL3
BCL3 transcription coactivator
decreases expression
EXP
picoxystrobin results in decreased expression of BCL3 mRNA
CTD
PMID:33512557
NCBI chr19:44,747,705...44,760,044
Ensembl chr19:44,747,705...44,760,044
G
BIRC5
baculoviral IAP repeat containing 5
increases expression
EXP
picoxystrobin results in increased expression of BIRC5 mRNA
CTD
PMID:33512557
NCBI chr17:78,214,253...78,225,635
Ensembl chr17:78,214,186...78,225,636
G
BLMH
bleomycin hydrolase
increases expression
EXP
picoxystrobin results in increased expression of BLMH mRNA
CTD
PMID:33512557
NCBI chr17:30,248,203...30,291,944
Ensembl chr17:30,248,203...30,292,056
G
BLOC1S2
biogenesis of lysosomal organelles complex 1 subunit 2
increases expression
EXP
picoxystrobin results in increased expression of BLOC1S2 mRNA
CTD
PMID:33512557
NCBI chr10:100,273,278...100,286,680
Ensembl chr10:100,273,280...100,286,680
G
BMF
Bcl2 modifying factor
decreases expression
EXP
picoxystrobin results in decreased expression of BMF mRNA
CTD
PMID:33512557
NCBI chr15:40,087,890...40,108,879
Ensembl chr15:40,087,890...40,108,892
G
BPHL
biphenyl hydrolase like
decreases expression
EXP
picoxystrobin results in decreased expression of BPHL mRNA
CTD
PMID:33512557
NCBI chr 6:3,118,376...3,153,578
Ensembl chr 6:3,118,374...3,153,578
G
BRD2
bromodomain containing 2
increases expression
EXP
picoxystrobin results in increased expression of BRD2 mRNA
CTD
PMID:33512557
NCBI chr 6:32,968,594...32,981,505
Ensembl chr 6:32,968,594...32,981,505
G
BTG3
BTG anti-proliferation factor 3
increases expression
EXP
picoxystrobin results in increased expression of BTG3 mRNA
CTD
PMID:33512557
NCBI chr21:17,593,653...17,612,901
Ensembl chr21:17,593,653...17,612,945
G
BTN3A2
butyrophilin subfamily 3 member A2
increases expression
EXP
picoxystrobin results in increased expression of BTN3A2 mRNA
CTD
PMID:33512557
NCBI chr 6:26,365,169...26,378,320
Ensembl chr 6:26,365,159...26,378,320
G
BUB1
BUB1 mitotic checkpoint serine/threonine kinase
increases expression
EXP
picoxystrobin results in increased expression of BUB1 mRNA
CTD
PMID:33512557
NCBI chr 2:110,637,528...110,678,063
Ensembl chr 2:110,637,528...110,678,063
G
BUB1B
BUB1 mitotic checkpoint serine/threonine kinase B
increases expression
EXP
picoxystrobin results in increased expression of BUB1B mRNA
CTD
PMID:33512557
NCBI chr15:40,161,069...40,221,123
Ensembl chr15:40,161,023...40,221,123
G
BZW1
basic leucine zipper and W2 domains 1
decreases expression
EXP
picoxystrobin results in decreased expression of BZW1 mRNA
CTD
PMID:33512557
NCBI chr 2:200,811,589...200,827,338
Ensembl chr 2:200,810,594...200,827,338
G
BZW2
basic leucine zipper and W2 domains 2
increases expression
EXP
picoxystrobin results in increased expression of BZW2 mRNA
CTD
PMID:33512557
NCBI chr 7:16,646,181...16,706,517
Ensembl chr 7:16,646,131...16,706,523
G
C2CD2
C2 calcium dependent domain containing 2
decreases expression
EXP
picoxystrobin results in decreased expression of C2CD2 mRNA
CTD
PMID:33512557
NCBI chr21:41,885,112...41,954,018
Ensembl chr21:41,885,112...41,954,018
G
C2CD5
C2 calcium dependent domain containing 5
decreases expression
EXP
picoxystrobin results in decreased expression of C2CD5 mRNA
CTD
PMID:33512557
NCBI chr12:22,448,583...22,544,542
Ensembl chr12:22,448,583...22,544,546
G
C5
complement C5
decreases expression
EXP
picoxystrobin results in decreased expression of C5 mRNA
CTD
PMID:33512557
NCBI chr 9:120,952,335...121,074,865
Ensembl chr 9:120,932,987...121,075,195
G
CAMK2B
calcium/calmodulin dependent protein kinase II beta
decreases expression
EXP
picoxystrobin results in decreased expression of CAMK2B mRNA
CTD
PMID:33512557
NCBI chr 7:44,217,154...44,326,013
Ensembl chr 7:44,210,019...44,334,577
G
CANX
calnexin
increases expression
EXP
picoxystrobin results in increased expression of CANX mRNA
CTD
PMID:33512557
NCBI chr 5:179,678,656...179,731,641
Ensembl chr 5:179,678,628...179,731,641
G
CARMIL1
capping protein regulator and myosin 1 linker 1
decreases expression
EXP
picoxystrobin results in decreased expression of CARMIL1 mRNA
CTD
PMID:33512557
NCBI chr 6:25,279,374...25,620,530
Ensembl chr 6:25,279,078...25,620,530
G
CASC3
CASC3 exon junction complex subunit
increases expression
EXP
picoxystrobin results in increased expression of CASC3 mRNA
CTD
PMID:33512557
NCBI chr17:40,140,537...40,172,171
Ensembl chr17:40,140,318...40,172,171
G
CASP2
caspase 2
decreases expression
EXP
picoxystrobin results in decreased expression of CASP2 mRNA
CTD
PMID:33512557
NCBI chr 7:143,288,351...143,307,696
Ensembl chr 7:143,288,215...143,307,696
G
CBLB
Cbl proto-oncogene B
decreases expression
EXP
picoxystrobin results in decreased expression of CBLB mRNA
CTD
PMID:33512557
NCBI chr 3:105,655,461...105,869,449
Ensembl chr 3:105,655,461...105,869,552
G
CBX4
chromobox 4
decreases expression
EXP
picoxystrobin results in decreased expression of CBX4 mRNA
CTD
PMID:33512557
NCBI chr17:79,833,156...79,839,440
Ensembl chr17:79,833,156...79,839,440
G
CCL15
C-C motif chemokine ligand 15
decreases expression
EXP
picoxystrobin results in decreased expression of CCL15 mRNA
CTD
PMID:33512557
NCBI chr17:35,997,582...36,001,553
Ensembl chr17:35,996,440...36,001,553
G
CCNA2
cyclin A2
increases expression
EXP
picoxystrobin results in increased expression of CCNA2 mRNA
CTD
PMID:33512557
NCBI chr 4:121,816,444...121,823,883
Ensembl chr 4:121,816,444...121,823,883
G
CCNB1
cyclin B1
increases expression
EXP
picoxystrobin results in increased expression of CCNB1 mRNA
CTD
PMID:33512557
NCBI chr 5:69,167,150...69,178,245
Ensembl chr 5:69,167,135...69,178,245
G
CCNB2
cyclin B2
increases expression
EXP
picoxystrobin results in increased expression of CCNB2 mRNA
CTD
PMID:33512557
NCBI chr15:59,105,146...59,125,045
Ensembl chr15:59,105,126...59,125,045
G
CCNG1
cyclin G1
increases expression
EXP
picoxystrobin results in increased expression of CCNG1 mRNA
CTD
PMID:33512557
NCBI chr 5:163,437,571...163,457,640
Ensembl chr 5:163,437,569...163,446,151
G
CCP110
centriolar coiled-coil protein 110
increases expression
EXP
picoxystrobin results in increased expression of CCP110 mRNA
CTD
PMID:33512557
NCBI chr16:19,523,942...19,553,408
Ensembl chr16:19,523,811...19,553,408
G
CD24
CD24 molecule
decreases expression
EXP
picoxystrobin results in decreased expression of CD24 mRNA
CTD
PMID:33512557
NCBI chr 6:106,969,831...106,976,855
Ensembl chr 6:106,969,831...106,975,627
G
CD55
CD55 molecule (Cromer blood group)
decreases expression
EXP
picoxystrobin results in decreased expression of CD55 mRNA
CTD
PMID:33512557
NCBI chr 1:207,321,678...207,360,966
Ensembl chr 1:207,321,519...207,386,804
G
CD58
CD58 molecule
increases expression
EXP
picoxystrobin results in increased expression of CD58 mRNA
CTD
PMID:33512557
NCBI chr 1:116,514,534...116,571,026
Ensembl chr 1:116,514,534...116,571,039
G
CDC26
cell division cycle 26
increases expression
EXP
picoxystrobin results in increased expression of CDC26 mRNA
CTD
PMID:33512557
NCBI chr 9:113,266,992...113,275,572
Ensembl chr 9:113,255,835...113,275,572
G
CDC6
cell division cycle 6
increases expression decreases expression
EXP
picoxystrobin results in increased expression of CDC6 mRNA picoxystrobin results in decreased expression of CDC6 mRNA
CTD
PMID:33512557 PMID:34642769
NCBI chr17:40,287,879...40,304,657
Ensembl chr17:40,287,879...40,304,657
G
CDC7
cell division cycle 7
increases expression
EXP
picoxystrobin results in increased expression of CDC7 mRNA
CTD
PMID:33512557
NCBI chr 1:91,500,851...91,525,764
Ensembl chr 1:91,500,851...91,525,764
G
CDH10
cadherin 10
decreases expression
EXP
picoxystrobin results in decreased expression of CDH10 mRNA
CTD
PMID:33512557
NCBI chr 5:24,487,100...24,644,978
Ensembl chr 5:24,487,100...24,644,978
G
CDH11
cadherin 11
decreases expression
EXP
picoxystrobin results in decreased expression of CDH11 mRNA
CTD
PMID:33512557
NCBI chr16:64,943,753...65,123,744
Ensembl chr16:64,943,753...65,126,112
G
CDH2
cadherin 2
decreases expression
EXP
picoxystrobin results in decreased expression of CDH2 mRNA
CTD
PMID:33512557
NCBI chr18:27,932,879...28,177,130
Ensembl chr18:27,932,879...28,177,946
G
CDK1
cyclin dependent kinase 1
increases expression
EXP
picoxystrobin results in increased expression of CDK1 mRNA
CTD
PMID:33512557
NCBI chr10:60,778,331...60,794,852
Ensembl chr10:60,778,331...60,794,852
G
CDK19
cyclin dependent kinase 19
decreases expression
EXP
picoxystrobin results in decreased expression of CDK19 mRNA
CTD
PMID:33512557
NCBI chr 6:110,609,978...110,815,855
Ensembl chr 6:110,609,978...110,815,958
G
CDK4
cyclin dependent kinase 4
decreases expression
EXP
picoxystrobin results in decreased expression of CDK4 mRNA
CTD
PMID:33512557
NCBI chr12:57,747,727...57,752,310
Ensembl chr12:57,747,727...57,756,013
G
CDK5R1
cyclin dependent kinase 5 regulatory subunit 1
decreases expression
EXP
picoxystrobin results in decreased expression of CDK5R1 mRNA
CTD
PMID:33512557
NCBI chr17:32,486,993...32,491,253
Ensembl chr17:32,486,993...32,491,253
G
CDKN1B
cyclin dependent kinase inhibitor 1B
decreases expression
EXP
picoxystrobin results in decreased expression of CDKN1B mRNA
CTD
PMID:33512557
NCBI chr12:12,717,368...12,722,369
Ensembl chr12:12,685,498...12,722,369
G
CDKN3
cyclin dependent kinase inhibitor 3
increases expression
EXP
picoxystrobin results in increased expression of CDKN3 mRNA
CTD
PMID:33512557
NCBI chr14:54,397,007...54,420,218
Ensembl chr14:54,396,849...54,420,218
G
CEL
carboxyl ester lipase
decreases expression
EXP
picoxystrobin results in decreased expression of CEL mRNA
CTD
PMID:33512557
NCBI chr 9:133,061,981...133,071,861
Ensembl chr 9:133,061,981...133,071,861
G
CENPK
centromere protein K
decreases expression
EXP
picoxystrobin results in decreased expression of CENPK mRNA
CTD
PMID:33512557
NCBI chr 5:65,495,624...65,563,168
Ensembl chr 5:65,517,766...65,563,168
G
CEP55
centrosomal protein 55
increases expression
EXP
picoxystrobin results in increased expression of CEP55 mRNA
CTD
PMID:33512557
NCBI chr10:93,496,612...93,529,092
Ensembl chr10:93,496,612...93,529,092
G
CEP57
centrosomal protein 57
decreases expression
EXP
picoxystrobin results in decreased expression of CEP57 mRNA
CTD
PMID:33512557
NCBI chr11:95,790,498...95,832,693
Ensembl chr11:95,789,965...95,832,693
G
CFL2
cofilin 2
decreases expression
EXP
picoxystrobin results in decreased expression of CFL2 mRNA
CTD
PMID:33512557
NCBI chr14:34,709,113...34,714,593
Ensembl chr14:34,709,113...34,714,823
G
CGRRF1
cell growth regulator with ring finger domain 1
increases expression
EXP
picoxystrobin results in increased expression of CGRRF1 mRNA
CTD
PMID:33512557
NCBI chr14:54,509,906...54,539,292
Ensembl chr14:54,509,812...54,539,292
G
CHAC1
ChaC glutathione specific gamma-glutamylcyclotransferase 1
increases expression
EXP
picoxystrobin results in increased expression of CHAC1 mRNA
CTD
PMID:33512557
NCBI chr15:40,953,471...40,956,512
Ensembl chr15:40,952,962...40,956,512
G
CHAC2
ChaC glutathione specific gamma-glutamylcyclotransferase 2
increases expression
EXP
picoxystrobin results in increased expression of CHAC2 mRNA
CTD
PMID:33512557
NCBI chr 2:53,767,783...53,775,196
Ensembl chr 2:53,767,804...53,775,196
G
CHMP4A
charged multivesicular body protein 4A
decreases expression
EXP
picoxystrobin results in decreased expression of CHMP4A mRNA
CTD
PMID:33512557
NCBI chr14:24,209,615...24,213,488
Ensembl chr14:24,209,615...24,213,830
G
CHMP6
charged multivesicular body protein 6
decreases expression
EXP
picoxystrobin results in decreased expression of CHMP6 mRNA
CTD
PMID:33512557
NCBI chr17:80,991,841...81,000,133
Ensembl chr17:80,991,598...81,009,517
G
CHRNA4
cholinergic receptor nicotinic alpha 4 subunit
decreases expression
EXP
picoxystrobin results in decreased expression of CHRNA4 mRNA
CTD
PMID:33512557
NCBI chr20:63,343,223...63,361,349
Ensembl chr20:63,343,223...63,378,401
G
CIB1
calcium and integrin binding 1
increases expression
EXP
picoxystrobin results in increased expression of CIB1 mRNA
CTD
PMID:33512557
NCBI chr15:90,229,975...90,265,759
Ensembl chr15:90,229,975...90,234,047
G
CISD1
CDGSH iron sulfur domain 1
increases expression
EXP
picoxystrobin results in increased expression of CISD1 mRNA
CTD
PMID:33512557
NCBI chr10:58,269,162...58,289,586
Ensembl chr10:58,269,162...58,289,586
G
CKS1B
CDC28 protein kinase regulatory subunit 1B
increases expression
EXP
picoxystrobin results in increased expression of CKS1B mRNA
CTD
PMID:33512557
NCBI chr 1:154,974,681...154,979,251
Ensembl chr 1:154,974,653...154,979,251
G
CKS2
CDC28 protein kinase regulatory subunit 2
increases expression
EXP
picoxystrobin results in increased expression of CKS2 mRNA
CTD
PMID:33512557
NCBI chr 9:89,311,195...89,316,703
Ensembl chr 9:89,311,195...89,316,703
G
CLDN5
claudin 5
decreases expression
EXP
picoxystrobin results in decreased expression of CLDN5 mRNA
CTD
PMID:33512557
NCBI chr22:19,523,024...19,525,337
Ensembl chr22:19,523,024...19,527,545
G
CLIC4
chloride intracellular channel 4
increases expression
EXP
picoxystrobin results in increased expression of CLIC4 mRNA
CTD
PMID:33512557
NCBI chr 1:24,745,447...24,844,321
Ensembl chr 1:24,745,382...24,844,321
G
CLK2
CDC like kinase 2
decreases expression
EXP
picoxystrobin results in decreased expression of CLK2 mRNA
CTD
PMID:33512557
NCBI chr 1:155,262,868...155,273,504
Ensembl chr 1:155,262,868...155,278,491
G
CLPX
caseinolytic mitochondrial matrix peptidase chaperone subunit X
increases expression
EXP
picoxystrobin results in increased expression of CLPX mRNA
CTD
PMID:33512557
NCBI chr15:65,148,219...65,185,342
Ensembl chr15:65,148,219...65,185,342
G
CLSTN1
calsyntenin 1
decreases expression
EXP
picoxystrobin results in decreased expression of CLSTN1 mRNA
CTD
PMID:33512557
NCBI chr 1:9,728,926...9,824,526
Ensembl chr 1:9,728,926...9,823,984
G
CLTB
clathrin light chain B
decreases expression
EXP
picoxystrobin results in decreased expression of CLTB mRNA
CTD
PMID:33512557
NCBI chr 5:176,392,455...176,416,569
Ensembl chr 5:176,392,501...176,416,539
G
COA6
cytochrome c oxidase assembly factor 6
increases expression
EXP
picoxystrobin results in increased expression of COA6 mRNA
CTD
PMID:33512557
NCBI chr 1:234,373,456...234,385,080
Ensembl chr 1:234,373,456...234,385,080
G
COASY
Coenzyme A synthase
increases expression
EXP
picoxystrobin results in increased expression of COASY mRNA
CTD
PMID:33512557
NCBI chr17:42,562,148...42,566,277
Ensembl chr17:42,561,467...42,566,277
G
COL1A1
collagen type I alpha 1 chain
decreases expression
EXP
picoxystrobin results in decreased expression of COL1A1 mRNA
CTD
PMID:33512557
NCBI chr17:50,184,101...50,201,631
Ensembl chr17:50,184,101...50,201,632
G
COPB2
COPI coat complex subunit beta 2
increases expression
EXP
picoxystrobin results in increased expression of COPB2 mRNA
CTD
PMID:33512557
NCBI chr 3:139,357,406...139,389,680
Ensembl chr 3:139,353,946...139,389,736
G
COQ5
coenzyme Q5, methyltransferase
increases expression
EXP
picoxystrobin results in increased expression of COQ5 mRNA
CTD
PMID:33512557
NCBI chr12:120,503,279...120,529,158
Ensembl chr12:120,503,279...120,534,434
G
COX6B1
cytochrome c oxidase subunit 6B1
increases expression
EXP
picoxystrobin results in increased expression of COX6B1 mRNA
CTD
PMID:33512557
NCBI chr19:35,648,323...35,658,782
Ensembl chr19:35,648,323...35,658,782
G
COX8A
cytochrome c oxidase subunit 8A
increases expression
EXP
picoxystrobin results in increased expression of COX8A mRNA
CTD
PMID:33512557
NCBI chr11:63,974,620...63,976,543
Ensembl chr11:63,974,620...63,976,543
G
CREM
cAMP responsive element modulator
increases expression
EXP
picoxystrobin results in increased expression of CREM mRNA
CTD
PMID:33512557
NCBI chr10:35,126,846...35,212,958
Ensembl chr10:35,126,791...35,212,958
G
CRYZ
crystallin zeta
increases expression
EXP
picoxystrobin results in increased expression of CRYZ mRNA
CTD
PMID:33512557
NCBI chr 1:74,705,486...74,733,050
Ensembl chr 1:74,705,482...74,733,408
G
CTNNAL1
catenin alpha like 1
increases expression
EXP
picoxystrobin results in increased expression of CTNNAL1 mRNA
CTD
PMID:33512557
NCBI chr 9:108,942,577...109,013,499
Ensembl chr 9:108,942,569...109,013,522
G
CTNND1
catenin delta 1
decreases expression
EXP
picoxystrobin results in decreased expression of CTNND1 mRNA
CTD
PMID:33512557
NCBI chr11:57,761,802...57,819,540
Ensembl chr11:57,753,243...57,819,546
G
CTSB
cathepsin B
decreases expression
EXP
picoxystrobin results in decreased expression of CTSB mRNA
CTD
PMID:33512557
NCBI chr 8:11,842,524...11,868,087
Ensembl chr 8:11,842,524...11,869,533
G
CTSS
cathepsin S
decreases expression
EXP
picoxystrobin results in decreased expression of CTSS mRNA
CTD
PMID:33512557
NCBI chr 1:150,730,188...150,765,778
Ensembl chr 1:150,730,079...150,765,957
G
CXCR4
C-X-C motif chemokine receptor 4
decreases expression
EXP
picoxystrobin results in decreased expression of CXCR4 mRNA
CTD
PMID:33512557
NCBI chr 2:136,114,349...136,118,149
Ensembl chr 2:136,114,349...136,119,177
G
CYP26B1
cytochrome P450 family 26 subfamily B member 1
decreases expression
EXP
picoxystrobin results in decreased expression of CYP26B1 mRNA
CTD
PMID:33512557
NCBI chr 2:72,129,238...72,147,862
Ensembl chr 2:72,129,238...72,147,862
G
CYP2C19
cytochrome P450 family 2 subfamily C member 19
decreases activity
EXP
picoxystrobin results in decreased activity of CYP2C19 protein
CTD
PMID:23611293
NCBI chr10:94,762,681...94,855,547
Ensembl chr10:94,762,681...94,855,547
G
CYP2C9
cytochrome P450 family 2 subfamily C member 9
decreases activity
EXP
picoxystrobin results in decreased activity of CYP2C9 protein
CTD
PMID:23611293
NCBI chr10:94,938,658...94,990,091
Ensembl chr10:94,938,658...94,990,091
G
CYP2D7
cytochrome P450 family 2 subfamily D member 7 (gene/pseudogene)
decreases expression
EXP
picoxystrobin results in decreased expression of CYP2D7 mRNA
CTD
PMID:33512557
NCBI chr22:42,139,576...42,144,483
Ensembl chr22:42,140,203...42,149,455
G
CYP3A5
cytochrome P450 family 3 subfamily A member 5
affects expression
EXP
picoxystrobin affects the expression of CYP3A5 mRNA
CTD
PMID:34642769
NCBI chr 7:99,648,194...99,679,996
Ensembl chr 7:99,648,194...99,679,996
G
CYP51A1
cytochrome P450 family 51 subfamily A member 1
increases expression
EXP
picoxystrobin results in increased expression of CYP51A1 mRNA
CTD
PMID:33512557
NCBI chr 7:92,112,153...92,134,803
Ensembl chr 7:92,084,987...92,134,803
G
DAAM1
dishevelled associated activator of morphogenesis 1
decreases expression
EXP
picoxystrobin results in decreased expression of DAAM1 mRNA
CTD
PMID:33512557
NCBI chr14:59,188,667...59,371,405
Ensembl chr14:59,188,646...59,371,405
G
DAD1
defender against cell death 1
increases expression
EXP
picoxystrobin results in increased expression of DAD1 mRNA
CTD
PMID:33512557
NCBI chr14:22,564,907...22,589,224
Ensembl chr14:22,564,907...22,589,224
G
DAPK1
death associated protein kinase 1
decreases expression
EXP
picoxystrobin results in decreased expression of DAPK1 mRNA
CTD
PMID:33512557
NCBI chr 9:87,497,228...87,708,634
Ensembl chr 9:87,497,228...87,708,634
G
DAXX
death domain associated protein
decreases expression
EXP
picoxystrobin results in decreased expression of DAXX mRNA
CTD
PMID:33512557
NCBI chr 6:33,318,558...33,322,959
Ensembl chr 6:33,318,558...33,323,016
G
DBF4
DBF4-CDC7 kinase regulatory subunit
increases expression
EXP
picoxystrobin results in increased expression of DBF4 mRNA
CTD
PMID:33512557
NCBI chr 7:87,876,493...87,909,553
Ensembl chr 7:87,876,216...87,909,553
G
DBNDD2
dysbindin domain containing 2
decreases expression
EXP
picoxystrobin results in decreased expression of DBNDD2 mRNA
CTD
PMID:33512557
NCBI chr20:45,405,993...45,410,610
Ensembl chr20:45,406,057...45,410,610
G
DCUN1D4
defective in cullin neddylation 1 domain containing 4
increases expression
EXP
picoxystrobin results in increased expression of DCUN1D4 mRNA
CTD
PMID:33512557
NCBI chr 4:51,833,884...51,916,837
Ensembl chr 4:51,843,000...51,916,837
G
DCX
doublecortin
decreases expression
EXP
picoxystrobin results in decreased expression of DCX mRNA
CTD
PMID:33512557
NCBI chr X:111,293,779...111,412,192
Ensembl chr X:111,293,779...111,412,429
G
DDC
dopa decarboxylase
decreases expression
EXP
picoxystrobin results in decreased expression of DDC mRNA
CTD
PMID:33512557 PMID:34642769
NCBI chr 7:50,458,442...50,565,405
Ensembl chr 7:50,458,436...50,565,405
G
DDIT3
DNA damage inducible transcript 3
decreases expression
EXP
picoxystrobin results in decreased expression of DDIT3 mRNA
CTD
PMID:33512557
NCBI chr12:57,516,588...57,520,517
Ensembl chr12:57,516,588...57,521,737
G
DDR1
discoidin domain receptor tyrosine kinase 1
decreases expression
EXP
picoxystrobin results in decreased expression of DDR1 mRNA
CTD
PMID:33512557
NCBI chr 6:30,880,970...30,900,156
Ensembl chr 6:30,876,421...30,900,156
G
DEK
DEK proto-oncogene
increases expression
EXP
picoxystrobin results in increased expression of DEK mRNA
CTD
PMID:33512557
NCBI chr 6:18,223,860...18,264,530
Ensembl chr 6:18,223,860...18,264,548
G
DENND3
DENN domain containing 3
decreases expression
EXP
picoxystrobin results in decreased expression of DENND3 mRNA
CTD
PMID:33512557
NCBI chr 8:141,128,589...141,195,804
Ensembl chr 8:141,117,278...141,195,808
G
DEPDC1B
DEP domain containing 1B
increases expression
EXP
picoxystrobin results in increased expression of DEPDC1B mRNA
CTD
PMID:33512557
NCBI chr 5:60,596,912...60,700,166
Ensembl chr 5:60,596,912...60,700,190
G
DFFB
DNA fragmentation factor subunit beta
decreases expression
EXP
picoxystrobin results in decreased expression of DFFB mRNA
CTD
PMID:33512557
NCBI chr 1:3,857,476...3,885,429
Ensembl chr 1:3,857,267...3,885,429
G
DHDDS
dehydrodolichyl diphosphate synthase subunit
decreases expression
EXP
picoxystrobin results in decreased expression of DHDDS mRNA
CTD
PMID:33512557
NCBI chr 1:26,432,321...26,471,306
Ensembl chr 1:26,432,282...26,471,306
G
DLGAP5
DLG associated protein 5
increases expression
EXP
picoxystrobin results in increased expression of DLGAP5 mRNA
CTD
PMID:33512557
NCBI chr14:55,148,135...55,191,585
Ensembl chr14:55,148,112...55,191,608
G
DLL4
delta like canonical Notch ligand 4
decreases expression
EXP
picoxystrobin results in decreased expression of DLL4 mRNA
CTD
PMID:33512557
NCBI chr15:40,929,340...40,939,073
Ensembl chr15:40,929,340...40,939,073
G
DNA2
DNA replication helicase/nuclease 2
increases expression
EXP
picoxystrobin results in increased expression of DNA2 mRNA
CTD
PMID:33512557
NCBI chr10:68,414,064...68,472,521
Ensembl chr10:68,414,064...68,472,121
G
DNAJB9
DnaJ heat shock protein family (Hsp40) member B9
increases expression
EXP
picoxystrobin results in increased expression of DNAJB9 mRNA
CTD
PMID:33512557
NCBI chr 7:108,569,874...108,574,850
Ensembl chr 7:108,569,867...108,574,850
G
DPP10
dipeptidyl peptidase like 10
increases expression
EXP
picoxystrobin results in increased expression of DPP10 mRNA
CTD
PMID:33512557
NCBI chr 2:114,442,641...115,845,780
Ensembl chr 2:114,442,299...115,845,780
G
DPY30
dpy-30 histone methyltransferase complex regulatory subunit
increases expression
EXP
picoxystrobin results in increased expression of DPY30 mRNA
CTD
PMID:33512557
NCBI chr 2:32,011,649...32,039,835
Ensembl chr 2:31,867,809...32,039,805
G
DRAP1
DR1 associated protein 1
increases expression
EXP
picoxystrobin results in increased expression of DRAP1 mRNA
CTD
PMID:33512557
NCBI chr11:65,919,426...65,921,563
Ensembl chr11:65,919,274...65,921,563
G
DRD2
dopamine receptor D2
decreases expression
EXP
picoxystrobin results in decreased expression of DRD2 mRNA
CTD
PMID:33512557
NCBI chr11:113,409,605...113,475,398
Ensembl chr11:113,409,605...113,475,691
G
DSG2
desmoglein 2
increases expression
EXP
picoxystrobin results in increased expression of DSG2 mRNA
CTD
PMID:33512557
NCBI chr18:31,498,177...31,549,008
Ensembl chr18:31,498,177...31,549,008
G
DUSP1
dual specificity phosphatase 1
decreases expression
EXP
picoxystrobin results in decreased expression of DUSP1 mRNA
CTD
PMID:33512557
NCBI chr 5:172,768,096...172,771,195
Ensembl chr 5:172,768,096...172,771,195
G
DUSP11
dual specificity phosphatase 11
increases expression
EXP
picoxystrobin results in increased expression of DUSP11 mRNA
CTD
PMID:33512557
NCBI chr 2:73,762,213...73,780,149
Ensembl chr 2:73,761,782...73,780,132
G
DUSP4
dual specificity phosphatase 4
decreases expression
EXP
picoxystrobin results in decreased expression of DUSP4 mRNA
CTD
PMID:33512557
NCBI chr 8:29,333,064...29,350,684
Ensembl chr 8:29,333,064...29,350,684
G
DYRK3
dual specificity tyrosine phosphorylation regulated kinase 3
increases expression
EXP
picoxystrobin results in increased expression of DYRK3 mRNA
CTD
PMID:33512557
NCBI chr 1:206,635,536...206,655,158
Ensembl chr 1:206,635,536...206,684,419
G
E2F7
E2F transcription factor 7
increases expression
EXP
picoxystrobin results in increased expression of E2F7 mRNA
CTD
PMID:33512557
NCBI chr12:77,021,251...77,065,569
Ensembl chr12:77,021,248...77,065,569
G
ECI1
enoyl-CoA delta isomerase 1
decreases expression
EXP
picoxystrobin results in decreased expression of ECI1 mRNA
CTD
PMID:33512557
NCBI chr16:2,239,402...2,251,587
Ensembl chr16:2,239,402...2,252,300
G
EEF1B2
eukaryotic translation elongation factor 1 beta 2
increases expression
EXP
picoxystrobin results in increased expression of EEF1B2 mRNA
CTD
PMID:33512557
NCBI chr 2:206,159,609...206,162,928
Ensembl chr 2:206,159,585...206,162,928
G
EIF1
eukaryotic translation initiation factor 1
decreases expression
EXP
picoxystrobin results in decreased expression of EIF1 mRNA
CTD
PMID:33512557
NCBI chr17:41,688,885...41,692,668
Ensembl chr17:41,688,885...41,692,668
G
EIF2B1
eukaryotic translation initiation factor 2B subunit alpha
increases expression
EXP
picoxystrobin results in increased expression of EIF2B1 mRNA
CTD
PMID:33512557
NCBI chr12:123,620,406...123,633,686
Ensembl chr12:123,620,406...123,633,766
G
EIF2S1
eukaryotic translation initiation factor 2 subunit alpha
decreases expression
EXP
picoxystrobin results in decreased expression of EIF2S1 mRNA
CTD
PMID:33512557
NCBI chr14:67,360,328...67,386,516
Ensembl chr14:67,360,328...67,386,516
G
EIF2S2
eukaryotic translation initiation factor 2 subunit beta
increases expression
EXP
picoxystrobin results in increased expression of EIF2S2 mRNA
CTD
PMID:33512557
NCBI chr20:34,088,309...34,112,243
Ensembl chr20:34,088,309...34,112,243
G
EIF3C
eukaryotic translation initiation factor 3 subunit C
decreases expression
EXP
picoxystrobin results in decreased expression of EIF3C mRNA
CTD
PMID:33512557
NCBI chr16:28,688,558...28,735,730
Ensembl chr16:28,688,558...28,735,727
G
EIF3D
eukaryotic translation initiation factor 3 subunit D
increases expression
EXP
picoxystrobin results in increased expression of EIF3D mRNA
CTD
PMID:33512557
NCBI chr22:36,510,855...36,529,166
Ensembl chr22:36,510,855...36,529,184
G
EIF3K
eukaryotic translation initiation factor 3 subunit K
increases expression
EXP
picoxystrobin results in increased expression of EIF3K mRNA
CTD
PMID:33512557
NCBI chr19:38,619,188...38,636,954
Ensembl chr19:38,619,082...38,636,955
G
EIF4B
eukaryotic translation initiation factor 4B
increases expression
EXP
picoxystrobin results in increased expression of EIF4B mRNA
CTD
PMID:33512557
NCBI chr12:53,006,456...53,042,215
Ensembl chr12:53,006,282...53,042,215
G
EIF4EBP1
eukaryotic translation initiation factor 4E binding protein 1
increases expression
EXP
picoxystrobin results in increased expression of EIF4EBP1 mRNA
CTD
PMID:33512557
NCBI chr 8:38,030,534...38,060,365
Ensembl chr 8:38,030,534...38,060,365
G
ELP1
elongator acetyltransferase complex subunit 1
decreases expression
EXP
picoxystrobin results in decreased expression of ELP1 mRNA
CTD
PMID:33512557
NCBI chr 9:108,867,517...108,934,124
Ensembl chr 9:108,866,898...108,934,328
G
EMX1
empty spiracles homeobox 1
decreases expression
EXP
picoxystrobin results in decreased expression of EMX1 mRNA
CTD
PMID:33512557
NCBI chr 2:72,916,189...72,934,891
Ensembl chr 2:72,916,260...72,936,071
G
EMX2
empty spiracles homeobox 2
decreases expression
EXP
picoxystrobin results in decreased expression of EMX2 mRNA
CTD
PMID:33512557
NCBI chr10:117,542,746...117,549,546
Ensembl chr10:117,542,445...117,549,546
G
ENO2
enolase 2
decreases expression
EXP
picoxystrobin results in decreased expression of ENO2 mRNA
CTD
PMID:33512557
NCBI chr12:6,914,580...6,923,697
Ensembl chr12:6,913,745...6,923,698
G
EP300
E1A binding protein p300
decreases expression
EXP
picoxystrobin results in decreased expression of EP300 mRNA
CTD
PMID:33512557
NCBI chr22:41,092,592...41,180,077
Ensembl chr22:41,092,592...41,180,077
G
EPHA3
EPH receptor A3
decreases expression
EXP
picoxystrobin results in decreased expression of EPHA3 mRNA
CTD
PMID:33512557
NCBI chr 3:89,107,621...89,482,134
Ensembl chr 3:89,107,621...89,482,134
G
EPHB2
EPH receptor B2
decreases expression
EXP
picoxystrobin results in decreased expression of EPHB2 mRNA
CTD
PMID:33512557
NCBI chr 1:22,710,838...22,921,500
Ensembl chr 1:22,710,839...22,921,500
G
ERO1A
endoplasmic reticulum oxidoreductase 1 alpha
increases expression
EXP
picoxystrobin results in increased expression of ERO1A mRNA
CTD
PMID:33512557
NCBI chr14:52,639,915...52,695,558
Ensembl chr14:52,639,915...52,695,900
G
ESR2
estrogen receptor 2
multiple interactions
EXP
picoxystrobin inhibits the reaction [Estradiol results in increased activity of ESR2 protein]
CTD
PMID:30818834
NCBI chr14:64,226,707...64,338,613
Ensembl chr14:64,084,232...64,338,112
G
ESRRA
estrogen related receptor alpha
multiple interactions
EXP
picoxystrobin inhibits the reaction [PPARGC1A protein results in increased activity of ESRRA protein]; picoxystrobin inhibits the reaction [XCT790 results in decreased activity of ESRRA protein]
CTD
PMID:30818834
NCBI chr11:64,305,524...64,316,743
Ensembl chr11:64,305,497...64,316,743
G
ETV1
ETS variant transcription factor 1
decreases expression
EXP
picoxystrobin results in decreased expression of ETV1 mRNA
CTD
PMID:33512557
NCBI chr 7:13,891,229...13,991,425
Ensembl chr 7:13,891,229...13,991,425
G
EVL
Enah/Vasp-like
decreases expression
EXP
picoxystrobin results in decreased expression of EVL mRNA
CTD
PMID:33512557
NCBI chr14:99,971,422...100,144,236
Ensembl chr14:99,971,449...100,144,236
G
EXO1
exonuclease 1
increases expression
EXP
picoxystrobin results in increased expression of EXO1 mRNA
CTD
PMID:33512557
NCBI chr 1:241,847,986...241,889,939
Ensembl chr 1:241,847,967...241,895,148
G
EXOSC8
exosome component 8
increases expression
EXP
picoxystrobin results in increased expression of EXOSC8 mRNA
CTD
PMID:33512557
NCBI chr13:37,000,786...37,009,614
Ensembl chr13:36,998,816...37,025,881
G
EXT1
exostosin glycosyltransferase 1
decreases expression
EXP
picoxystrobin results in decreased expression of EXT1 mRNA
CTD
PMID:33512557
NCBI chr 8:117,794,490...118,111,826
Ensembl chr 8:117,794,490...118,111,826
G
FAM13A
family with sequence similarity 13 member A
decreases expression
EXP
picoxystrobin results in decreased expression of FAM13A mRNA
CTD
PMID:33512557
NCBI chr 4:88,725,960...89,057,185
Ensembl chr 4:88,725,955...89,111,398
G
FAM174A
family with sequence similarity 174 member A
decreases expression
EXP
picoxystrobin results in decreased expression of FAM174A mRNA
CTD
PMID:33512557
NCBI chr 5:100,535,374...100,586,741
Ensembl chr 5:100,535,374...100,586,741
G
FAM72A
family with sequence similarity 72 member A
decreases expression
EXP
picoxystrobin results in decreased expression of FAM72A mRNA
CTD
PMID:33512557
NCBI chr 1:206,186,179...206,205,773
Ensembl chr 1:206,186,179...206,204,414
G
FAS
Fas cell surface death receptor
increases expression
EXP
picoxystrobin results in increased expression of FAS mRNA
CTD
PMID:33512557
NCBI chr10:88,964,050...89,017,059
Ensembl chr10:88,953,813...89,029,605
G
FBL
fibrillarin
increases expression
EXP
picoxystrobin results in increased expression of FBL mRNA
CTD
PMID:33512557
NCBI chr19:39,834,458...39,846,379
Ensembl chr19:39,834,458...39,846,379
G
FBXO11
F-box protein 11
increases expression
EXP
picoxystrobin results in increased expression of FBXO11 mRNA
CTD
PMID:33512557
NCBI chr 2:47,806,920...47,906,498
Ensembl chr 2:47,789,316...47,906,498
G
FBXO7
F-box protein 7
decreases expression
EXP
picoxystrobin results in decreased expression of FBXO7 mRNA
CTD
PMID:33512557
NCBI chr22:32,474,811...32,498,829
Ensembl chr22:32,474,676...32,498,829
G
FCHO1
FCH and mu domain containing endocytic adaptor 1
decreases expression
EXP
picoxystrobin results in decreased expression of FCHO1 mRNA
CTD
PMID:33512557
NCBI chr19:17,747,744...17,788,561
Ensembl chr19:17,747,718...17,788,568
G
FDFT1
farnesyl-diphosphate farnesyltransferase 1
increases expression
EXP
picoxystrobin results in increased expression of FDFT1 mRNA
CTD
PMID:33512557
NCBI chr 8:11,795,582...11,839,309
Ensembl chr 8:11,795,573...11,839,395
G
FDPS
farnesyl diphosphate synthase
increases expression
EXP
picoxystrobin results in increased expression of FDPS mRNA
CTD
PMID:33512557
NCBI chr 1:155,308,866...155,320,665
Ensembl chr 1:155,308,748...155,320,666
G
FEN1
flap structure-specific endonuclease 1
increases expression
EXP
picoxystrobin results in increased expression of FEN1 mRNA
CTD
PMID:33512557
NCBI chr11:61,792,911...61,797,238
Ensembl chr11:61,792,911...61,797,238
G
FKBP14
FKBP prolyl isomerase 14
decreases expression
EXP
picoxystrobin results in decreased expression of FKBP14 mRNA
CTD
PMID:33512557
NCBI chr 7:30,005,923...30,026,702
Ensembl chr 7:30,010,587...30,026,702
G
FKBP1A
FKBP prolyl isomerase 1A
increases expression
EXP
picoxystrobin results in increased expression of FKBP1A mRNA
CTD
PMID:33512557
NCBI chr20:1,368,978...1,393,054
Ensembl chr20:1,368,977...1,393,164
G
FKBP5
FKBP prolyl isomerase 5
increases expression
EXP
picoxystrobin results in increased expression of FKBP5 mRNA
CTD
PMID:33512557
NCBI chr 6:35,573,590...35,728,583
Ensembl chr 6:35,573,585...35,728,583
G
FLNA
filamin A
decreases expression
EXP
picoxystrobin results in decreased expression of FLNA mRNA
CTD
PMID:33512557
NCBI chr X:154,348,531...154,374,634
Ensembl chr X:154,348,524...154,374,634
G
FN1
fibronectin 1
decreases expression
EXP
picoxystrobin results in decreased expression of FN1 mRNA
CTD
PMID:33512557
NCBI chr 2:215,360,865...215,436,068
Ensembl chr 2:215,360,440...215,436,073
G
FOSL1
FOS like 1, AP-1 transcription factor subunit
increases expression
EXP
picoxystrobin results in increased expression of FOSL1 mRNA
CTD
PMID:33512557
NCBI chr11:65,892,049...65,900,545
Ensembl chr11:65,892,049...65,900,573
G
FOXO4
forkhead box O4
decreases expression
EXP
picoxystrobin results in decreased expression of FOXO4 mRNA
CTD
PMID:33512557
NCBI chr X:71,095,851...71,103,532
Ensembl chr X:71,095,851...71,103,532
G
FPGS
folylpolyglutamate synthase
decreases expression
EXP
picoxystrobin results in decreased expression of FPGS mRNA
CTD
PMID:33512557
NCBI chr 9:127,802,858...127,814,506
Ensembl chr 9:127,794,597...127,814,327
G
FRS2
fibroblast growth factor receptor substrate 2
decreases expression
EXP
picoxystrobin results in decreased expression of FRS2 mRNA
CTD
PMID:33512557
NCBI chr12:69,470,388...69,579,793
Ensembl chr12:69,470,349...69,579,793
G
FSD1
fibronectin type III and SPRY domain containing 1
decreases expression
EXP
picoxystrobin results in decreased expression of FSD1 mRNA
CTD
PMID:33512557
NCBI chr19:4,304,598...4,323,836
Ensembl chr19:4,304,598...4,323,843
G
FSTL1
follistatin like 1
decreases expression
EXP
picoxystrobin results in decreased expression of FSTL1 mRNA
CTD
PMID:33512557
NCBI chr 3:120,392,293...120,450,992
Ensembl chr 3:120,392,293...120,451,016
G
FTH1
ferritin heavy chain 1
increases expression
EXP
picoxystrobin results in increased expression of FTH1 mRNA
CTD
PMID:33512557
NCBI chr11:61,964,285...61,967,634
Ensembl chr11:61,959,718...61,967,634
G
FTL
ferritin light chain
increases expression
EXP
picoxystrobin results in increased expression of FTL mRNA
CTD
PMID:33512557
NCBI chr19:48,965,309...48,966,879
Ensembl chr19:48,965,309...48,966,879
G
FYN
FYN proto-oncogene, Src family tyrosine kinase
decreases expression
EXP
picoxystrobin results in decreased expression of FYN mRNA
CTD
PMID:33512557
NCBI chr 6:111,660,332...111,873,452
Ensembl chr 6:111,660,332...111,873,452
G
G6PD
glucose-6-phosphate dehydrogenase
decreases expression
EXP
picoxystrobin results in decreased expression of G6PD mRNA
CTD
PMID:33512557
NCBI chr X:154,531,390...154,547,569
Ensembl chr X:154,517,825...154,547,572
G
GAA
alpha glucosidase
decreases expression
EXP
picoxystrobin results in decreased expression of GAA mRNA
CTD
PMID:33512557
NCBI chr17:80,101,581...80,119,881
Ensembl chr17:80,101,533...80,119,881
G
GABBR1
gamma-aminobutyric acid type B receptor subunit 1
decreases expression
EXP
picoxystrobin results in decreased expression of GABBR1 mRNA
CTD
PMID:33512557
NCBI chr 6:29,602,238...29,633,183
Ensembl chr 6:29,555,629...29,633,976
G
GADD45A
growth arrest and DNA damage inducible alpha
increases expression
EXP
picoxystrobin results in increased expression of GADD45A mRNA
CTD
PMID:33512557
NCBI chr 1:67,685,201...67,688,334
Ensembl chr 1:67,685,201...67,688,334
G
GAGE2A
G antigen 2A
decreases expression
EXP
picoxystrobin results in decreased expression of GAGE2A mRNA
CTD
PMID:33512557
NCBI chr X:49,589,496...49,596,824
Ensembl chr X:49,589,496...49,596,824
G
GALNT3
polypeptide N-acetylgalactosaminyltransferase 3
decreases expression
EXP
picoxystrobin results in decreased expression of GALNT3 mRNA
CTD
PMID:33512557
NCBI chr 2:165,747,588...165,794,692
Ensembl chr 2:165,747,588...165,794,659
G
GAP43
growth associated protein 43
decreases expression
EXP
picoxystrobin results in decreased expression of GAP43 mRNA
CTD
PMID:33512557
NCBI chr 3:115,623,510...115,721,483
Ensembl chr 3:115,623,510...115,721,490
G
GCLM
glutamate-cysteine ligase modifier subunit
increases expression
EXP
picoxystrobin results in increased expression of GCLM mRNA
CTD
PMID:33512557
NCBI chr 1:93,885,199...93,909,430
Ensembl chr 1:93,885,199...93,909,456
G
GDF15
growth differentiation factor 15
increases expression
EXP
picoxystrobin results in increased expression of GDF15 mRNA
CTD
PMID:33512557
NCBI chr19:18,386,158...18,389,176
Ensembl chr19:18,374,731...18,389,176
G
GEMIN5
gem nuclear organelle associated protein 5
decreases expression
EXP
picoxystrobin results in decreased expression of GEMIN5 mRNA
CTD
PMID:33512557
NCBI chr 5:154,887,411...154,938,211
Ensembl chr 5:154,887,411...154,938,211
G
GEN1
GEN1 Holliday junction 5' flap endonuclease
decreases expression
EXP
picoxystrobin results in decreased expression of GEN1 mRNA
CTD
PMID:33512557
NCBI chr 2:17,753,278...17,788,946
Ensembl chr 2:17,753,858...17,788,946
G
GFUS
GDP-L-fucose synthase
increases expression
EXP
picoxystrobin results in increased expression of GFUS mRNA
CTD
PMID:33512557
NCBI chr 8:143,612,618...143,618,048
Ensembl chr 8:143,612,618...143,618,048
G
GGH
gamma-glutamyl hydrolase
increases expression
EXP
picoxystrobin results in increased expression of GGH mRNA
CTD
PMID:33512557
NCBI chr 8:63,015,079...63,038,806
Ensembl chr 8:63,014,881...63,039,407
G
GIMAP8
GTPase, IMAP family member 8
decreases expression
EXP
picoxystrobin results in decreased expression of GIMAP8 mRNA
CTD
PMID:33512557
NCBI chr 7:150,450,630...150,479,393
Ensembl chr 7:150,450,630...150,479,393
G
GINS2
GINS complex subunit 2
increases expression
EXP
picoxystrobin results in increased expression of GINS2 mRNA
CTD
PMID:33512557
NCBI chr16:85,676,198...85,688,954
Ensembl chr16:85,676,198...85,690,073
G
GINS3
GINS complex subunit 3
decreases expression
EXP
picoxystrobin results in decreased expression of GINS3 mRNA
CTD
PMID:33512557
NCBI chr16:58,392,471...58,406,147
Ensembl chr16:58,295,080...58,406,147
G
GJA1
gap junction protein alpha 1
increases expression
EXP
picoxystrobin results in increased expression of GJA1 mRNA
CTD
PMID:33512557
NCBI chr 6:121,435,646...121,449,727
Ensembl chr 6:121,435,595...121,449,727
G
GLB1
galactosidase beta 1
affects expression
EXP
picoxystrobin affects the expression of GLB1 mRNA
CTD
PMID:33512557
NCBI chr 3:32,961,108...33,097,146
Ensembl chr 3:32,996,609...33,097,202
G
GLI3
GLI family zinc finger 3
decreases expression
EXP
picoxystrobin results in decreased expression of GLI3 mRNA
CTD
PMID:33512557
NCBI chr 7:41,960,949...42,264,268
Ensembl chr 7:41,960,949...42,264,100
G
GLRX
glutaredoxin
decreases expression
EXP
picoxystrobin results in decreased expression of GLRX mRNA
CTD
PMID:33512557
NCBI chr 5:95,813,849...95,822,726
Ensembl chr 5:95,751,319...95,822,726
G
GMNN
geminin DNA replication inhibitor
increases expression
EXP
picoxystrobin results in increased expression of GMNN mRNA
CTD
PMID:33512557
NCBI chr 6:24,774,937...24,786,099
Ensembl chr 6:24,774,931...24,786,099
G
GNAI2
G protein subunit alpha i2
decreases expression
EXP
picoxystrobin results in decreased expression of GNAI2 mRNA
CTD
PMID:33512557
NCBI chr 3:50,227,068...50,263,358
Ensembl chr 3:50,226,292...50,259,362
G
GNB3
G protein subunit beta 3
decreases expression
EXP
picoxystrobin results in decreased expression of GNB3 mRNA
CTD
PMID:33512557
NCBI chr12:6,840,925...6,847,393
Ensembl chr12:6,839,954...6,847,393
G
GNMT
glycine N-methyltransferase
decreases expression
EXP
picoxystrobin results in decreased expression of GNMT mRNA
CTD
PMID:33512557
NCBI chr 6:42,960,754...42,963,880
Ensembl chr 6:42,960,754...42,963,880
G
GNS
glucosamine (N-acetyl)-6-sulfatase
increases expression
EXP
picoxystrobin results in increased expression of GNS mRNA
CTD
PMID:33512557
NCBI chr12:64,713,449...64,759,406
Ensembl chr12:64,713,445...64,759,431
G
GOLT1B
golgi transport 1B
increases expression
EXP
picoxystrobin results in increased expression of GOLT1B mRNA
CTD
PMID:33512557
NCBI chr12:21,501,789...21,518,408
Ensembl chr12:21,501,781...21,518,408
G
GPC1
glypican 1
decreases expression
EXP
picoxystrobin results in decreased expression of GPC1 mRNA
CTD
PMID:33512557
NCBI chr 2:240,435,663...240,468,076
Ensembl chr 2:240,435,663...240,468,076
G
GPI
glucose-6-phosphate isomerase
increases expression
EXP
picoxystrobin results in increased expression of GPI mRNA
CTD
PMID:33512557
NCBI chr19:34,359,718...34,402,413
Ensembl chr19:34,359,480...34,402,413
G
GPR89B
G protein-coupled receptor 89B
increases expression
EXP
picoxystrobin results in increased expression of GPR89B mRNA
CTD
PMID:33512557
NCBI chr 1:147,928,420...148,025,934
Ensembl chr 1:147,928,393...147,993,592 Ensembl chr 1:147,928,393...147,993,592 Ensembl chr 1:147,928,393...147,993,592
G
GRB10
growth factor receptor bound protein 10
increases expression
EXP
picoxystrobin results in increased expression of GRB10 mRNA
CTD
PMID:33512557
NCBI chr 7:50,590,068...50,793,453
Ensembl chr 7:50,590,063...50,793,462
G
GREB1
growth regulating estrogen receptor binding 1
decreases expression
EXP
picoxystrobin results in decreased expression of GREB1 mRNA
CTD
PMID:33512557
NCBI chr 2:11,482,888...11,642,788
Ensembl chr 2:11,482,341...11,642,788
G
GRIA2
glutamate ionotropic receptor AMPA type subunit 2
decreases expression
EXP
picoxystrobin results in decreased expression of GRIA2 mRNA
CTD
PMID:33512557
NCBI chr 4:157,220,120...157,366,075
Ensembl chr 4:157,204,182...157,387,146
G
GRM4
glutamate metabotropic receptor 4
decreases expression
EXP
picoxystrobin results in decreased expression of GRM4 mRNA
CTD
PMID:33512557
NCBI chr 6:34,018,643...34,155,622
Ensembl chr 6:34,018,643...34,155,622
G
GSTM2
glutathione S-transferase mu 2
decreases expression
EXP
picoxystrobin results in decreased expression of GSTM2 mRNA
CTD
PMID:33512557
NCBI chr 1:109,668,057...109,683,997
Ensembl chr 1:109,668,022...109,709,551
G
GSTM3
glutathione S-transferase mu 3
increases expression
EXP
picoxystrobin results in increased expression of GSTM3 mRNA
CTD
PMID:33512557
NCBI chr 1:109,733,937...109,741,038
Ensembl chr 1:109,733,932...109,741,038
G
GTF2E2
general transcription factor IIE subunit 2
increases expression
EXP
picoxystrobin results in increased expression of GTF2E2 mRNA
CTD
PMID:33512557
NCBI chr 8:30,578,318...30,658,236
Ensembl chr 8:30,578,318...30,658,236
G
GTPBP8
GTP binding protein 8 (putative)
increases expression
EXP
picoxystrobin results in increased expression of GTPBP8 mRNA
CTD
PMID:33512557
NCBI chr 3:112,990,984...113,001,969
Ensembl chr 3:112,990,984...113,015,060
G
GUCY2C
guanylate cyclase 2C
decreases expression
EXP
picoxystrobin results in decreased expression of GUCY2C mRNA
CTD
PMID:33512557
NCBI chr12:14,612,632...14,696,599
Ensembl chr12:14,612,632...14,696,599
G
GUSB
glucuronidase beta
increases expression
EXP
picoxystrobin results in increased expression of GUSB mRNA
CTD
PMID:33512557
NCBI chr 7:65,960,684...65,982,213
Ensembl chr 7:65,960,684...65,982,215
G
GUSBP15
GUSB pseudogene 15
decreases expression
EXP
picoxystrobin results in decreased expression of GUSBP15 mRNA
CTD
PMID:33512557
NCBI chr 5:70,481,043...70,585,722
Ensembl chr 5:70,516,387...70,555,266
G
GXYLT1
glucoside xylosyltransferase 1
increases expression
EXP
picoxystrobin results in increased expression of GXYLT1 mRNA
CTD
PMID:33512557
NCBI chr12:42,081,845...42,144,874
Ensembl chr12:42,081,845...42,144,874
G
H1-4
H1.4 linker histone, cluster member
decreases expression
EXP
picoxystrobin results in decreased expression of H1-4 mRNA
CTD
PMID:33512557
NCBI chr 6:26,156,329...26,157,115
Ensembl chr 6:26,156,329...26,157,115
G
H2AZ2
H2A.Z variant histone 2
increases expression
EXP
picoxystrobin results in increased expression of H2AZ2 mRNA
CTD
PMID:33512557
NCBI chr 7:44,826,889...44,848,126
Ensembl chr 7:44,826,791...44,848,087
G
HAT1
histone acetyltransferase 1
increases expression
EXP
picoxystrobin results in increased expression of HAT1 mRNA
CTD
PMID:33512557
NCBI chr 2:171,922,461...171,983,686
Ensembl chr 2:171,922,448...171,983,686
G
HAUS1
HAUS augmin like complex subunit 1
increases expression
EXP
picoxystrobin results in increased expression of HAUS1 mRNA
CTD
PMID:33512557
NCBI chr18:46,104,385...46,128,333
Ensembl chr18:46,104,378...46,128,333
G
HBA2
hemoglobin subunit alpha 2
increases expression
EXP
picoxystrobin results in increased expression of HBA2 mRNA
CTD
PMID:33512557
NCBI chr16:172,876...173,710
Ensembl chr16:172,876...173,710
G
HDAC2
histone deacetylase 2
decreases expression
EXP
picoxystrobin results in decreased expression of HDAC2 mRNA
CTD
PMID:33512557
NCBI chr 6:113,933,028...113,971,148
Ensembl chr 6:113,933,028...114,011,308
G
HDAC9
histone deacetylase 9
decreases expression
EXP
picoxystrobin results in decreased expression of HDAC9 mRNA
CTD
PMID:33512557
NCBI chr 7:18,086,825...19,002,416
Ensembl chr 7:18,086,949...19,002,416
G
HDGFL3
HDGF like 3
decreases expression
EXP
picoxystrobin results in decreased expression of HDGFL3 mRNA
CTD
PMID:33512557
NCBI chr15:83,112,738...83,207,823
Ensembl chr15:83,112,738...83,207,823
G
HELLS
helicase, lymphoid specific
increases expression
EXP
picoxystrobin results in increased expression of HELLS mRNA
CTD
PMID:33512557
NCBI chr10:94,545,788...94,613,905
Ensembl chr10:94,545,329...94,613,905
G
HERC5
HECT and RLD domain containing E3 ubiquitin protein ligase 5
increases expression
EXP
picoxystrobin results in increased expression of HERC5 mRNA
CTD
PMID:33512557
NCBI chr 4:88,457,119...88,506,163
Ensembl chr 4:88,457,119...88,506,163
G
HERPUD1
homocysteine inducible ER protein with ubiquitin like domain 1
increases expression
EXP
picoxystrobin results in increased expression of HERPUD1 mRNA
CTD
PMID:33512557
NCBI chr16:56,932,142...56,944,864
Ensembl chr16:56,932,142...56,944,864
G
HES5
hes family bHLH transcription factor 5
decreases expression
EXP
picoxystrobin results in decreased expression of HES5 mRNA
CTD
PMID:33512557
NCBI chr 1:2,528,745...2,530,263
Ensembl chr 1:2,528,745...2,530,263
G
HEXB
hexosaminidase subunit beta
increases expression
EXP
picoxystrobin results in increased expression of HEXB mRNA
CTD
PMID:33512557
NCBI chr 5:74,640,023...74,721,288
Ensembl chr 5:74,640,023...74,722,647
G
HMGCR
3-hydroxy-3-methylglutaryl-CoA reductase
increases expression
EXP
picoxystrobin results in increased expression of HMGCR mRNA
CTD
PMID:33512557
NCBI chr 5:75,336,529...75,362,116
Ensembl chr 5:75,336,329...75,364,001
G
HMMR
hyaluronan mediated motility receptor
decreases expression
EXP
picoxystrobin results in decreased expression of HMMR mRNA
CTD
PMID:33512557
NCBI chr 5:163,460,632...163,491,941
Ensembl chr 5:163,460,203...163,491,941
G
HMOX1
heme oxygenase 1
increases expression
EXP
picoxystrobin results in increased expression of HMOX1 mRNA
CTD
PMID:33512557
NCBI chr22:35,381,096...35,394,207
Ensembl chr22:35,380,361...35,394,214
G
HNRNPM
heterogeneous nuclear ribonucleoprotein M
decreases expression
EXP
picoxystrobin results in decreased expression of HNRNPM mRNA
CTD
PMID:33512557
NCBI chr19:8,444,975...8,489,114
Ensembl chr19:8,444,767...8,489,114
G
HOMER2
homer scaffold protein 2
decreases expression
EXP
picoxystrobin results in decreased expression of HOMER2 mRNA
CTD
PMID:33512557
NCBI chr15:82,834,661...82,986,157
Ensembl chr15:82,836,946...82,986,153
G
HPRT1
hypoxanthine phosphoribosyltransferase 1
increases expression
EXP
picoxystrobin results in increased expression of HPRT1 mRNA
CTD
PMID:33512557
NCBI chr X:134,460,165...134,500,668
Ensembl chr X:134,460,165...134,520,513
G
HSP90AA1
heat shock protein 90 alpha family class A member 1
increases expression
EXP
picoxystrobin results in increased expression of HSP90AA1 mRNA
CTD
PMID:33512557
NCBI chr14:102,080,742...102,139,749
Ensembl chr14:102,080,742...102,139,699
G
HSP90B1
heat shock protein 90 beta family member 1
increases expression
EXP
picoxystrobin results in increased expression of HSP90B1 mRNA
CTD
PMID:33512557
NCBI chr12:103,930,410...103,947,926
Ensembl chr12:103,930,107...103,953,931
G
HSPA13
heat shock protein family A (Hsp70) member 13
increases expression
EXP
picoxystrobin results in increased expression of HSPA13 mRNA
CTD
PMID:33512557
NCBI chr21:14,371,115...14,383,146
Ensembl chr21:14,371,115...14,383,484
G
HSPA1B
heat shock protein family A (Hsp70) member 1B
increases expression
EXP
picoxystrobin results in increased expression of HSPA1B mRNA
CTD
PMID:33512557
NCBI chr 6:31,827,738...31,830,254
Ensembl chr 6:31,827,738...31,830,254
G
HSPA2
heat shock protein family A (Hsp70) member 2
decreases expression
EXP
picoxystrobin results in decreased expression of HSPA2 mRNA
CTD
PMID:33512557
NCBI chr14:64,535,905...64,543,237
Ensembl chr14:64,535,905...64,546,173
G
HSPA4
heat shock protein family A (Hsp70) member 4
increases expression
EXP
picoxystrobin results in increased expression of HSPA4 mRNA
CTD
PMID:33512557
NCBI chr 5:133,052,013...133,106,449
Ensembl chr 5:133,052,013...133,106,449
G
HSPA6
heat shock protein family A (Hsp70) member 6
increases expression
EXP
picoxystrobin results in increased expression of HSPA6 mRNA
CTD
PMID:33512557
NCBI chr 1:161,524,540...161,526,894
Ensembl chr 1:161,524,540...161,526,894
G
HSPD1
heat shock protein family D (Hsp60) member 1
increases expression
EXP
picoxystrobin results in increased expression of HSPD1 mRNA
CTD
PMID:33512557
NCBI chr 2:197,486,584...197,500,274
Ensembl chr 2:197,486,584...197,516,737
G
HSPE1
heat shock protein family E (Hsp10) member 1
increases expression
EXP
picoxystrobin results in increased expression of HSPE1 mRNA
CTD
PMID:33512557
NCBI chr 2:197,500,379...197,503,449
Ensembl chr 2:197,500,140...197,503,449
G
HTATSF1
HIV-1 Tat specific factor 1
decreases expression
EXP
picoxystrobin results in decreased expression of HTATSF1 mRNA
CTD
PMID:33512557
NCBI chr X:136,497,229...136,512,346
Ensembl chr X:136,497,079...136,512,346
G
IARS2
isoleucyl-tRNA synthetase 2, mitochondrial
increases expression
EXP
picoxystrobin results in increased expression of IARS2 mRNA
CTD
PMID:33512557
NCBI chr 1:220,094,132...220,148,041
Ensembl chr 1:220,094,132...220,148,041
G
ID1
inhibitor of DNA binding 1
decreases expression
EXP
picoxystrobin results in decreased expression of ID1 mRNA
CTD
PMID:33512557
NCBI chr20:31,605,289...31,606,510
Ensembl chr20:31,605,283...31,606,515
G
IDI1
isopentenyl-diphosphate delta isomerase 1
increases expression
EXP
picoxystrobin results in increased expression of IDI1 mRNA
CTD
PMID:33512557
NCBI chr10:1,039,152...1,056,704
Ensembl chr10:1,039,152...1,049,119
G
IER2
immediate early response 2
decreases expression
EXP
picoxystrobin results in decreased expression of IER2 mRNA
CTD
PMID:33512557
NCBI chr19:13,150,411...13,154,911
Ensembl chr19:13,150,411...13,154,911
G
IFI44
interferon induced protein 44
increases expression
EXP
picoxystrobin results in increased expression of IFI44 mRNA
CTD
PMID:33512557
NCBI chr 1:78,649,789...78,664,078
Ensembl chr 1:78,649,796...78,664,078
G
IFI44L
interferon induced protein 44 like
increases expression
EXP
picoxystrobin results in increased expression of IFI44L mRNA
CTD
PMID:33512557
NCBI chr 1:78,620,448...78,646,145
Ensembl chr 1:78,619,902...78,646,145
G
IFITM3
interferon induced transmembrane protein 3
decreases expression
EXP
picoxystrobin results in decreased expression of IFITM3 mRNA
CTD
PMID:33512557
NCBI chr11:319,676...320,860
Ensembl chr11:319,676...329,475
G
IFRD1
interferon related developmental regulator 1
increases expression
EXP
picoxystrobin results in increased expression of IFRD1 mRNA
CTD
PMID:33512557
NCBI chr 7:112,423,174...112,477,203
Ensembl chr 7:112,422,887...112,481,017
G
IFRD2
interferon related developmental regulator 2
increases expression
EXP
picoxystrobin results in increased expression of IFRD2 mRNA
CTD
PMID:33512557
NCBI chr 3:50,287,732...50,292,429
Ensembl chr 3:50,287,732...50,292,918
G
IGF1R
insulin like growth factor 1 receptor
decreases expression
EXP
picoxystrobin results in decreased expression of IGF1R mRNA
CTD
PMID:33512557
NCBI chr15:98,648,539...98,964,530
Ensembl chr15:98,648,539...98,964,530
G
IGF2R
insulin like growth factor 2 receptor
decreases expression
EXP
picoxystrobin results in decreased expression of IGF2R mRNA
CTD
PMID:33512557
NCBI chr 6:159,969,082...160,111,504
Ensembl chr 6:159,969,082...160,113,507
G
IGFBP2
insulin like growth factor binding protein 2
decreases expression
EXP
picoxystrobin results in decreased expression of IGFBP2 mRNA
CTD
PMID:33512557
NCBI chr 2:216,632,828...216,664,436
Ensembl chr 2:216,632,828...216,664,436
G
IGFBP4
insulin like growth factor binding protein 4
decreases expression
EXP
picoxystrobin results in decreased expression of IGFBP4 mRNA
CTD
PMID:33512557
NCBI chr17:40,443,450...40,457,725
Ensembl chr17:40,443,450...40,457,725
G
IGHMBP2
immunoglobulin mu DNA binding protein 2
decreases expression
EXP
picoxystrobin results in decreased expression of IGHMBP2 mRNA
CTD
PMID:33512557
NCBI chr11:68,903,891...68,940,601
Ensembl chr11:68,903,863...68,940,602
G
IKBIP
IKBKB interacting protein
increases expression
EXP
picoxystrobin results in increased expression of IKBIP mRNA
CTD
PMID:33512557
NCBI chr12:98,613,404...98,644,788
Ensembl chr12:98,613,405...98,645,113
G
IKZF1
IKAROS family zinc finger 1
decreases expression
EXP
picoxystrobin results in decreased expression of IKZF1 mRNA
CTD
PMID:33512557
NCBI chr 7:50,303,455...50,405,101
Ensembl chr 7:50,304,068...50,405,101
G
ILK
integrin linked kinase
decreases expression
EXP
picoxystrobin results in decreased expression of ILK mRNA
CTD
PMID:33512557
NCBI chr11:6,603,774...6,610,870
Ensembl chr11:6,603,708...6,610,874
G
INA
internexin neuronal intermediate filament protein alpha
decreases expression
EXP
picoxystrobin results in decreased expression of INA mRNA
CTD
PMID:33512557
NCBI chr10:103,277,138...103,290,346
Ensembl chr10:103,277,138...103,290,346
G
IPO5
importin 5
increases expression
EXP
picoxystrobin results in increased expression of IPO5 mRNA
CTD
PMID:33512557
NCBI chr13:97,953,675...98,024,296
Ensembl chr13:97,953,658...98,024,296
G
IRS1
insulin receptor substrate 1
decreases expression
EXP
picoxystrobin results in decreased expression of IRS1 mRNA
CTD
PMID:33512557
NCBI chr 2:226,731,312...226,799,820
Ensembl chr 2:226,731,312...226,799,820
G
ITFG1
integrin alpha FG-GAP repeat containing 1
increases expression
EXP
picoxystrobin results in increased expression of ITFG1 mRNA
CTD
PMID:33512557
NCBI chr16:47,154,391...47,461,246
Ensembl chr16:47,154,387...47,464,149
G
ITGAE
integrin subunit alpha E
increases expression
EXP
picoxystrobin results in increased expression of ITGAE mRNA
CTD
PMID:33512557
NCBI chr17:3,714,628...3,801,188
Ensembl chr17:3,714,628...3,801,188
G
ITGB1
integrin subunit beta 1
increases expression
EXP
picoxystrobin results in increased expression of ITGB1 mRNA
CTD
PMID:33512557
NCBI chr10:32,900,318...32,958,230
Ensembl chr10:32,887,273...33,005,792
G
ITPR2
inositol 1,4,5-trisphosphate receptor type 2
decreases expression
EXP
picoxystrobin results in decreased expression of ITPR2 mRNA
CTD
PMID:33512557
NCBI chr12:26,335,352...26,833,194
Ensembl chr12:26,335,352...26,833,194
G
KAT6B
lysine acetyltransferase 6B
decreases expression
EXP
picoxystrobin results in decreased expression of KAT6B mRNA
CTD
PMID:33512557
NCBI chr10:74,824,936...75,032,624
Ensembl chr10:74,824,927...75,032,624
G
KDELR2
KDEL endoplasmic reticulum protein retention receptor 2
increases expression
EXP
picoxystrobin results in increased expression of KDELR2 mRNA
CTD
PMID:33512557
NCBI chr 7:6,461,089...6,484,152
Ensembl chr 7:6,445,953...6,484,190
G
KDM3A
lysine demethylase 3A
decreases expression
EXP
picoxystrobin results in decreased expression of KDM3A mRNA
CTD
PMID:33512557
NCBI chr 2:86,437,044...86,492,716
Ensembl chr 2:86,440,647...86,492,716
G
KDM5A
lysine demethylase 5A
decreases expression
EXP
picoxystrobin results in decreased expression of KDM5A mRNA
CTD
PMID:33512557
NCBI chr12:280,057...389,320
Ensembl chr12:280,057...389,320
G
KDM5B
lysine demethylase 5B
decreases expression
EXP
picoxystrobin results in decreased expression of KDM5B mRNA
CTD
PMID:33512557
NCBI chr 1:202,724,495...202,808,421
Ensembl chr 1:202,724,495...202,808,487
G
KIAA0753
KIAA0753
decreases expression
EXP
picoxystrobin results in decreased expression of KIAA0753 mRNA
CTD
PMID:33512557
NCBI chr17:6,578,147...6,640,711
Ensembl chr17:6,578,147...6,640,711
G
KIF13A
kinesin family member 13A
decreases expression
EXP
picoxystrobin results in decreased expression of KIF13A mRNA
CTD
PMID:33512557
NCBI chr 6:17,759,126...17,987,635
Ensembl chr 6:17,759,183...17,987,635
G
KIF15
kinesin family member 15
increases expression
EXP
picoxystrobin results in increased expression of KIF15 mRNA
CTD
PMID:33512557
NCBI chr 3:44,761,794...44,868,687
Ensembl chr 3:44,761,721...44,873,376
G
KIF20A
kinesin family member 20A
increases expression
EXP
picoxystrobin results in increased expression of KIF20A mRNA
CTD
PMID:33512557
NCBI chr 5:138,179,112...138,187,723
Ensembl chr 5:138,178,719...138,187,723
G
KIF5C
kinesin family member 5C
decreases expression
EXP
picoxystrobin results in decreased expression of KIF5C mRNA
CTD
PMID:33512557
NCBI chr 2:148,875,227...149,026,759
Ensembl chr 2:148,875,227...149,026,759
G
KLHL24
kelch like family member 24
increases expression
EXP
picoxystrobin results in increased expression of KLHL24 mRNA
CTD
PMID:34642769
NCBI chr 3:183,635,623...183,684,519
Ensembl chr 3:183,635,610...183,684,519
G
KNL1
kinetochore scaffold 1
increases expression
EXP
picoxystrobin results in increased expression of KNL1 mRNA
CTD
PMID:33512557
NCBI chr15:40,594,249...40,664,342
Ensembl chr15:40,594,020...40,664,342
G
KRT18
keratin 18
decreases expression
EXP
picoxystrobin results in decreased expression of KRT18 mRNA
CTD
PMID:33512557
NCBI chr12:52,948,855...52,952,906
Ensembl chr12:52,948,871...52,952,906
G
KRT19
keratin 19
decreases expression
EXP
picoxystrobin results in decreased expression of KRT19 mRNA
CTD
PMID:33512557
NCBI chr17:41,523,617...41,528,308
Ensembl chr17:41,523,617...41,528,308
G
KTN1
kinectin 1
increases expression
EXP
picoxystrobin results in increased expression of KTN1 mRNA
CTD
PMID:33512557
NCBI chr14:55,580,207...55,684,584
Ensembl chr14:55,559,072...55,701,526
G
KYAT3
kynurenine aminotransferase 3
decreases expression
EXP
picoxystrobin results in decreased expression of KYAT3 mRNA
CTD
PMID:33512557
NCBI chr 1:88,921,044...88,992,960
Ensembl chr 1:88,935,773...88,992,953
G
L1CAM
L1 cell adhesion molecule
decreases expression
EXP
picoxystrobin results in decreased expression of L1CAM mRNA
CTD
PMID:33512557
NCBI chr X:153,861,514...153,886,173
Ensembl chr X:153,861,514...153,886,173
G
LAMC2
laminin subunit gamma 2
decreases expression
EXP
picoxystrobin results in decreased expression of LAMC2 mRNA
CTD
PMID:33512557
NCBI chr 1:183,186,264...183,258,968
Ensembl chr 1:183,186,238...183,245,127
G
LAMP1
lysosomal associated membrane protein 1
decreases expression
EXP
picoxystrobin results in decreased expression of LAMP1 mRNA
CTD
PMID:33512557
NCBI chr13:113,297,239...113,323,672
Ensembl chr13:113,297,239...113,323,672
G
LBR
lamin B receptor
increases expression
EXP
picoxystrobin results in increased expression of LBR mRNA
CTD
PMID:33512557
NCBI chr 1:225,401,502...225,428,821
Ensembl chr 1:225,401,502...225,428,925
G
LDHA
lactate dehydrogenase A
increases expression
EXP
picoxystrobin results in increased expression of LDHA mRNA
CTD
PMID:33512557
NCBI chr11:18,394,563...18,408,425
Ensembl chr11:18,394,560...18,408,425
G
LILRB3
leukocyte immunoglobulin like receptor B3
decreases expression
EXP
picoxystrobin results in decreased expression of LILRB3 mRNA
CTD
PMID:33512557
NCBI chr19:54,216,278...54,223,007
Ensembl chr19:54,216,278...54,223,506
G
LMNA
lamin A/C
decreases expression
EXP
picoxystrobin results in decreased expression of LMNA mRNA
CTD
PMID:33512557
NCBI chr 1:156,082,573...156,140,081
Ensembl chr 1:156,082,573...156,140,081
G
LMOD1
leiomodin 1
decreases expression
EXP
picoxystrobin results in decreased expression of LMOD1 mRNA
CTD
PMID:33512557
NCBI chr 1:201,896,456...201,946,548
Ensembl chr 1:201,896,456...201,946,548
G
LOXL1
lysyl oxidase like 1
decreases expression
EXP
picoxystrobin results in decreased expression of LOXL1 mRNA
CTD
PMID:33512557
NCBI chr15:73,926,462...73,952,136
Ensembl chr15:73,925,989...73,952,137
G
LPAR2
lysophosphatidic acid receptor 2
decreases expression
EXP
picoxystrobin results in decreased expression of LPAR2 mRNA
CTD
PMID:33512557
NCBI chr19:19,623,655...19,628,220
Ensembl chr19:19,623,655...19,628,930
G
LPCAT1
lysophosphatidylcholine acyltransferase 1
decreases expression
EXP
picoxystrobin results in decreased expression of LPCAT1 mRNA
CTD
PMID:33512557
NCBI chr 5:1,461,427...1,523,960
Ensembl chr 5:1,456,480...1,523,962
G
LRP1
LDL receptor related protein 1
decreases expression
EXP
picoxystrobin results in decreased expression of LRP1 mRNA
CTD
PMID:33512557
NCBI chr12:57,128,483...57,213,361
Ensembl chr12:57,128,483...57,213,361
G
LRP4
LDL receptor related protein 4
decreases expression
EXP
picoxystrobin results in decreased expression of LRP4 mRNA
CTD
PMID:33512557
NCBI chr11:46,856,717...46,918,550
Ensembl chr11:46,856,717...46,918,642
G
LRRC41
leucine rich repeat containing 41
decreases expression
EXP
picoxystrobin results in decreased expression of LRRC41 mRNA
CTD
PMID:33512557
NCBI chr 1:46,277,462...46,303,616
Ensembl chr 1:46,261,196...46,303,616
G
LUM
lumican
increases expression
EXP
picoxystrobin results in increased expression of LUM mRNA
CTD
PMID:33512557
NCBI chr12:91,102,629...91,111,494
Ensembl chr12:91,102,629...91,111,494
G
MAD2L1
mitotic arrest deficient 2 like 1
increases expression
EXP
picoxystrobin results in increased expression of MAD2L1 mRNA
CTD
PMID:33512557
NCBI chr 4:120,055,623...120,066,848
Ensembl chr 4:120,055,623...120,066,858
G
MAFF
MAF bZIP transcription factor F
decreases expression
EXP
picoxystrobin results in decreased expression of MAFF mRNA
CTD
PMID:33512557
NCBI chr22:38,201,994...38,216,511
Ensembl chr22:38,200,767...38,216,507
G
MAFG
MAF bZIP transcription factor G
decreases expression
EXP
picoxystrobin results in decreased expression of MAFG mRNA
CTD
PMID:33512557
NCBI chr17:81,918,270...81,931,244
Ensembl chr17:81,918,270...81,927,735
G
MAGI1
membrane associated guanylate kinase, WW and PDZ domain containing 1
decreases expression
EXP
picoxystrobin results in decreased expression of MAGI1 mRNA
CTD
PMID:33512557
NCBI chr 3:65,353,526...66,038,918
Ensembl chr 3:65,353,525...66,038,918
G
MAP1LC3A
microtubule associated protein 1 light chain 3 alpha
decreases expression
EXP
picoxystrobin results in decreased expression of MAP1LC3A mRNA
CTD
PMID:33512557
NCBI chr20:34,546,844...34,560,345
Ensembl chr20:34,546,854...34,560,345
G
MAP2
microtubule associated protein 2
decreases expression
EXP
picoxystrobin results in decreased expression of MAP2 mRNA
CTD
PMID:33512557
NCBI chr 2:209,424,047...209,734,112
Ensembl chr 2:209,424,047...209,734,147
G
MAP2K4
mitogen-activated protein kinase kinase 4
decreases expression
EXP
picoxystrobin results in decreased expression of MAP2K4 mRNA
CTD
PMID:33512557
NCBI chr17:12,020,877...12,143,828
Ensembl chr17:12,020,829...12,143,830
G
MAP6
microtubule associated protein 6
decreases expression
EXP
picoxystrobin results in decreased expression of MAP6 mRNA
CTD
PMID:33512557
NCBI chr11:75,586,918...75,669,038
Ensembl chr11:75,586,918...75,669,038
G
MAPK14
mitogen-activated protein kinase 14
decreases expression
EXP
picoxystrobin results in decreased expression of MAPK14 mRNA
CTD
PMID:33512557
NCBI chr 6:36,027,808...36,124,214
Ensembl chr 6:36,027,782...36,111,236
G
MAPK3
mitogen-activated protein kinase 3
decreases expression
EXP
picoxystrobin results in decreased expression of MAPK3 mRNA
CTD
PMID:33512557
NCBI chr16:30,114,105...30,123,220
Ensembl chr16:30,114,105...30,123,506
G
MAPKAPK2
MAPK activated protein kinase 2
decreases expression
EXP
picoxystrobin results in decreased expression of MAPKAPK2 mRNA
CTD
PMID:33512557
NCBI chr 1:206,684,905...206,734,281
Ensembl chr 1:206,684,905...206,734,281
G
MAPRE3
microtubule associated protein RP/EB family member 3
decreases expression
EXP
picoxystrobin results in decreased expression of MAPRE3 mRNA
CTD
PMID:33512557
NCBI chr 2:26,970,637...27,027,219
Ensembl chr 2:26,970,637...27,027,219
G
MAPT
microtubule associated protein tau
decreases expression
EXP
picoxystrobin results in decreased expression of MAPT mRNA
CTD
PMID:33512557
NCBI chr17:45,894,554...46,028,334
Ensembl chr17:45,894,527...46,028,334
G
MAT2A
methionine adenosyltransferase 2A
decreases expression
EXP
picoxystrobin results in decreased expression of MAT2A mRNA
CTD
PMID:33512557
NCBI chr 2:85,539,168...85,545,281
Ensembl chr 2:85,539,168...85,545,281
G
MBNL1
muscleblind like splicing regulator 1
decreases expression
EXP
picoxystrobin results in decreased expression of MBNL1 mRNA
CTD
PMID:33512557
NCBI chr 3:152,243,632...152,465,780
Ensembl chr 3:152,243,828...152,465,780
G
MCM10
minichromosome maintenance 10 replication initiation factor
increases expression
EXP
picoxystrobin results in increased expression of MCM10 mRNA
CTD
PMID:33512557
NCBI chr10:13,161,558...13,211,110
Ensembl chr10:13,161,558...13,211,110
G
MCM3
minichromosome maintenance complex component 3
decreases expression
EXP
picoxystrobin results in decreased expression of MCM3 mRNA
CTD
PMID:33512557
NCBI chr 6:52,264,015...52,284,742
Ensembl chr 6:52,264,014...52,284,881
G
MDK
midkine
increases expression
EXP
picoxystrobin results in increased expression of MDK mRNA
CTD
PMID:33512557
NCBI chr11:46,380,784...46,383,837
Ensembl chr11:46,380,756...46,383,837
G
MDM2
MDM2 proto-oncogene
increases expression
EXP
picoxystrobin results in increased expression of MDM2 mRNA
CTD
PMID:33512557
NCBI chr12:68,808,172...68,850,686
Ensembl chr12:68,808,177...68,845,544
G
ME1
malic enzyme 1
increases expression
EXP
picoxystrobin results in increased expression of ME1 mRNA
CTD
PMID:33512557
NCBI chr 6:83,210,402...83,431,051
Ensembl chr 6:83,210,402...83,431,051
G
ME2
malic enzyme 2
increases expression
EXP
picoxystrobin results in increased expression of ME2 mRNA
CTD
PMID:33512557
NCBI chr18:50,879,118...50,954,257
Ensembl chr18:50,879,080...50,954,257
G
MED12
mediator complex subunit 12
decreases expression
EXP
picoxystrobin results in decreased expression of MED12 mRNA
CTD
PMID:33512557
NCBI chr X:71,118,596...71,142,450
Ensembl chr X:71,118,543...71,144,103
G
MED21
mediator complex subunit 21
increases expression
EXP
picoxystrobin results in increased expression of MED21 mRNA
CTD
PMID:33512557
NCBI chr12:27,022,558...27,038,951
Ensembl chr12:27,022,546...27,066,343
G
MEX3B
mex-3 RNA binding family member B
decreases expression
EXP
picoxystrobin results in decreased expression of MEX3B mRNA
CTD
PMID:33512557
NCBI chr15:82,041,778...82,046,018
Ensembl chr15:82,041,778...82,046,119
G
MLLT11
MLLT11 transcription factor 7 cofactor
decreases expression
EXP
picoxystrobin results in decreased expression of MLLT11 mRNA
CTD
PMID:33512557
NCBI chr 1:151,060,397...151,069,544
Ensembl chr 1:151,060,397...151,069,544
G
MMP2
matrix metallopeptidase 2
decreases expression
EXP
picoxystrobin results in decreased expression of MMP2 mRNA
CTD
PMID:33512557
NCBI chr16:55,478,830...55,506,691
Ensembl chr16:55,389,700...55,506,691
G
MNAT1
MNAT1 component of CDK activating kinase
decreases expression
EXP
picoxystrobin results in decreased expression of MNAT1 mRNA
CTD
PMID:33512557
NCBI chr14:60,734,761...60,969,965
Ensembl chr14:60,734,742...60,969,965
G
MND1
meiotic nuclear divisions 1
increases expression
EXP
picoxystrobin results in increased expression of MND1 mRNA
CTD
PMID:33512557
NCBI chr 4:153,344,649...153,415,118
Ensembl chr 4:153,344,649...153,415,118
G
MOB1A
MOB kinase activator 1A
increases expression
EXP
picoxystrobin results in increased expression of MOB1A mRNA
CTD
PMID:33512557
NCBI chr 2:74,152,528...74,178,879
Ensembl chr 2:74,152,528...74,178,898
G
MPO
myeloperoxidase
decreases expression
EXP
picoxystrobin results in decreased expression of MPO mRNA
CTD
PMID:33512557
NCBI chr17:58,269,855...58,280,935
Ensembl chr17:58,269,855...58,280,935
G
MRE11
MRE11 homolog, double strand break repair nuclease
decreases expression
EXP
picoxystrobin results in decreased expression of MRE11 mRNA
CTD
PMID:33512557
NCBI chr11:94,415,570...94,512,412
Ensembl chr11:94,415,570...94,493,885
G
MRPL19
mitochondrial ribosomal protein L19
increases expression
EXP
picoxystrobin results in increased expression of MRPL19 mRNA
CTD
PMID:33512557
NCBI chr 2:75,646,783...75,662,206
Ensembl chr 2:75,646,783...75,690,851
G
MRPL58
mitochondrial ribosomal protein L58
decreases expression
EXP
picoxystrobin results in decreased expression of MRPL58 mRNA
CTD
PMID:33512557
NCBI chr17:75,012,670...75,021,261
Ensembl chr17:75,012,670...75,021,261
G
MRPS16
mitochondrial ribosomal protein S16
increases expression
EXP
picoxystrobin results in increased expression of MRPS16 mRNA
CTD
PMID:33512557
NCBI chr10:73,248,849...73,252,644
Ensembl chr10:73,248,843...73,252,693
G
MRPS17
mitochondrial ribosomal protein S17
increases expression
EXP
picoxystrobin results in increased expression of MRPS17 mRNA
CTD
PMID:33512557
NCBI chr 7:55,951,877...55,956,500
Ensembl chr 7:55,951,877...55,956,500
G
MSH6
mutS homolog 6
increases expression
EXP
picoxystrobin results in increased expression of MSH6 mRNA
CTD
PMID:33512557
NCBI chr 2:47,783,145...47,810,101
Ensembl chr 2:47,695,530...47,810,063
G
MSI2
musashi RNA binding protein 2
decreases expression
EXP
picoxystrobin results in decreased expression of MSI2 mRNA
CTD
PMID:33512557
NCBI chr17:57,255,851...57,701,581
Ensembl chr17:57,255,851...57,684,689
G
MSMO1
methylsterol monooxygenase 1
increases expression
EXP
picoxystrobin results in increased expression of MSMO1 mRNA
CTD
PMID:33512557
NCBI chr 4:165,327,669...165,343,164
Ensembl chr 4:165,327,667...165,343,164
G
MT-ND6
mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 6
decreases expression
EXP
picoxystrobin results in decreased expression of ND6 mRNA
CTD
PMID:33512557
NCBI chr MT:14,149...14,673
Ensembl chr MT:14,149...14,673
G
MTA1
metastasis associated 1
decreases expression
EXP
picoxystrobin results in decreased expression of MTA1 mRNA
CTD
PMID:33512557
NCBI chr14:105,419,827...105,470,729
Ensembl chr14:105,419,820...105,470,729
G
MTFR1
mitochondrial fission regulator 1
increases expression
EXP
picoxystrobin results in increased expression of MTFR1 mRNA
CTD
PMID:33512557
NCBI chr 8:65,643,889...65,778,598
Ensembl chr 8:65,644,734...65,771,261
G
MTHFD2
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase
increases expression
EXP
picoxystrobin results in increased expression of MTHFD2 mRNA
CTD
PMID:33512557
NCBI chr 2:74,198,615...74,217,565
Ensembl chr 2:74,186,172...74,217,565
G
MYCBP2
MYC binding protein 2
decreases expression
EXP
picoxystrobin results in decreased expression of MYCBP2 mRNA
CTD
PMID:33512557
NCBI chr13:77,044,657...77,327,094
Ensembl chr13:77,042,474...77,327,094
G
MYL4
myosin light chain 4
decreases expression
EXP
picoxystrobin results in decreased expression of MYL4 mRNA
CTD
PMID:33512557
NCBI chr17:47,189,433...47,227,650
Ensembl chr17:47,200,446...47,223,679
G
NAMPT
nicotinamide phosphoribosyltransferase
increases expression
EXP
picoxystrobin results in increased expression of NAMPT mRNA
CTD
PMID:33512557
NCBI chr 7:106,248,298...106,285,888
Ensembl chr 7:106,248,298...106,285,966
G
NAV1
neuron navigator 1
decreases expression
EXP
picoxystrobin results in decreased expression of NAV1 mRNA
CTD
PMID:33512557
NCBI chr 1:201,539,127...201,826,969
Ensembl chr 1:201,539,127...201,826,969
G
NCAM1
neural cell adhesion molecule 1
decreases expression
EXP
picoxystrobin results in decreased expression of NCAM1 mRNA
CTD
PMID:33512557
NCBI chr11:112,961,420...113,278,436
Ensembl chr11:112,961,275...113,278,436
G
NCAN
neurocan
decreases expression
EXP
picoxystrobin results in decreased expression of NCAN mRNA
CTD
PMID:33512557
NCBI chr19:19,211,958...19,252,233
Ensembl chr19:19,211,958...19,252,233
G
NCAPH
non-SMC condensin I complex subunit H
increases expression
EXP
picoxystrobin results in increased expression of NCAPH mRNA
CTD
PMID:33512557
NCBI chr 2:96,335,766...96,377,091
Ensembl chr 2:96,335,766...96,377,091
G
NDRG1
N-myc downstream regulated 1
decreases expression
EXP
picoxystrobin results in decreased expression of NDRG1 mRNA
CTD
PMID:33512557
NCBI chr 8:133,237,175...133,297,252
Ensembl chr 8:133,237,175...133,302,022
G
NDUFA1
NADH:ubiquinone oxidoreductase subunit A1
increases expression
EXP
picoxystrobin results in increased expression of NDUFA1 mRNA
CTD
PMID:33512557
NCBI chr X:119,871,832...119,876,662
Ensembl chr X:119,871,832...119,876,662
G
NDUFA4
NDUFA4 mitochondrial complex associated
increases expression
EXP
picoxystrobin results in increased expression of NDUFA4 mRNA
CTD
PMID:33512557
NCBI chr 7:10,931,943...10,940,153
Ensembl chr 7:10,931,943...10,940,153
G
NDUFB3
NADH:ubiquinone oxidoreductase subunit B3
increases expression
EXP
picoxystrobin results in increased expression of NDUFB3 mRNA
CTD
PMID:33512557
NCBI chr 2:201,072,001...201,085,750
Ensembl chr 2:201,071,433...201,085,750
G
NDUFV2
NADH:ubiquinone oxidoreductase core subunit V2
increases expression
EXP
picoxystrobin results in increased expression of NDUFV2 mRNA
CTD
PMID:33512557
NCBI chr18:9,102,699...9,134,341
Ensembl chr18:9,102,630...9,134,345
G
NEFH
neurofilament heavy chain
decreases expression
EXP
picoxystrobin results in decreased expression of NEFH mRNA
CTD
PMID:33512557
NCBI chr22:29,480,218...29,491,390
Ensembl chr22:29,480,218...29,491,390
G
NEFL
neurofilament light chain
decreases expression
EXP
picoxystrobin results in decreased expression of NEFL mRNA
CTD
PMID:33512557
NCBI chr 8:24,950,955...24,956,612
Ensembl chr 8:24,950,955...24,956,721
G
NEIL3
nei like DNA glycosylase 3
increases expression
EXP
picoxystrobin results in increased expression of NEIL3 mRNA
CTD
PMID:33512557
NCBI chr 4:177,309,874...177,371,268
Ensembl chr 4:177,309,874...177,362,936
G
NEK2
NIMA related kinase 2
increases expression
EXP
picoxystrobin results in increased expression of NEK2 mRNA
CTD
PMID:33512557
NCBI chr 1:211,658,256...211,675,621
Ensembl chr 1:211,658,657...211,675,630
G
NENF
neudesin neurotrophic factor
increases expression
EXP
picoxystrobin results in increased expression of NENF mRNA
CTD
PMID:33512557
NCBI chr 1:212,432,920...212,446,379
Ensembl chr 1:212,432,920...212,446,379
G
NFATC3
nuclear factor of activated T cells 3
decreases expression
EXP
picoxystrobin results in decreased expression of NFATC3 mRNA
CTD
PMID:33512557
NCBI chr16:68,085,370...68,229,259
Ensembl chr16:68,084,751...68,229,259
G
NFE2L2
NFE2 like bZIP transcription factor 2
increases activity decreases expression
EXP
picoxystrobin results in increased activity of NFE2L2 protein picoxystrobin results in decreased expression of NFE2L2 mRNA
CTD
PMID:30818834 PMID:33512557
NCBI chr 2:177,230,303...177,264,727
Ensembl chr 2:177,218,667...177,392,756
G
NFIL3
nuclear factor, interleukin 3 regulated
decreases expression
EXP
picoxystrobin results in decreased expression of NFIL3 mRNA
CTD
PMID:33512557
NCBI chr 9:91,409,045...91,483,497
Ensembl chr 9:91,409,045...91,423,832
G
NFKBIB
NFKB inhibitor beta
decreases expression
EXP
picoxystrobin results in decreased expression of NFKBIB mRNA
CTD
PMID:33512557
NCBI chr19:38,899,666...38,908,889
Ensembl chr19:38,899,700...38,908,893
G
NGRN
neugrin, neurite outgrowth associated
decreases expression
EXP
picoxystrobin results in decreased expression of NGRN mRNA
CTD
PMID:33512557
NCBI chr15:90,265,663...90,272,211
Ensembl chr15:90,265,659...90,275,778
G
NHP2
NHP2 ribonucleoprotein
increases expression
EXP
picoxystrobin results in increased expression of NHP2 mRNA
CTD
PMID:33512557
NCBI chr 5:178,149,463...178,153,885
Ensembl chr 5:178,149,463...178,153,894
G
NISCH
nischarin
decreases expression
EXP
picoxystrobin results in decreased expression of NISCH mRNA
CTD
PMID:33512557
NCBI chr 3:52,455,604...52,493,068
Ensembl chr 3:52,455,118...52,493,068
G
NIT1
nitrilase 1
decreases expression
EXP
picoxystrobin results in decreased expression of NIT1 mRNA
CTD
PMID:33512557
NCBI chr 1:161,118,105...161,125,445
Ensembl chr 1:161,118,086...161,125,445
G
NNT
nicotinamide nucleotide transhydrogenase
decreases expression
EXP
picoxystrobin results in decreased expression of NNT mRNA
CTD
PMID:33512557
NCBI chr 5:43,602,675...43,707,396
Ensembl chr 5:43,602,692...43,707,405
G
NOL3
nucleolar protein 3
decreases expression
EXP
picoxystrobin results in decreased expression of NOL3 mRNA
CTD
PMID:33512557
NCBI chr16:67,170,538...67,175,737
Ensembl chr16:67,170,154...67,175,737
G
NOP58
NOP58 ribonucleoprotein
increases expression
EXP
picoxystrobin results in increased expression of NOP58 mRNA
CTD
PMID:33512557
NCBI chr 2:202,265,763...202,303,661
Ensembl chr 2:202,265,736...202,303,661
G
NOS3
nitric oxide synthase 3
affects expression
EXP
picoxystrobin affects the expression of NOS3 mRNA
CTD
PMID:34642769
NCBI chr 7:150,991,017...151,014,588
Ensembl chr 7:150,991,017...151,014,588
G
NOTCH3
notch receptor 3
decreases expression
EXP
picoxystrobin results in decreased expression of NOTCH3 mRNA
CTD
PMID:33512557
NCBI chr19:15,159,038...15,200,995
Ensembl chr19:15,159,038...15,200,995
G
NPDC1
neural proliferation, differentiation and control 1
decreases expression
EXP
picoxystrobin results in decreased expression of NPDC1 mRNA
CTD
PMID:33512557
NCBI chr 9:137,039,463...137,046,177
Ensembl chr 9:137,039,463...137,046,179
G
NPEPL1
aminopeptidase like 1
decreases expression
EXP
picoxystrobin results in decreased expression of NPEPL1 mRNA
CTD
PMID:33512557
NCBI chr20:58,689,131...58,715,844
Ensembl chr20:58,689,131...58,719,238
G
NPRL2
NPR2 like, GATOR1 complex subunit
decreases expression
EXP
picoxystrobin results in decreased expression of NPRL2 mRNA
CTD
PMID:33512557
NCBI chr 3:50,347,330...50,350,775
Ensembl chr 3:50,347,330...50,350,826
G
NPTX1
neuronal pentraxin 1
decreases expression
EXP
picoxystrobin results in decreased expression of NPTX1 mRNA
CTD
PMID:33512557
NCBI chr17:80,466,834...80,476,607
Ensembl chr17:80,466,834...80,477,843
G
NQO1
NAD(P)H quinone dehydrogenase 1
increases expression
EXP
picoxystrobin results in increased expression of NQO1 mRNA
CTD
PMID:33512557
NCBI chr16:69,709,401...69,726,560
Ensembl chr16:69,706,996...69,726,668
G
NR1H4
nuclear receptor subfamily 1 group H member 4
multiple interactions
EXP
picoxystrobin inhibits the reaction [Chenodeoxycholic Acid results in increased activity of NR1H4 protein]
CTD
PMID:30818834
NCBI chr12:100,473,866...100,564,414
Ensembl chr12:100,473,708...100,564,414
G
NR1I2
nuclear receptor subfamily 1 group I member 2
increases activity
EXP
picoxystrobin results in increased activity of NR1I2 protein
CTD
PMID:28728110
NCBI chr 3:119,782,101...119,818,487
Ensembl chr 3:119,780,484...119,818,487
G
NR4A2
nuclear receptor subfamily 4 group A member 2
decreases expression
EXP
picoxystrobin results in decreased expression of NR4A2 mRNA
CTD
PMID:33512557
NCBI chr 2:156,324,437...156,332,721
Ensembl chr 2:156,324,437...156,342,348
G
NR5A1
nuclear receptor subfamily 5 group A member 1
decreases expression
EXP
picoxystrobin results in decreased expression of NR5A1 mRNA
CTD
PMID:33512557
NCBI chr 9:124,481,236...124,507,399
Ensembl chr 9:124,481,236...124,507,420
G
NRCAM
neuronal cell adhesion molecule
decreases expression
EXP
picoxystrobin results in decreased expression of NRCAM mRNA
CTD
PMID:33512557
NCBI chr 7:108,147,649...108,456,720
Ensembl chr 7:108,147,623...108,456,717
G
NRG1
neuregulin 1
decreases expression
EXP
picoxystrobin results in decreased expression of NRG1 mRNA
CTD
PMID:33512557
NCBI chr 8:31,639,245...32,774,046
Ensembl chr 8:31,639,222...32,855,666
G
NRXN1
neurexin 1
decreases expression
EXP
picoxystrobin results in decreased expression of NRXN1 mRNA
CTD
PMID:33512557
NCBI chr 2:49,918,503...51,032,132
Ensembl chr 2:49,918,503...51,225,575
G
NSA2
NSA2 ribosome biogenesis factor
decreases expression
EXP
picoxystrobin results in decreased expression of NSA2 mRNA
CTD
PMID:33512557
NCBI chr 5:74,767,249...74,780,113
Ensembl chr 5:74,766,991...74,780,113
G
NTRK1
neurotrophic receptor tyrosine kinase 1
decreases expression
EXP
picoxystrobin results in decreased expression of NTRK1 mRNA
CTD
PMID:33512557
NCBI chr 1:156,815,750...156,881,850
Ensembl chr 1:156,815,636...156,881,850
G
NUDCD3
NudC domain containing 3
decreases expression
EXP
picoxystrobin results in decreased expression of NUDCD3 mRNA
CTD
PMID:33512557
NCBI chr 7:44,379,119...44,490,658
Ensembl chr 7:44,379,119...44,490,658
G
NUDT5
nudix hydrolase 5
decreases expression
EXP
picoxystrobin results in decreased expression of NUDT5 mRNA
CTD
PMID:33512557
NCBI chr10:12,165,330...12,195,891
Ensembl chr10:12,165,330...12,195,891
G
NUP62
nucleoporin 62
increases expression
EXP
picoxystrobin results in increased expression of NUP62 mRNA
CTD
PMID:33512557
NCBI chr19:49,906,825...49,929,504
Ensembl chr19:49,906,825...49,929,764
G
NVL
nuclear VCP like
increases expression
EXP
picoxystrobin results in increased expression of NVL mRNA
CTD
PMID:33512557
NCBI chr 1:224,227,345...224,330,172
Ensembl chr 1:224,227,334...224,330,189
G
OIP5
Opa interacting protein 5
increases expression
EXP
picoxystrobin results in increased expression of OIP5 mRNA
CTD
PMID:33512557
NCBI chr15:41,309,273...41,332,591
Ensembl chr15:41,309,273...41,332,591
G
OLFML2B
olfactomedin like 2B
decreases expression
EXP
picoxystrobin results in decreased expression of OLFML2B mRNA
CTD
PMID:33512557
NCBI chr 1:161,983,192...162,023,869
Ensembl chr 1:161,983,192...162,023,869
G
ONECUT1
one cut homeobox 1
decreases expression
EXP
picoxystrobin results in decreased expression of ONECUT1 mRNA
CTD
PMID:33512557
NCBI chr15:52,755,053...52,790,336
Ensembl chr15:52,755,053...52,791,078
G
ORC3
origin recognition complex subunit 3
decreases expression
EXP
picoxystrobin results in decreased expression of ORC3 mRNA
CTD
PMID:33512557
NCBI chr 6:87,590,135...87,677,823
Ensembl chr 6:87,590,067...87,667,453
G
ORC6
origin recognition complex subunit 6
increases expression
EXP
picoxystrobin results in increased expression of ORC6 mRNA
CTD
PMID:33512557
NCBI chr16:46,689,659...46,698,394
Ensembl chr16:46,689,643...46,698,394
G
ORMDL2
ORMDL sphingolipid biosynthesis regulator 2
increases expression
EXP
picoxystrobin results in increased expression of ORMDL2 mRNA
CTD
PMID:33512557
NCBI chr12:55,818,041...55,821,879
Ensembl chr12:55,818,041...55,821,879
G
ORMDL3
ORMDL sphingolipid biosynthesis regulator 3
decreases expression
EXP
picoxystrobin results in decreased expression of ORMDL3 mRNA
CTD
PMID:33512557
NCBI chr17:39,921,041...39,927,601
Ensembl chr17:39,921,041...39,927,601
G
OXCT1
3-oxoacid CoA-transferase 1
decreases expression
EXP
picoxystrobin results in decreased expression of OXCT1 mRNA
CTD
PMID:33512557
NCBI chr 5:41,730,065...41,870,425
Ensembl chr 5:41,730,065...41,870,425
G
P2RX3
purinergic receptor P2X 3
decreases expression
EXP
picoxystrobin results in decreased expression of P2RX3 mRNA
CTD
PMID:33512557
NCBI chr11:57,335,950...57,372,396
Ensembl chr11:57,338,352...57,372,396
G
P4HTM
prolyl 4-hydroxylase, transmembrane
decreases expression
EXP
picoxystrobin results in decreased expression of P4HTM mRNA
CTD
PMID:33512557
NCBI chr 3:48,989,908...49,007,153
Ensembl chr 3:48,989,889...49,007,153
G
PAFAH1B3
platelet activating factor acetylhydrolase 1b catalytic subunit 3
decreases expression
EXP
picoxystrobin results in decreased expression of PAFAH1B3 mRNA
CTD
PMID:33512557
NCBI chr19:42,297,033...42,302,800
Ensembl chr19:42,297,033...42,303,546
G
PAPSS1
3'-phosphoadenosine 5'-phosphosulfate synthase 1
increases expression
EXP
picoxystrobin results in increased expression of PAPSS1 mRNA
CTD
PMID:33512557
NCBI chr 4:107,613,666...107,720,234
Ensembl chr 4:107,590,276...107,720,234
G
PBK
PDZ binding kinase
increases expression
EXP
picoxystrobin results in increased expression of PBK mRNA
CTD
PMID:33512557
NCBI chr 8:27,809,624...27,837,817
Ensembl chr 8:27,809,624...27,838,082
G
PCDHA1
protocadherin alpha 1
decreases expression
EXP
picoxystrobin results in decreased expression of PCDHA1 mRNA
CTD
PMID:33512557
NCBI chr 5:140,786,136...141,012,347
Ensembl chr 5:140,786,136...141,012,347
G
PCDHA9
protocadherin alpha 9
decreases expression
EXP
picoxystrobin results in decreased expression of PCDHA9 mRNA
CTD
PMID:33512557
NCBI chr 5:140,847,772...141,012,347
Ensembl chr 5:140,847,772...141,012,347
G
PCMT1
protein-L-isoaspartate (D-aspartate) O-methyltransferase
increases expression
EXP
picoxystrobin results in increased expression of PCMT1 mRNA
CTD
PMID:33512557
NCBI chr 6:149,749,695...149,811,421
Ensembl chr 6:149,749,444...149,811,420
G
PCNA
proliferating cell nuclear antigen
increases expression
EXP
picoxystrobin results in increased expression of PCNA mRNA
CTD
PMID:33512557
NCBI chr20:5,114,953...5,126,622
Ensembl chr20:5,114,953...5,126,626
G
PDCD6IP
programmed cell death 6 interacting protein
decreases expression
EXP
picoxystrobin results in decreased expression of PDCD6IP mRNA
CTD
PMID:33512557
NCBI chr 3:33,798,630...33,869,703
Ensembl chr 3:33,798,571...33,869,707
G
PDE1A
phosphodiesterase 1A
decreases expression
EXP
picoxystrobin results in decreased expression of PDE1A mRNA
CTD
PMID:33512557
NCBI chr 2:182,140,041...182,716,797
Ensembl chr 2:182,139,968...182,523,359
G
PDE4C
phosphodiesterase 4C
decreases expression
EXP
picoxystrobin results in decreased expression of PDE4C mRNA
CTD
PMID:33512557
NCBI chr19:18,207,965...18,255,362
Ensembl chr19:18,207,965...18,248,200
G
PDGFB
platelet derived growth factor subunit B
decreases expression
EXP
picoxystrobin results in decreased expression of PDGFB mRNA
CTD
PMID:33512557
NCBI chr22:39,223,359...39,244,982
Ensembl chr22:39,223,359...39,244,982
G
PDHA1
pyruvate dehydrogenase E1 subunit alpha 1
increases expression
EXP
picoxystrobin results in increased expression of PDHA1 mRNA
CTD
PMID:33512557
NCBI chr X:19,343,927...19,361,718
Ensembl chr X:19,343,893...19,361,718
G
PDIA6
protein disulfide isomerase family A member 6
increases expression
EXP
picoxystrobin results in increased expression of PDIA6 mRNA
CTD
PMID:33512557
NCBI chr 2:10,783,391...10,837,712
Ensembl chr 2:10,783,391...10,837,977
G
PDK4
pyruvate dehydrogenase kinase 4
decreases expression
EXP
picoxystrobin results in decreased expression of PDK4 mRNA
CTD
PMID:33512557
NCBI chr 7:95,583,499...95,596,516
Ensembl chr 7:95,583,499...95,596,516
G
PDS5A
PDS5 cohesin associated factor A
increases expression
EXP
picoxystrobin results in increased expression of PDS5A mRNA
CTD
PMID:33512557
NCBI chr 4:39,822,863...39,977,911
Ensembl chr 4:39,822,863...39,977,956
G
PECAM1
platelet and endothelial cell adhesion molecule 1
decreases expression
EXP
picoxystrobin results in decreased expression of PECAM1 mRNA
CTD
PMID:33512557
NCBI chr17:64,319,415...64,390,860
Ensembl chr17:64,319,415...64,413,776
G
PEG10
paternally expressed 10
decreases expression
EXP
picoxystrobin results in decreased expression of PEG10 mRNA
CTD
PMID:33512557
NCBI chr 7:94,656,325...94,669,695
Ensembl chr 7:94,656,325...94,669,695
G
PGA5
pepsinogen A5
increases expression
EXP
picoxystrobin results in increased expression of PGA5 mRNA
CTD
PMID:33512557
NCBI chr11:61,241,175...61,251,444
Ensembl chr11:61,241,175...61,251,444
G
PGF
placental growth factor
decreases expression
EXP
picoxystrobin results in decreased expression of PGF mRNA
CTD
PMID:33512557
NCBI chr14:74,941,830...74,955,764
Ensembl chr14:74,941,834...74,955,626
G
PGM1
phosphoglucomutase 1
increases expression
EXP
picoxystrobin results in increased expression of PGM1 mRNA
CTD
PMID:33512557
NCBI chr 1:63,593,411...63,660,245
Ensembl chr 1:63,593,411...63,660,245
G
PGM3
phosphoglucomutase 3
increases expression
EXP
picoxystrobin results in increased expression of PGM3 mRNA
CTD
PMID:33512557
NCBI chr 6:83,148,705...83,193,900
Ensembl chr 6:83,147,324...83,193,936
G
PGR
progesterone receptor
multiple interactions
EXP
picoxystrobin inhibits the reaction [Promegestone results in increased activity of PGR protein]
CTD
PMID:30818834
NCBI chr11:101,029,624...101,129,813
Ensembl chr11:101,029,624...101,129,813
G
PGRMC1
progesterone receptor membrane component 1
increases expression
EXP
picoxystrobin results in increased expression of PGRMC1 mRNA
CTD
PMID:33512557
NCBI chr X:119,236,285...119,244,466
Ensembl chr X:119,236,245...119,244,466
G
PHF5A
PHD finger protein 5A
increases expression
EXP
picoxystrobin results in increased expression of PHF5A mRNA
CTD
PMID:33512557
NCBI chr22:41,459,717...41,468,692
Ensembl chr22:41,459,717...41,468,692
G
PHGDH
phosphoglycerate dehydrogenase
increases expression
EXP
picoxystrobin results in increased expression of PHGDH mRNA
CTD
PMID:33512557
NCBI chr 1:119,711,934...119,744,215
Ensembl chr 1:119,648,411...119,744,218
G
PHKB
phosphorylase kinase regulatory subunit beta
decreases expression
EXP
picoxystrobin results in decreased expression of PHKB mRNA
CTD
PMID:33512557
NCBI chr16:47,461,299...47,701,523
Ensembl chr16:47,461,123...47,701,523
G
PHLDA1
pleckstrin homology like domain family A member 1
decreases expression
EXP
picoxystrobin results in decreased expression of PHLDA1 mRNA
CTD
PMID:33512557
NCBI chr12:76,025,447...76,031,776
Ensembl chr12:76,025,447...76,031,776
G
PIGP
phosphatidylinositol glycan anchor biosynthesis class P
increases expression
EXP
picoxystrobin results in increased expression of PIGP mRNA
CTD
PMID:33512557
NCBI chr21:37,065,364...37,073,071
Ensembl chr21:37,062,846...37,073,170
G
PINK1
PTEN induced kinase 1
decreases expression
EXP
picoxystrobin results in decreased expression of PINK1 mRNA
CTD
PMID:33512557
NCBI chr 1:20,633,458...20,651,511
Ensembl chr 1:20,633,458...20,651,511
G
PITPNA
phosphatidylinositol transfer protein alpha
decreases expression
EXP
picoxystrobin results in decreased expression of PITPNA mRNA
CTD
PMID:33512557
NCBI chr17:1,517,718...1,562,792
Ensembl chr17:1,517,718...1,562,792
G
PLRG1
pleiotropic regulator 1
increases expression
EXP
picoxystrobin results in increased expression of PLRG1 mRNA
CTD
PMID:33512557
NCBI chr 4:154,535,005...154,550,400
Ensembl chr 4:154,535,005...154,550,400
G
PLSCR3
phospholipid scramblase 3
decreases expression
EXP
picoxystrobin results in decreased expression of PLSCR3 mRNA
CTD
PMID:33512557
NCBI chr17:7,389,727...7,394,525
Ensembl chr17:7,389,727...7,394,842
G
PLXDC2
plexin domain containing 2
decreases expression
EXP
picoxystrobin results in decreased expression of PLXDC2 mRNA
CTD
PMID:33512557
NCBI chr10:19,816,432...20,289,856
Ensembl chr10:19,816,239...20,289,856
G
PMM2
phosphomannomutase 2
decreases expression
EXP
picoxystrobin results in decreased expression of PMM2 mRNA
CTD
PMID:33512557
NCBI chr16:8,797,839...8,849,325
Ensembl chr16:8,788,823...8,862,534
G
PNKP
polynucleotide kinase 3'-phosphatase
decreases expression
EXP
picoxystrobin results in decreased expression of PNKP mRNA
CTD
PMID:33512557
NCBI chr19:49,861,204...49,867,576
Ensembl chr19:49,859,882...49,878,351
G
POLE2
DNA polymerase epsilon 2, accessory subunit
increases expression
EXP
picoxystrobin results in increased expression of POLE2 mRNA
CTD
PMID:33512557
NCBI chr14:49,643,555...49,688,214
Ensembl chr14:49,643,555...49,688,422
G
POLR2H
RNA polymerase II, I and III subunit H
increases expression
EXP
picoxystrobin results in increased expression of POLR2H mRNA
CTD
PMID:33512557
NCBI chr 3:184,361,710...184,368,591
Ensembl chr 3:184,361,710...184,368,596
G
POP5
POP5 homolog, ribonuclease P/MRP subunit
increases expression
EXP
picoxystrobin results in increased expression of POP5 mRNA
CTD
PMID:33512557
NCBI chr12:120,578,764...120,581,402
Ensembl chr12:120,578,764...120,581,402
G
POU4F1
POU class 4 homeobox 1
decreases expression
EXP
picoxystrobin results in decreased expression of POU4F1 mRNA
CTD
PMID:33512557
NCBI chr13:78,598,362...78,603,552
Ensembl chr13:78,598,362...78,603,552
G
POU4F2
POU class 4 homeobox 2
decreases expression
EXP
picoxystrobin results in decreased expression of POU4F2 mRNA
CTD
PMID:33512557
NCBI chr 4:146,638,893...146,642,474
Ensembl chr 4:146,638,893...146,642,474
G
PPA1
inorganic pyrophosphatase 1
increases expression
EXP
picoxystrobin results in increased expression of PPA1 mRNA
CTD
PMID:33512557
NCBI chr10:70,202,835...70,233,429
Ensembl chr10:70,202,835...70,233,911
G
PPARA
peroxisome proliferator activated receptor alpha
decreases expression
EXP
picoxystrobin results in decreased expression of PPARA mRNA
CTD
PMID:33512557
NCBI chr22:46,150,526...46,243,756
Ensembl chr22:46,150,521...46,243,755
G
PPARG
peroxisome proliferator activated receptor gamma
multiple interactions
EXP
picoxystrobin inhibits the reaction [Rosiglitazone results in increased activity of PPARG protein]
CTD
PMID:30818834
NCBI chr 3:12,287,368...12,434,344
Ensembl chr 3:12,287,368...12,434,356
G
PPARGC1A
PPARG coactivator 1 alpha
multiple interactions
EXP
picoxystrobin inhibits the reaction [PPARGC1A protein results in increased activity of ESRRA protein]
CTD
PMID:30818834
NCBI chr 4:23,792,021...24,472,905
Ensembl chr 4:23,755,041...23,904,089
G
PPIA
peptidylprolyl isomerase A
increases expression
EXP
picoxystrobin results in increased expression of PPIA mRNA
CTD
PMID:33512557
NCBI chr 7:44,796,681...44,803,117
Ensembl chr 7:44,796,680...44,824,564
G
PPIL1
peptidylprolyl isomerase like 1
decreases expression
EXP
picoxystrobin results in decreased expression of PPIL1 mRNA
CTD
PMID:33512557
NCBI chr 6:36,854,829...36,874,803
Ensembl chr 6:36,854,827...36,874,803
G
PPP1R15A
protein phosphatase 1 regulatory subunit 15A
decreases expression
EXP
picoxystrobin results in decreased expression of PPP1R15A mRNA
CTD
PMID:33512557
NCBI chr19:48,872,421...48,876,058
Ensembl chr19:48,872,212...48,876,059
G
PRDX1
peroxiredoxin 1
increases expression
EXP
picoxystrobin results in increased expression of PRDX1 mRNA
CTD
PMID:33512557
NCBI chr 1:45,511,051...45,522,890
Ensembl chr 1:45,510,914...45,542,732
G
PRDX2
peroxiredoxin 2
increases expression
EXP
picoxystrobin results in increased expression of PRDX2 mRNA
CTD
PMID:33512557
NCBI chr19:12,796,823...12,801,800
Ensembl chr19:12,796,820...12,801,800
G
PRKAG1
protein kinase AMP-activated non-catalytic subunit gamma 1
decreases expression
EXP
picoxystrobin results in decreased expression of PRKAG1 mRNA
CTD
PMID:33512557
NCBI chr12:49,002,274...49,018,776
Ensembl chr12:49,002,274...49,018,807
G
PRKAR1A
protein kinase cAMP-dependent type I regulatory subunit alpha
decreases expression
EXP
picoxystrobin results in decreased expression of PRKAR1A mRNA
CTD
PMID:33512557
NCBI chr17:68,413,623...68,551,316
Ensembl chr17:68,511,780...68,551,319
G
PRKG1
protein kinase cGMP-dependent 1
decreases expression
EXP
picoxystrobin results in decreased expression of PRKG1 mRNA
CTD
PMID:33512557
NCBI chr10:50,990,888...52,298,350
Ensembl chr10:50,990,888...52,298,423
G
PRKN
parkin RBR E3 ubiquitin protein ligase
decreases expression
EXP
picoxystrobin results in decreased expression of PRKN mRNA
CTD
PMID:33512557
NCBI chr 6:161,347,417...162,727,766
Ensembl chr 6:161,347,417...162,727,775
G
PRL
prolactin
increases expression
EXP
picoxystrobin results in increased expression of PRL mRNA
CTD
PMID:33512557
NCBI chr 6:22,287,246...22,302,835
Ensembl chr 6:22,287,244...22,302,826
G
PRR7
proline rich 7, synaptic
decreases expression
EXP
picoxystrobin results in decreased expression of PRR7 mRNA
CTD
PMID:33512557
NCBI chr 5:177,445,995...177,456,286
Ensembl chr 5:177,446,445...177,456,286
G
PSAT1
phosphoserine aminotransferase 1
increases expression
EXP
picoxystrobin results in increased expression of PSAT1 mRNA
CTD
PMID:33512557
NCBI chr 9:78,297,125...78,330,093
Ensembl chr 9:78,297,125...78,330,093
G
PSEN2
presenilin 2
decreases expression
EXP
picoxystrobin results in decreased expression of PSEN2 mRNA
CTD
PMID:33512557
NCBI chr 1:226,870,616...226,903,668
Ensembl chr 1:226,870,184...226,927,726
G
PSIP1
PC4 and SRSF1 interacting protein 1
decreases expression
EXP
picoxystrobin results in decreased expression of PSIP1 mRNA
CTD
PMID:33512557
NCBI chr 9:15,464,066...15,510,970
Ensembl chr 9:15,464,066...15,510,995
G
PSMA1
proteasome 20S subunit alpha 1
increases expression
EXP
picoxystrobin results in increased expression of PSMA1 mRNA
CTD
PMID:33512557
NCBI chr11:14,504,876...14,643,662
Ensembl chr11:14,504,874...14,643,635
G
PSMA4
proteasome 20S subunit alpha 4
increases expression
EXP
picoxystrobin results in increased expression of PSMA4 mRNA
CTD
PMID:33512557
NCBI chr15:78,540,405...78,552,417
Ensembl chr15:78,540,405...78,552,417
G
PSMB6
proteasome 20S subunit beta 6
increases expression
EXP
picoxystrobin results in increased expression of PSMB6 mRNA
CTD
PMID:33512557
NCBI chr17:4,796,164...4,798,495
Ensembl chr17:4,796,144...4,798,502
G
PSMD10
proteasome 26S subunit, non-ATPase 10
increases expression
EXP
picoxystrobin results in increased expression of PSMD10 mRNA
CTD
PMID:33512557
NCBI chr X:108,084,207...108,091,542
Ensembl chr X:108,084,207...108,091,549
G
PSMD12
proteasome 26S subunit, non-ATPase 12
increases expression
EXP
picoxystrobin results in increased expression of PSMD12 mRNA
CTD
PMID:33512557
NCBI chr17:67,337,916...67,366,577
Ensembl chr17:67,337,916...67,366,605
G
PSMD2
proteasome 26S subunit ubiquitin receptor, non-ATPase 2
decreases expression
EXP
picoxystrobin results in decreased expression of PSMD2 mRNA
CTD
PMID:33512557
NCBI chr 3:184,299,241...184,309,050
Ensembl chr 3:184,299,198...184,309,050
G
PTK2
protein tyrosine kinase 2
increases expression
EXP
picoxystrobin results in increased expression of PTK2 mRNA
CTD
PMID:33512557
NCBI chr 8:140,657,900...141,002,079
Ensembl chr 8:140,657,900...141,002,216
G
PTK2B
protein tyrosine kinase 2 beta
decreases expression
EXP
picoxystrobin results in decreased expression of PTK2B mRNA
CTD
PMID:33512557
NCBI chr 8:27,310,506...27,459,391
Ensembl chr 8:27,311,482...27,459,391
G
PTTG1
PTTG1 regulator of sister chromatid separation, securin
increases expression
EXP
picoxystrobin results in increased expression of PTTG1 mRNA
CTD
PMID:33512557
NCBI chr 5:160,421,855...160,428,744
Ensembl chr 5:160,421,855...160,428,739
G
PUS1
pseudouridine synthase 1
decreases expression
EXP
picoxystrobin results in decreased expression of PUS1 mRNA
CTD
PMID:33512557
NCBI chr12:131,929,276...131,945,896
Ensembl chr12:131,929,200...131,945,896
G
PUS7
pseudouridine synthase 7
decreases expression
EXP
picoxystrobin results in decreased expression of PUS7 mRNA
CTD
PMID:33512557
NCBI chr 7:105,456,501...105,522,271
Ensembl chr 7:105,439,661...105,522,271
G
RABGGTB
Rab geranylgeranyltransferase subunit beta
increases expression
EXP
picoxystrobin results in increased expression of RABGGTB mRNA
CTD
PMID:33512557
NCBI chr 1:75,786,194...75,795,090
Ensembl chr 1:75,786,197...75,795,086
G
RAC1
Rac family small GTPase 1
decreases expression
EXP
picoxystrobin results in decreased expression of RAC1 mRNA
CTD
PMID:33512557
NCBI chr 7:6,374,527...6,403,967
Ensembl chr 7:6,374,527...6,403,967
G
RAD51AP1
RAD51 associated protein 1
increases expression
EXP
picoxystrobin results in increased expression of RAD51AP1 mRNA
CTD
PMID:33512557
NCBI chr12:4,538,890...4,560,047
Ensembl chr12:4,538,798...4,560,047
G
RAD51C
RAD51 paralog C
increases expression
EXP
picoxystrobin results in increased expression of RAD51C mRNA
CTD
PMID:33512557
NCBI chr17:58,692,573...58,735,611
Ensembl chr17:58,692,573...58,735,611
G
RALA
RAS like proto-oncogene A
increases expression
EXP
picoxystrobin results in increased expression of RALA mRNA
CTD
PMID:33512557
NCBI chr 7:39,623,572...39,708,120
Ensembl chr 7:39,623,565...39,708,120
G
RASSF1
Ras association domain family member 1
decreases expression
EXP
picoxystrobin results in decreased expression of RASSF1 mRNA
CTD
PMID:33512557
NCBI chr 3:50,329,788...50,340,836
Ensembl chr 3:50,329,782...50,340,980
G
RB1
RB transcriptional corepressor 1
increases expression
EXP
picoxystrobin results in increased expression of RB1 mRNA
CTD
PMID:33512557
NCBI chr13:48,303,751...48,481,890
Ensembl chr13:48,303,744...48,599,436
G
RELN
reelin
decreases expression
EXP
picoxystrobin results in decreased expression of RELN mRNA
CTD
PMID:33512557
NCBI chr 7:103,471,789...103,989,658
Ensembl chr 7:103,471,381...103,989,658
G
RFC4
replication factor C subunit 4
increases expression
EXP
picoxystrobin results in increased expression of RFC4 mRNA
CTD
PMID:33512557
NCBI chr 3:186,789,900...186,806,482
Ensembl chr 3:186,789,880...186,807,058
G
RFNG
RFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase
decreases expression
EXP
picoxystrobin results in decreased expression of RFNG mRNA
CTD
PMID:33512557
NCBI chr17:82,047,902...82,051,811
Ensembl chr17:82,047,902...82,051,831
G
RIPK1
receptor interacting serine/threonine kinase 1
decreases expression
EXP
picoxystrobin results in decreased expression of RIPK1 mRNA
CTD
PMID:33512557
NCBI chr 6:3,063,967...3,115,187
Ensembl chr 6:3,063,824...3,115,187
G
RMI1
RecQ mediated genome instability 1
increases expression
EXP
picoxystrobin results in increased expression of RMI1 mRNA
CTD
PMID:33512557
NCBI chr 9:83,980,359...84,004,074
Ensembl chr 9:83,980,798...84,004,074
G
RNF167
ring finger protein 167
decreases expression
EXP
picoxystrobin results in decreased expression of RNF167 mRNA
CTD
PMID:33512557
NCBI chr17:4,940,092...4,945,222
Ensembl chr17:4,940,008...4,945,222
G
RNPS1
RNA binding protein with serine rich domain 1
decreases expression
EXP
picoxystrobin results in decreased expression of RNPS1 mRNA
CTD
PMID:33512557
NCBI chr16:2,253,116...2,268,126
Ensembl chr16:2,253,116...2,268,397
G
RPA2
replication protein A2
increases expression
EXP
picoxystrobin results in increased expression of RPA2 mRNA
CTD
PMID:33512557
NCBI chr 1:27,891,524...27,914,797
Ensembl chr 1:27,891,524...27,914,746
G
RPAP3
RNA polymerase II associated protein 3
decreases expression
EXP
picoxystrobin results in decreased expression of RPAP3 mRNA
CTD
PMID:33512557
NCBI chr12:47,661,249...47,706,030
Ensembl chr12:47,661,249...47,706,030
G
RPL11
ribosomal protein L11
increases expression
EXP
picoxystrobin results in increased expression of RPL11 mRNA
CTD
PMID:33512557
NCBI chr 1:23,691,779...23,696,835
Ensembl chr 1:23,691,742...23,696,835
G
RPL13A
ribosomal protein L13a
increases expression
EXP
picoxystrobin results in increased expression of RPL13A mRNA
CTD
PMID:33512557
NCBI chr19:49,487,608...49,492,308
Ensembl chr19:49,487,510...49,493,057
G
RPL17
ribosomal protein L17
increases expression
EXP
picoxystrobin results in increased expression of RPL17 mRNA
CTD
PMID:33512557
NCBI chr18:49,488,481...49,492,465
Ensembl chr18:49,488,453...49,492,508
G
RPL22
ribosomal protein L22
increases expression
EXP
picoxystrobin results in increased expression of RPL22 mRNA
CTD
PMID:33512557
NCBI chr 1:6,185,020...6,199,595
Ensembl chr 1:6,185,020...6,209,389
G
RPL26
ribosomal protein L26
increases expression
EXP
picoxystrobin results in increased expression of RPL26 mRNA
CTD
PMID:33512557
NCBI chr17:8,377,516...8,383,193
Ensembl chr17:8,377,516...8,383,213
G
RPL27
ribosomal protein L27
increases expression
EXP
picoxystrobin results in increased expression of RPL27 mRNA
CTD
PMID:33512557
NCBI chr17:42,998,273...43,002,959
Ensembl chr17:42,998,273...43,002,959
G
RPL36
ribosomal protein L36
increases expression
EXP
picoxystrobin results in increased expression of RPL36 mRNA
CTD
PMID:33512557
NCBI chr19:5,690,295...5,691,875
Ensembl chr19:5,674,947...5,691,875
G
RPL36AL
ribosomal protein L36a like
increases expression
EXP
picoxystrobin results in increased expression of RPL36AL mRNA
CTD
PMID:33512557
NCBI chr14:49,618,530...49,620,626
Ensembl chr14:49,618,530...49,620,626
G
RPL39L
ribosomal protein L39 like
increases expression
EXP
picoxystrobin results in increased expression of RPL39L mRNA
CTD
PMID:33512557
NCBI chr 3:187,120,948...187,139,496
Ensembl chr 3:187,120,948...187,180,908
G
RPL4
ribosomal protein L4
increases expression
EXP
picoxystrobin results in increased expression of RPL4 mRNA
CTD
PMID:33512557
NCBI chr15:66,498,015...66,504,855
Ensembl chr15:66,498,015...66,524,532
G
RPL6
ribosomal protein L6
increases expression
EXP
picoxystrobin results in increased expression of RPL6 mRNA
CTD
PMID:33512557
NCBI chr12:112,405,181...112,418,835
Ensembl chr12:112,405,189...112,418,838
G
RPL8
ribosomal protein L8
increases expression
EXP
picoxystrobin results in increased expression of RPL8 mRNA
CTD
PMID:33512557
NCBI chr 8:144,789,769...144,792,390
Ensembl chr 8:144,789,765...144,792,587
G
RPL9
ribosomal protein L9
increases expression
EXP
picoxystrobin results in increased expression of RPL9 mRNA
CTD
PMID:33512557
NCBI chr 4:39,454,124...39,458,922
Ensembl chr 4:39,452,587...39,458,931
G
RPP38
ribonuclease P/MRP subunit p38
decreases expression
EXP
picoxystrobin results in decreased expression of RPP38 mRNA
CTD
PMID:33512557
NCBI chr10:15,097,355...15,104,257
Ensembl chr10:15,097,180...15,139,818
G
RPP40
ribonuclease P/MRP subunit p40
increases expression
EXP
picoxystrobin results in increased expression of RPP40 mRNA
CTD
PMID:33512557
NCBI chr 6:4,988,426...5,004,037
Ensembl chr 6:4,994,717...5,004,063
G
RPS13
ribosomal protein S13
increases expression
EXP
picoxystrobin results in increased expression of RPS13 mRNA
CTD
PMID:33512557
NCBI chr11:17,074,388...17,077,667
Ensembl chr11:17,074,388...17,077,715
G
RPS18
ribosomal protein S18
increases expression
EXP
picoxystrobin results in increased expression of RPS18 mRNA
CTD
PMID:33512557
NCBI chr 6:33,272,075...33,276,511
Ensembl chr 6:33,272,075...33,276,511
G
RPS20
ribosomal protein S20
increases expression
EXP
picoxystrobin results in increased expression of RPS20 mRNA
CTD
PMID:33512557
NCBI chr 8:56,067,254...56,074,506
Ensembl chr 8:56,067,254...56,074,510
G
RPS25
ribosomal protein S25
increases expression
EXP
picoxystrobin results in increased expression of RPS25 mRNA
CTD
PMID:33512557
NCBI chr11:119,015,717...119,018,343
Ensembl chr11:119,015,712...119,018,691
G
RPS27A
ribosomal protein S27a
increases expression
EXP
picoxystrobin results in increased expression of RPS27A mRNA
CTD
PMID:33512557
NCBI chr 2:55,231,903...55,235,853
Ensembl chr 2:55,231,903...55,235,853
G
RPS27L
ribosomal protein S27 like
increases expression
EXP
picoxystrobin results in increased expression of RPS27L mRNA
CTD
PMID:33512557
NCBI chr15:63,148,249...63,157,477
Ensembl chr15:63,125,872...63,158,021
G
RPS3
ribosomal protein S3
increases expression
EXP
picoxystrobin results in increased expression of RPS3 mRNA
CTD
PMID:33512557
NCBI chr11:75,399,518...75,422,302
Ensembl chr11:75,399,515...75,422,280
G
RPS5
ribosomal protein S5
increases expression
EXP
picoxystrobin results in increased expression of RPS5 mRNA
CTD
PMID:33512557
NCBI chr19:58,387,269...58,394,804
Ensembl chr19:58,386,400...58,394,806
G
RPS6
ribosomal protein S6
increases expression
EXP
picoxystrobin results in increased expression of RPS6 mRNA
CTD
PMID:33512557
NCBI chr 9:19,375,715...19,380,236
Ensembl chr 9:19,375,715...19,380,236
G
RPS7
ribosomal protein S7
increases expression
EXP
picoxystrobin results in increased expression of RPS7 mRNA
CTD
PMID:33512557
NCBI chr 2:3,575,260...3,580,920
Ensembl chr 2:3,575,260...3,580,920
G
RPSA
ribosomal protein SA
increases expression
EXP
picoxystrobin results in increased expression of RPSA mRNA
CTD
PMID:33512557
NCBI chr 3:39,406,720...39,412,542
Ensembl chr 3:39,406,716...39,426,255
G
RRAGA
Ras related GTP binding A
increases expression
EXP
picoxystrobin results in increased expression of RRAGA mRNA
CTD
PMID:33512557
NCBI chr 9:19,049,427...19,051,025
Ensembl chr 9:19,049,427...19,051,025
G
RRM1
ribonucleotide reductase catalytic subunit M1
increases expression
EXP
picoxystrobin results in increased expression of RRM1 mRNA
CTD
PMID:33512557
NCBI chr11:4,094,685...4,138,932
Ensembl chr11:4,094,707...4,138,932
G
RRM2
ribonucleotide reductase regulatory subunit M2
increases expression
EXP
picoxystrobin results in increased expression of RRM2 mRNA
CTD
PMID:33512557
NCBI chr 2:10,122,568...10,211,010
Ensembl chr 2:10,120,698...10,211,725
G
RTN2
reticulon 2
decreases expression
EXP
picoxystrobin results in decreased expression of RTN2 mRNA
CTD
PMID:33512557
NCBI chr19:45,485,294...45,497,047
Ensembl chr19:45,485,294...45,497,055
G
RTN4IP1
reticulon 4 interacting protein 1
decreases expression
EXP
picoxystrobin results in decreased expression of RTN4IP1 mRNA
CTD
PMID:33512557
NCBI chr 6:106,570,771...106,630,491
Ensembl chr 6:106,570,771...106,629,498
G
S100A4
S100 calcium binding protein A4
increases expression
EXP
picoxystrobin results in increased expression of S100A4 mRNA
CTD
PMID:33512557
NCBI chr 1:153,543,621...153,545,806
Ensembl chr 1:153,543,613...153,550,136
G
SAMHD1
SAM and HD domain containing deoxynucleoside triphosphate triphosphohydrolase 1
increases expression
EXP
picoxystrobin results in increased expression of SAMHD1 mRNA
CTD
PMID:33512557
NCBI chr20:36,889,773...36,951,708
Ensembl chr20:36,890,229...36,951,893
G
SATB1
SATB homeobox 1
decreases expression
EXP
picoxystrobin results in decreased expression of SATB1 mRNA
CTD
PMID:33512557
NCBI chr 3:18,345,377...18,445,592
Ensembl chr 3:18,345,377...18,445,621
G
SCOC
short coiled-coil protein
decreases expression
EXP
picoxystrobin results in decreased expression of SCOC mRNA
CTD
PMID:33512557
NCBI chr 4:140,257,308...140,385,728
Ensembl chr 4:140,257,286...140,385,728
G
SCRN1
secernin 1
decreases expression
EXP
picoxystrobin results in decreased expression of SCRN1 mRNA
CTD
PMID:33512557
NCBI chr 7:29,920,103...29,990,289
Ensembl chr 7:29,920,104...29,990,289
G
SDHB
succinate dehydrogenase complex iron sulfur subunit B
increases expression
EXP
picoxystrobin results in increased expression of SDHB mRNA
CTD
PMID:33512557
NCBI chr 1:17,018,722...17,054,032
Ensembl chr 1:17,018,664...17,054,032
G
SDK2
sidekick cell adhesion molecule 2
decreases expression
EXP
picoxystrobin results in decreased expression of SDK2 mRNA
CTD
PMID:33512557
NCBI chr17:73,334,384...73,644,445
Ensembl chr17:73,334,384...73,644,445
G
SEC11A
SEC11 homolog A, signal peptidase complex subunit
increases expression
EXP
picoxystrobin results in increased expression of SEC11A mRNA
CTD
PMID:33512557
NCBI chr15:84,669,544...84,716,139
Ensembl chr15:84,669,538...84,716,460
G
SEC62
SEC62 homolog, preprotein translocation factor
increases expression
EXP
picoxystrobin results in increased expression of SEC62 mRNA
CTD
PMID:33512557
NCBI chr 3:169,966,807...169,998,373
Ensembl chr 3:169,966,635...169,998,373
G
SELENOS
selenoprotein S
increases expression
EXP
picoxystrobin results in increased expression of SELENOS mRNA
CTD
PMID:33512557
NCBI chr15:101,270,809...101,277,485
Ensembl chr15:101,270,817...101,277,500
G
SEM1
SEM1 26S proteasome subunit
decreases expression
EXP
picoxystrobin results in decreased expression of SEM1 mRNA
CTD
PMID:33512557
NCBI chr 7:96,481,626...96,709,846
Ensembl chr 7:96,481,626...96,709,880
G
SEMA4B
semaphorin 4B
decreases expression
EXP
picoxystrobin results in decreased expression of SEMA4B mRNA
CTD
PMID:33512557
NCBI chr15:90,184,920...90,229,661
Ensembl chr15:90,160,604...90,229,679
G
SEMA6D
semaphorin 6D
decreases expression
EXP
picoxystrobin results in decreased expression of SEMA6D mRNA
CTD
PMID:33512557
NCBI chr15:47,184,089...47,774,228
Ensembl chr15:47,184,101...47,774,228
G
SERTAD1
SERTA domain containing 1
increases expression
EXP
picoxystrobin results in increased expression of SERTAD1 mRNA
CTD
PMID:33512557
NCBI chr19:40,421,589...40,425,992
Ensembl chr19:40,421,589...40,425,992
G
SESN1
sestrin 1
increases expression
EXP
picoxystrobin results in increased expression of SESN1 mRNA
CTD
PMID:33512557
NCBI chr 6:108,984,309...109,094,846
Ensembl chr 6:108,984,309...109,094,846
G
SESN2
sestrin 2
increases expression
EXP
picoxystrobin results in increased expression of SESN2 mRNA
CTD
PMID:33512557
NCBI chr 1:28,259,518...28,282,491
Ensembl chr 1:28,259,518...28,282,491
G
SGCE
sarcoglycan epsilon
increases expression
EXP
picoxystrobin results in increased expression of SGCE mRNA
CTD
PMID:33512557
NCBI chr 7:94,584,980...94,656,133
Ensembl chr 7:94,524,204...94,656,572
G
SGK2
serum/glucocorticoid regulated kinase 2
decreases expression
EXP
picoxystrobin results in decreased expression of SGK2 mRNA
CTD
PMID:33512557
NCBI chr20:43,559,027...43,585,627
Ensembl chr20:43,558,968...43,588,237
G
SGO2
shugoshin 2
increases expression
EXP
picoxystrobin results in increased expression of SGO2 mRNA
CTD
PMID:33512557
NCBI chr 2:200,526,142...200,584,096
Ensembl chr 2:200,510,008...200,584,096
G
SGPP1
sphingosine-1-phosphate phosphatase 1
increases expression
EXP
picoxystrobin results in increased expression of SGPP1 mRNA
CTD
PMID:33512557
NCBI chr14:63,684,216...63,728,065
Ensembl chr14:63,684,216...63,728,065
G
SLBP
stem-loop histone mRNA binding protein
increases expression
EXP
picoxystrobin results in increased expression of SLBP mRNA
CTD
PMID:33512557
NCBI chr 4:1,692,731...1,712,319
Ensembl chr 4:1,692,731...1,712,344
G
SLC11A2
solute carrier family 11 member 2
decreases expression
EXP
picoxystrobin results in decreased expression of SLC11A2 mRNA
CTD
PMID:33512557
NCBI chr12:50,952,263...51,028,886
Ensembl chr12:50,979,401...51,028,566
G
SLC17A6
solute carrier family 17 member 6
decreases expression
EXP
picoxystrobin results in decreased expression of SLC17A6 mRNA
CTD
PMID:33512557
NCBI chr11:22,338,381...22,379,503
Ensembl chr11:22,338,381...22,379,503
G
SLC1A2
solute carrier family 1 member 2
decreases expression
EXP
picoxystrobin results in decreased expression of SLC1A2 mRNA
CTD
PMID:33512557
NCBI chr11:35,251,205...35,420,507
Ensembl chr11:35,251,205...35,420,063
G
SLC1A3
solute carrier family 1 member 3
increases expression
EXP
picoxystrobin results in increased expression of SLC1A3 mRNA
CTD
PMID:33512557
NCBI chr 5:36,606,606...36,688,334
Ensembl chr 5:36,596,588...36,688,334
G
SLC25A5
solute carrier family 25 member 5
increases expression
EXP
picoxystrobin results in increased expression of SLC25A5 mRNA
CTD
PMID:33512557
NCBI chr X:119,468,444...119,471,396
Ensembl chr X:119,468,422...119,471,396
G
SLC2A6
solute carrier family 2 member 6
decreases expression
EXP
picoxystrobin results in decreased expression of SLC2A6 mRNA
CTD
PMID:33512557
NCBI chr 9:133,471,094...133,479,099
Ensembl chr 9:133,471,094...133,479,127
G
SLC30A1
solute carrier family 30 member 1
increases expression
EXP
picoxystrobin results in increased expression of SLC30A1 mRNA
CTD
PMID:33512557
NCBI chr 1:211,571,568...211,579,161
Ensembl chr 1:211,571,568...211,579,161
G
SLC6A3
solute carrier family 6 member 3
decreases expression
EXP
picoxystrobin results in decreased expression of SLC6A3 mRNA
CTD
PMID:33512557
NCBI chr 5:1,392,794...1,445,440
Ensembl chr 5:1,392,794...1,445,440
G
SLC7A5
solute carrier family 7 member 5
increases expression
EXP
picoxystrobin results in increased expression of SLC7A5 mRNA
CTD
PMID:33512557
NCBI chr16:87,830,023...87,869,507
Ensembl chr16:87,830,023...87,869,507
G
SMAD3
SMAD family member 3
decreases expression
EXP
picoxystrobin results in decreased expression of SMAD3 mRNA
CTD
PMID:33512557
NCBI chr15:67,065,602...67,195,169
Ensembl chr15:67,063,763...67,195,173
G
SMAD4
SMAD family member 4
decreases expression
EXP
picoxystrobin results in decreased expression of SMAD4 mRNA
CTD
PMID:33512557
NCBI chr18:51,030,213...51,085,042
Ensembl chr18:51,028,528...51,085,045
G
SMAD5
SMAD family member 5
increases expression
EXP
picoxystrobin results in increased expression of SMAD5 mRNA
CTD
PMID:33512557
NCBI chr 5:136,132,845...136,182,733
Ensembl chr 5:136,132,845...136,188,747
G
SMC3
structural maintenance of chromosomes 3
increases expression
EXP
picoxystrobin results in increased expression of SMC3 mRNA
CTD
PMID:33512557
NCBI chr10:110,567,695...110,606,048
Ensembl chr10:110,567,684...110,606,048
G
SMIM15
small integral membrane protein 15
increases expression
EXP
picoxystrobin results in increased expression of SMIM15 mRNA
CTD
PMID:33512557
NCBI chr 5:61,157,704...61,162,468
Ensembl chr 5:61,157,704...61,162,468
G
SMIM19
small integral membrane protein 19
decreases expression
EXP
picoxystrobin results in decreased expression of SMIM19 mRNA
CTD
PMID:33512557
NCBI chr 8:42,541,148...42,555,195
Ensembl chr 8:42,541,155...42,555,195
G
SMNDC1
survival motor neuron domain containing 1
decreases expression
EXP
picoxystrobin results in decreased expression of SMNDC1 mRNA
CTD
PMID:33512557
NCBI chr10:110,290,730...110,304,920
Ensembl chr10:110,290,730...110,304,938
G
SNX13
sorting nexin 13
decreases expression
EXP
picoxystrobin results in decreased expression of SNX13 mRNA
CTD
PMID:33512557
NCBI chr 7:17,790,761...17,940,494
Ensembl chr 7:17,790,761...17,940,501
G
SOCS2
suppressor of cytokine signaling 2
decreases expression
EXP
picoxystrobin results in decreased expression of SOCS2 mRNA
CTD
PMID:33512557
NCBI chr12:93,569,969...93,626,236
Ensembl chr12:93,569,814...93,583,487
G
SOD1
superoxide dismutase 1
increases expression
EXP
picoxystrobin results in increased expression of SOD1 mRNA
CTD
PMID:33512557
NCBI chr21:31,659,693...31,668,931
Ensembl chr21:31,659,666...31,668,931
G
SOX4
SRY-box transcription factor 4
decreases expression
EXP
picoxystrobin results in decreased expression of SOX4 mRNA
CTD
PMID:33512557
NCBI chr 6:21,593,751...21,598,619
Ensembl chr 6:21,593,751...21,598,619
G
SPAG5
sperm associated antigen 5
increases expression
EXP
picoxystrobin results in increased expression of SPAG5 mRNA
CTD
PMID:33512557
NCBI chr17:28,577,574...28,599,025
Ensembl chr17:28,577,565...28,599,025
G
SPC25
SPC25 component of NDC80 kinetochore complex
increases expression
EXP
picoxystrobin results in increased expression of SPC25 mRNA
CTD
PMID:33512557
NCBI chr 2:168,861,521...168,890,430
Ensembl chr 2:168,834,132...168,913,371
G
SPDEF
SAM pointed domain containing ETS transcription factor
decreases expression
EXP
picoxystrobin results in decreased expression of SPDEF mRNA
CTD
PMID:33512557
NCBI chr 6:34,537,802...34,556,329
Ensembl chr 6:34,537,802...34,556,333
G
SPEN
spen family transcriptional repressor
decreases expression
EXP
picoxystrobin results in decreased expression of SPEN mRNA
CTD
PMID:33512557
NCBI chr 1:15,847,707...15,940,456
Ensembl chr 1:15,836,095...15,940,456
G
SRD5A1
steroid 5 alpha-reductase 1
decreases expression
EXP
picoxystrobin results in decreased expression of SRD5A1 mRNA
CTD
PMID:33512557
NCBI chr 5:6,633,440...6,674,386
Ensembl chr 5:6,633,290...6,676,539
G
SRP72
signal recognition particle 72
increases expression
EXP
picoxystrobin results in increased expression of SRP72 mRNA
CTD
PMID:33512557
NCBI chr 4:56,467,617...56,503,681
Ensembl chr 4:56,467,617...56,503,681
G
SRSF10
serine and arginine rich splicing factor 10
increases expression
EXP
picoxystrobin results in increased expression of SRSF10 mRNA
CTD
PMID:33512557
NCBI chr 1:23,964,347...23,980,327
Ensembl chr 1:23,964,347...23,980,927
G
SST
somatostatin
decreases expression
EXP
picoxystrobin results in decreased expression of SST mRNA
CTD
PMID:33512557
NCBI chr 3:187,668,912...187,670,394
Ensembl chr 3:187,668,912...187,670,394
G
ST7
suppression of tumorigenicity 7
decreases expression
EXP
picoxystrobin results in decreased expression of ST7 mRNA
CTD
PMID:33512557
NCBI chr 7:116,953,501...117,230,176
Ensembl chr 7:116,953,238...117,230,176
G
STAT4
signal transducer and activator of transcription 4
decreases expression
EXP
picoxystrobin results in decreased expression of STAT4 mRNA
CTD
PMID:33512557
NCBI chr 2:191,029,576...191,151,596
Ensembl chr 2:191,029,576...191,151,596
G
STAT5B
signal transducer and activator of transcription 5B
decreases expression
EXP
picoxystrobin results in decreased expression of STAT5B mRNA
CTD
PMID:33512557
NCBI chr17:42,199,177...42,288,370
Ensembl chr17:42,199,176...42,288,633
G
STEAP1
STEAP family member 1
increases expression
EXP
picoxystrobin results in increased expression of STEAP1 mRNA
CTD
PMID:33512557
NCBI chr 7:90,154,469...90,164,827
Ensembl chr 7:90,154,456...90,164,829
G
STK10
serine/threonine kinase 10
decreases expression
EXP
picoxystrobin results in decreased expression of STK10 mRNA
CTD
PMID:33512557
NCBI chr 5:172,042,079...172,188,224
Ensembl chr 5:172,042,079...172,188,224
G
STK25
serine/threonine kinase 25
decreases expression
EXP
picoxystrobin results in decreased expression of STK25 mRNA
CTD
PMID:33512557
NCBI chr 2:241,492,670...241,509,572
Ensembl chr 2:241,492,670...241,509,730
G
STMN1
stathmin 1
increases expression
EXP
picoxystrobin results in increased expression of STMN1 mRNA
CTD
PMID:33512557
NCBI chr 1:25,884,179...25,906,880
Ensembl chr 1:25,884,181...25,906,991
G
SUCLA2
succinate-CoA ligase ADP-forming subunit beta
increases expression
EXP
picoxystrobin results in increased expression of SUCLA2 mRNA
CTD
PMID:33512557
NCBI chr13:47,942,656...48,001,273
Ensembl chr13:47,745,736...48,037,968
G
SULF1
sulfatase 1
decreases expression
EXP
picoxystrobin results in decreased expression of SULF1 mRNA
CTD
PMID:33512557
NCBI chr 8:69,466,781...69,660,912
Ensembl chr 8:69,466,624...69,660,915
G
SULT1A1
sulfotransferase family 1A member 1
decreases expression
EXP
picoxystrobin results in decreased expression of SULT1A1 mRNA
CTD
PMID:33512557
NCBI chr16:28,605,258...28,623,375
Ensembl chr16:28,605,196...28,610,044
G
SUMO1
small ubiquitin like modifier 1
increases expression
EXP
picoxystrobin results in increased expression of SUMO1 mRNA
CTD
PMID:33512557
NCBI chr 2:202,206,171...202,238,597
Ensembl chr 2:202,206,182...202,238,599
G
SUPV3L1
Suv3 like RNA helicase
increases expression
EXP
picoxystrobin results in increased expression of SUPV3L1 mRNA
CTD
PMID:33512557
NCBI chr10:69,180,234...69,209,093
Ensembl chr10:69,180,234...69,209,099
G
SUZ12
SUZ12 polycomb repressive complex 2 subunit
increases expression
EXP
picoxystrobin results in increased expression of SUZ12 mRNA
CTD
PMID:33512557
NCBI chr17:31,937,007...32,001,038
Ensembl chr17:31,937,007...32,001,038
G
SYNE2
spectrin repeat containing nuclear envelope protein 2
decreases expression
EXP
picoxystrobin results in decreased expression of SYNE2 mRNA
CTD
PMID:33512557
NCBI chr14:63,761,596...64,226,449
Ensembl chr14:63,761,899...64,226,433
G
SYNGR3
synaptogyrin 3
decreases expression
EXP
picoxystrobin results in decreased expression of SYNGR3 mRNA
CTD
PMID:33512557
NCBI chr16:1,989,970...1,994,275
Ensembl chr16:1,989,660...1,994,275
G
SYPL1
synaptophysin like 1
increases expression
EXP
picoxystrobin results in increased expression of SYPL1 mRNA
CTD
PMID:33512557
NCBI chr 7:106,090,505...106,112,576
Ensembl chr 7:106,090,505...106,112,589
G
TAF7
TATA-box binding protein associated factor 7
increases expression
EXP
picoxystrobin results in increased expression of TAF7 mRNA
CTD
PMID:33512557
NCBI chr 5:141,318,490...141,320,784
Ensembl chr 5:141,259,884...141,320,784
G
TAF9
TATA-box binding protein associated factor 9
increases expression
EXP
picoxystrobin results in increased expression of TAF9 mRNA
CTD
PMID:33512557
NCBI chr 5:69,364,743...69,369,824
Ensembl chr 5:69,362,026...69,370,013
G
TAGLN
transgelin
increases expression
EXP
picoxystrobin results in increased expression of TAGLN mRNA
CTD
PMID:33512557
NCBI chr11:117,199,294...117,207,465
Ensembl chr11:117,199,370...117,207,464
G
TAPBP
TAP binding protein
decreases expression
EXP
picoxystrobin results in decreased expression of TAPBP mRNA
CTD
PMID:33512557
NCBI chr 6:33,299,694...33,314,078
Ensembl chr 6:33,299,694...33,314,284
G
TARBP1
TAR (HIV-1) RNA binding protein 1
decreases expression
EXP
picoxystrobin results in decreased expression of TARBP1 mRNA
CTD
PMID:33512557
NCBI chr 1:234,391,313...234,479,179
Ensembl chr 1:234,391,313...234,479,179
G
TCEAL4
transcription elongation factor A like 4
decreases expression
EXP
picoxystrobin results in decreased expression of TCEAL4 mRNA
CTD
PMID:33512557
NCBI chr X:103,576,231...103,587,729
Ensembl chr X:103,576,231...103,587,729
G
TCEAL9
transcription elongation factor A like 9
increases expression
EXP
picoxystrobin results in increased expression of TCEAL9 mRNA
CTD
PMID:33512557
NCBI chr X:103,356,506...103,358,462
Ensembl chr X:103,356,489...103,358,462
G
TCF4
transcription factor 4
decreases expression
EXP
picoxystrobin results in decreased expression of TCF4 mRNA
CTD
PMID:33512557
NCBI chr18:55,222,185...55,635,957
Ensembl chr18:55,222,185...55,664,787
G
TCFL5
transcription factor like 5
increases expression
EXP
picoxystrobin results in increased expression of TCFL5 mRNA
CTD
PMID:33512557
NCBI chr20:62,841,005...62,861,822
Ensembl chr20:62,841,005...62,861,822
G
TCTN1
tectonic family member 1
decreases expression
EXP
picoxystrobin results in decreased expression of TCTN1 mRNA
CTD
PMID:33512557
NCBI chr12:110,614,129...110,649,430
Ensembl chr12:110,614,027...110,663,431
G
TERF2IP
TERF2 interacting protein
decreases expression
EXP
picoxystrobin results in decreased expression of TERF2IP mRNA
CTD
PMID:33512557
NCBI chr16:75,647,773...75,657,432
Ensembl chr16:75,647,773...75,761,872
G
TERT
telomerase reverse transcriptase
decreases expression
EXP
picoxystrobin results in decreased expression of TERT mRNA
CTD
PMID:33512557
NCBI chr 5:1,253,167...1,295,068
Ensembl chr 5:1,253,147...1,295,068
G
TFAM
transcription factor A, mitochondrial
increases expression
EXP
picoxystrobin results in increased expression of TFAM mRNA
CTD
PMID:33512557
NCBI chr10:58,385,410...58,399,220
Ensembl chr10:58,385,345...58,399,220
G
TFAP2A
transcription factor AP-2 alpha
decreases expression
EXP
picoxystrobin results in decreased expression of TFAP2A mRNA
CTD
PMID:33512557
NCBI chr 6:10,396,677...10,419,659
Ensembl chr 6:10,393,186...10,419,659
G
TGFB3
transforming growth factor beta 3
decreases expression
EXP
picoxystrobin results in decreased expression of TGFB3 mRNA
CTD
PMID:33512557
NCBI chr14:75,958,097...75,983,011
Ensembl chr14:75,958,097...75,983,011
G
TGFBR2
transforming growth factor beta receptor 2
decreases expression
EXP
picoxystrobin results in decreased expression of TGFBR2 mRNA
CTD
PMID:33512557
NCBI chr 3:30,606,356...30,694,142
Ensembl chr 3:30,606,601...30,694,142
G
TIMMDC1
translocase of inner mitochondrial membrane domain containing 1
increases expression
EXP
picoxystrobin results in increased expression of TIMMDC1 mRNA
CTD
PMID:33512557
NCBI chr 3:119,498,547...119,525,090
Ensembl chr 3:119,498,547...119,525,090
G
TIPARP
TCDD inducible poly(ADP-ribose) polymerase
increases expression
EXP
picoxystrobin results in increased expression of TIPARP mRNA
CTD
PMID:33512557
NCBI chr 3:156,674,590...156,706,770
Ensembl chr 3:156,673,235...156,706,770
G
TJP1
tight junction protein 1
decreases expression
EXP
picoxystrobin results in decreased expression of TJP1 mRNA
CTD
PMID:33512557
NCBI chr15:29,699,367...29,969,049
Ensembl chr15:29,699,367...29,968,915
G
TLK2
tousled like kinase 2
decreases expression
EXP
picoxystrobin results in decreased expression of TLK2 mRNA
CTD
PMID:33512557
NCBI chr17:62,470,914...62,615,481
Ensembl chr17:62,458,658...62,615,481
G
TM7SF3
transmembrane 7 superfamily member 3
increases expression
EXP
picoxystrobin results in increased expression of TM7SF3 mRNA
CTD
PMID:33512557
NCBI chr12:26,971,579...27,014,384
Ensembl chr12:26,971,579...27,014,434
G
TM9SF3
transmembrane 9 superfamily member 3
decreases expression
EXP
picoxystrobin results in decreased expression of TM9SF3 mRNA
CTD
PMID:33512557
NCBI chr10:96,518,110...96,587,012
Ensembl chr10:96,518,110...96,587,452
G
TMBIM6
transmembrane BAX inhibitor motif containing 6
increases expression
EXP
picoxystrobin results in increased expression of TMBIM6 mRNA
CTD
PMID:33512557
NCBI chr12:49,741,557...49,764,934
Ensembl chr12:49,707,725...49,764,934
G
TMEM126A
transmembrane protein 126A
increases expression
EXP
picoxystrobin results in increased expression of TMEM126A mRNA
CTD
PMID:33512557
NCBI chr11:85,647,967...85,656,542
Ensembl chr11:85,647,967...85,656,547
G
TMEM14C
transmembrane protein 14C
increases expression
EXP
picoxystrobin results in increased expression of TMEM14C mRNA
CTD
PMID:33512557
NCBI chr 6:10,723,070...10,731,127
Ensembl chr 6:10,722,915...10,731,129
G
TMEM185A
transmembrane protein 185A
decreases expression
EXP
picoxystrobin results in decreased expression of TMEM185A mRNA
CTD
PMID:33512557
NCBI chr X:149,596,556...149,631,792
Ensembl chr X:149,596,556...149,631,912
G
TNC
tenascin C
decreases expression
EXP
picoxystrobin results in decreased expression of TNC mRNA
CTD
PMID:33512557
NCBI chr 9:115,019,575...115,118,157
Ensembl chr 9:115,019,575...115,118,207
G
TNFRSF10B
TNF receptor superfamily member 10b
increases expression
EXP
picoxystrobin results in increased expression of TNFRSF10B mRNA
CTD
PMID:33512557
NCBI chr 8:23,020,133...23,069,031
Ensembl chr 8:23,020,133...23,069,031
G
TNFSF13B
TNF superfamily member 13b
increases expression
EXP
picoxystrobin results in increased expression of TNFSF13B mRNA
CTD
PMID:33512557
NCBI chr13:108,269,629...108,308,484
Ensembl chr13:108,251,240...108,308,484
G
TNIP1
TNFAIP3 interacting protein 1
decreases expression
EXP
picoxystrobin results in decreased expression of TNIP1 mRNA
CTD
PMID:33512557
NCBI chr 5:151,029,943...151,087,685
Ensembl chr 5:151,029,945...151,093,577
G
TOMM20
translocase of outer mitochondrial membrane 20
increases expression
EXP
picoxystrobin results in increased expression of TOMM20 mRNA
CTD
PMID:33512557
NCBI chr 1:235,109,341...235,128,837
Ensembl chr 1:235,109,341...235,128,837
G
TOP2A
DNA topoisomerase II alpha
increases expression
EXP
picoxystrobin results in increased expression of TOP2A mRNA
CTD
PMID:33512557
NCBI chr17:40,388,525...40,417,896
Ensembl chr17:40,388,525...40,417,896
G
TP53
tumor protein p53
increases activity affects activity
EXP
picoxystrobin results in increased activity of TP53 protein picoxystrobin affects the activity of TP53 protein
CTD
PMID:30818834 PMID:35435491
NCBI chr17:7,668,421...7,687,490
Ensembl chr17:7,661,779...7,687,538
G
TP53I3
tumor protein p53 inducible protein 3
increases expression
EXP
picoxystrobin results in increased expression of TP53I3 mRNA
CTD
PMID:33512557
NCBI chr 2:24,077,433...24,084,834
Ensembl chr 2:24,077,433...24,085,861
G
TPM1
tropomyosin 1
decreases expression
EXP
picoxystrobin results in decreased expression of TPM1 mRNA
CTD
PMID:33512557
NCBI chr15:63,042,747...63,071,915
Ensembl chr15:63,042,620...63,071,915
G
TPX2
TPX2 microtubule nucleation factor
increases expression
EXP
picoxystrobin results in increased expression of TPX2 mRNA
CTD
PMID:33512557
NCBI chr20:31,739,290...31,801,800
Ensembl chr20:31,739,271...31,801,805
G
TRAM1
translocation associated membrane protein 1
increases expression
EXP
picoxystrobin results in increased expression of TRAM1 mRNA
CTD
PMID:33512557
NCBI chr 8:70,573,218...70,608,416
Ensembl chr 8:70,573,218...70,608,416
G
TRAPPC3
trafficking protein particle complex subunit 3
increases expression
EXP
picoxystrobin results in increased expression of TRAPPC3 mRNA
CTD
PMID:33512557
NCBI chr 1:36,136,572...36,156,053
Ensembl chr 1:36,136,570...36,156,053
G
TRIB3
tribbles pseudokinase 3
increases expression
EXP
picoxystrobin results in increased expression of TRIB3 mRNA
CTD
PMID:33512557
NCBI chr20:380,760...397,559
Ensembl chr20:362,835...397,559
G
TRIM13
tripartite motif containing 13
decreases expression
EXP
picoxystrobin results in decreased expression of TRIM13 mRNA
CTD
PMID:33512557
NCBI chr13:49,997,042...50,018,467
Ensembl chr13:49,995,888...50,020,481
G
TRIP13
thyroid hormone receptor interactor 13
increases expression
EXP
picoxystrobin results in increased expression of TRIP13 mRNA
CTD
PMID:33512557
NCBI chr 5:892,884...919,348
Ensembl chr 5:892,884...919,357
G
TSC22D3
TSC22 domain family member 3
increases expression
EXP
picoxystrobin results in increased expression of TSC22D3 mRNA
CTD
PMID:33512557
NCBI chr X:107,713,221...107,775,988
Ensembl chr X:107,713,221...107,777,342
G
TSG101
tumor susceptibility 101
decreases expression
EXP
picoxystrobin results in decreased expression of TSG101 mRNA
CTD
PMID:33512557
NCBI chr11:18,480,311...18,526,942
Ensembl chr11:18,468,336...18,526,951
G
TSKU
tsukushi, small leucine rich proteoglycan
decreases expression
EXP
picoxystrobin results in decreased expression of TSKU mRNA
CTD
PMID:33512557
NCBI chr11:76,782,280...76,798,144
Ensembl chr11:76,782,251...76,798,153
G
TSPAN3
tetraspanin 3
decreases expression
EXP
picoxystrobin results in decreased expression of TSPAN3 mRNA
CTD
PMID:33512557
NCBI chr15:77,041,404...77,071,109
Ensembl chr15:77,041,404...77,083,984
G
TSPO
translocator protein
decreases activity
ISO EXP
picoxystrobin results in decreased activity of TSPO protein
CTD
PMID:23611293
NCBI chr22:43,151,559...43,163,242
Ensembl chr22:43,151,547...43,163,242
G
TST
thiosulfate sulfurtransferase
decreases expression
EXP
picoxystrobin results in decreased expression of TST mRNA
CTD
PMID:33512557
NCBI chr22:37,010,859...37,020,183
Ensembl chr22:37,010,859...37,020,183
G
TTK
TTK protein kinase
increases expression
EXP
picoxystrobin results in increased expression of TTK mRNA
CTD
PMID:33512557
NCBI chr 6:80,004,649...80,042,527
Ensembl chr 6:80,003,887...80,042,527
G
TUBA1A
tubulin alpha 1a
decreases expression
EXP
picoxystrobin results in decreased expression of TUBA1A mRNA
CTD
PMID:33512557
NCBI chr12:49,184,795...49,189,080
Ensembl chr12:49,184,686...49,189,080
G
TUBA1B
tubulin alpha 1b
increases expression
EXP
picoxystrobin results in increased expression of TUBA1B mRNA
CTD
PMID:33512557
NCBI chr12:49,127,782...49,131,395
Ensembl chr12:49,127,782...49,131,397
G
TUBB2B
tubulin beta 2B class IIb
decreases expression
EXP
picoxystrobin results in decreased expression of TUBB2B mRNA
CTD
PMID:33512557
NCBI chr 6:3,224,277...3,227,653
Ensembl chr 6:3,223,324...3,231,730
G
TUBB6
tubulin beta 6 class V
increases expression
EXP
picoxystrobin results in increased expression of TUBB6 mRNA
CTD
PMID:33512557
NCBI chr18:12,307,669...12,329,826
Ensembl chr18:12,307,669...12,344,320
G
TUBG1
tubulin gamma 1
increases expression
EXP
picoxystrobin results in increased expression of TUBG1 mRNA
CTD
PMID:33512557
NCBI chr17:42,609,683...42,615,238
Ensembl chr17:42,609,641...42,615,238
G
TUT7
terminal uridylyl transferase 7
decreases expression
EXP
picoxystrobin results in decreased expression of TUT7 mRNA
CTD
PMID:33512557
NCBI chr 9:86,287,733...86,354,410
Ensembl chr 9:86,287,733...86,354,454
G
TWF2
twinfilin actin binding protein 2
decreases expression
EXP
picoxystrobin results in decreased expression of TWF2 mRNA
CTD
PMID:33512557
NCBI chr 3:52,228,612...52,239,158
Ensembl chr 3:52,228,612...52,246,788
G
TXLNA
taxilin alpha
decreases expression
EXP
picoxystrobin results in decreased expression of TXLNA mRNA
CTD
PMID:33512557
NCBI chr 1:32,179,675...32,198,285
Ensembl chr 1:32,179,675...32,198,285
G
TXNIP
thioredoxin interacting protein
decreases expression
EXP
picoxystrobin results in decreased expression of TXNIP mRNA
CTD
PMID:33512557
NCBI chr 1:145,992,435...145,996,579
Ensembl chr 1:145,992,435...145,996,579
G
TXNL4B
thioredoxin like 4B
decreases expression
EXP
picoxystrobin results in decreased expression of TXNL4B mRNA
CTD
PMID:33512557
NCBI chr16:72,084,857...72,094,378
Ensembl chr16:72,044,289...72,094,431
G
TXNRD1
thioredoxin reductase 1
increases expression
EXP
picoxystrobin results in increased expression of TXNRD1 mRNA
CTD
PMID:33512557
NCBI chr12:104,215,779...104,350,307
Ensembl chr12:104,215,779...104,350,307
G
UBA52
ubiquitin A-52 residue ribosomal protein fusion product 1
increases expression
EXP
picoxystrobin results in increased expression of UBA52 mRNA
CTD
PMID:33512557
NCBI chr19:18,563,766...18,577,550
Ensembl chr19:18,571,730...18,577,550
G
UBE2C
ubiquitin conjugating enzyme E2 C
increases expression
EXP
picoxystrobin results in increased expression of UBE2C mRNA
CTD
PMID:33512557
NCBI chr20:45,812,644...45,816,952
Ensembl chr20:45,812,576...45,816,957
G
UBE2L6
ubiquitin conjugating enzyme E2 L6
decreases expression
EXP
picoxystrobin results in decreased expression of UBE2L6 mRNA
CTD
PMID:33512557
NCBI chr11:57,551,662...57,567,935
Ensembl chr11:57,551,656...57,568,284
G
UQCRQ
ubiquinol-cytochrome c reductase complex III subunit VII
increases expression
EXP
picoxystrobin results in increased expression of UQCRQ mRNA
CTD
PMID:33512557
NCBI chr 5:132,866,642...132,868,847
Ensembl chr 5:132,866,630...132,868,847
G
USP7
ubiquitin specific peptidase 7
decreases expression
EXP
picoxystrobin results in decreased expression of USP7 mRNA
CTD
PMID:33512557
NCBI chr16:8,892,097...8,963,906
Ensembl chr16:8,892,097...8,975,328
G
VAPB
VAMP associated protein B and C
decreases expression
EXP
picoxystrobin results in decreased expression of VAPB mRNA
CTD
PMID:33512557
NCBI chr20:58,389,229...58,451,101
Ensembl chr20:58,389,229...58,451,101
G
VDAC2
voltage dependent anion channel 2
increases expression
EXP
picoxystrobin results in increased expression of VDAC2 mRNA
CTD
PMID:33512557
NCBI chr10:75,210,170...75,231,448
Ensembl chr10:75,210,154...75,231,448
G
VEGFD
vascular endothelial growth factor D
decreases expression
EXP
picoxystrobin results in decreased expression of VEGFD mRNA
CTD
PMID:33512557
NCBI chr X:15,345,596...15,384,413
Ensembl chr X:15,345,596...15,384,413
G
VIM
vimentin
decreases expression
EXP
picoxystrobin results in decreased expression of VIM mRNA
CTD
PMID:33512557
NCBI chr10:17,228,241...17,237,593
Ensembl chr10:17,228,241...17,237,593
G
VPS72
vacuolar protein sorting 72 homolog
decreases expression
EXP
picoxystrobin results in decreased expression of VPS72 mRNA
CTD
PMID:33512557
NCBI chr 1:151,176,304...151,190,197
Ensembl chr 1:151,176,304...151,195,321
G
VRK1
VRK serine/threonine kinase 1
increases expression
EXP
picoxystrobin results in increased expression of VRK1 mRNA
CTD
PMID:33512557
NCBI chr14:96,797,382...96,881,609
Ensembl chr14:96,797,304...96,954,846
G
VWF
von Willebrand factor
decreases expression
EXP
picoxystrobin results in decreased expression of VWF mRNA
CTD
PMID:33512557
NCBI chr12:5,948,877...6,124,670
Ensembl chr12:5,948,877...6,124,770
G
WARS1
tryptophanyl-tRNA synthetase 1
increases expression
EXP
picoxystrobin results in increased expression of WARS1 mRNA
CTD
PMID:33512557
NCBI chr14:100,333,790...100,376,327
Ensembl chr14:100,333,790...100,376,805
G
WDR12
WD repeat domain 12
decreases expression
EXP
picoxystrobin results in decreased expression of WDR12 mRNA
CTD
PMID:33512557
NCBI chr 2:202,874,261...202,911,673
Ensembl chr 2:202,874,261...203,014,798
G
WDR3
WD repeat domain 3
decreases expression
EXP
picoxystrobin results in decreased expression of WDR3 mRNA
CTD
PMID:33512557
NCBI chr 1:117,929,739...117,966,543
Ensembl chr 1:117,929,720...117,966,543
G
WDTC1
WD and tetratricopeptide repeats 1
decreases expression
EXP
picoxystrobin results in decreased expression of WDTC1 mRNA
CTD
PMID:33512557
NCBI chr 1:27,234,441...27,308,636
Ensembl chr 1:27,234,632...27,308,636
G
WNT5A
Wnt family member 5A
decreases expression
EXP
picoxystrobin results in decreased expression of WNT5A mRNA
CTD
PMID:33512557
NCBI chr 3:55,465,715...55,505,263
Ensembl chr 3:55,465,715...55,490,539
G
XBP1
X-box binding protein 1
increases expression
EXP
picoxystrobin results in increased expression of XBP1 mRNA
CTD
PMID:33512557
NCBI chr22:28,794,560...28,800,569
Ensembl chr22:28,794,555...28,800,597
G
XPC
XPC complex subunit, DNA damage recognition and repair factor
decreases expression
EXP
picoxystrobin results in decreased expression of XPC mRNA
CTD
PMID:33512557
NCBI chr 3:14,145,147...14,178,601
Ensembl chr 3:14,145,147...14,178,621
G
XPNPEP1
X-prolyl aminopeptidase 1
decreases expression
EXP
picoxystrobin results in decreased expression of XPNPEP1 mRNA
CTD
PMID:33512557
NCBI chr10:109,864,766...109,923,511
Ensembl chr10:109,864,766...109,923,553
G
XRCC5
X-ray repair cross complementing 5
decreases expression
EXP
picoxystrobin results in decreased expression of XRCC5 mRNA
CTD
PMID:33512557
NCBI chr 2:216,109,348...216,206,293
Ensembl chr 2:216,107,464...216,206,303
G
YME1L1
YME1 like 1 ATPase
increases expression
EXP
picoxystrobin results in increased expression of YME1L1 mRNA
CTD
PMID:33512557
NCBI chr10:27,110,111...27,154,384
Ensembl chr10:27,110,111...27,155,266
G
YWHAB
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein beta
decreases expression
EXP
picoxystrobin results in decreased expression of YWHAB mRNA
CTD
PMID:33512557
NCBI chr20:44,885,705...44,908,532
Ensembl chr20:44,885,702...44,908,532
G
ZBTB41
zinc finger and BTB domain containing 41
decreases expression
EXP
picoxystrobin results in decreased expression of ZBTB41 mRNA
CTD
PMID:33512557
NCBI chr 1:197,153,682...197,201,293
Ensembl chr 1:197,153,682...197,201,293
G
ZEB2
zinc finger E-box binding homeobox 2
decreases expression
EXP
picoxystrobin results in decreased expression of ZEB2 mRNA
CTD
PMID:33512557
NCBI chr 2:144,384,081...144,520,119
Ensembl chr 2:144,364,364...144,521,057
G
ZFAND2A
zinc finger AN1-type containing 2A
increases expression
EXP
picoxystrobin results in increased expression of ZFAND2A mRNA
CTD
PMID:33512557
NCBI chr 7:1,148,850...1,160,196
Ensembl chr 7:1,152,071...1,160,759
G
ZMIZ1
zinc finger MIZ-type containing 1
decreases expression
EXP
picoxystrobin results in decreased expression of ZMIZ1 mRNA
CTD
PMID:33512557
NCBI chr10:79,068,966...79,316,519
Ensembl chr10:79,068,966...79,316,519
G
ZNF274
zinc finger protein 274
increases expression
EXP
picoxystrobin results in increased expression of ZNF274 mRNA
CTD
PMID:33512557
NCBI chr19:58,183,061...58,213,562
Ensembl chr19:58,183,029...58,213,562
G
ZNF587
zinc finger protein 587
decreases expression
EXP
picoxystrobin results in decreased expression of ZNF587 mRNA
CTD
PMID:33512557
NCBI chr19:57,849,859...57,865,117
Ensembl chr19:57,849,859...57,865,117
G
ZNF682
zinc finger protein 682
increases expression
EXP
picoxystrobin results in increased expression of ZNF682 mRNA
CTD
PMID:33512557
NCBI chr19:19,995,131...20,039,505
Ensembl chr19:19,997,058...20,039,505
G
ZNG1A
Zn regulated GTPase metalloprotein activator 1A
increases expression
EXP
picoxystrobin results in increased expression of ZNG1A mRNA
CTD
PMID:33512557
NCBI chr 9:120,837...179,056
Ensembl chr 9:120,837...179,147
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all
Path 1
CHEBI ontology
26034
chemical entity
26024
atom
26009
nonmetal atom
25498
carbon atom
25403
organic molecular entity
25392
olefinic compound
18212
enol ether
1172
(+)-(4S,5S)-4-hydroxy-3-methoxy-5-methyl-2-cyclopentenone
0
(+)-nigrosporione D
0
(-)-(4R,5R)-4-hydroxy-3-methoxy-5-methyl-2-cyclopentenone
0
(-)-Acorenone
0
(-)-microdiplodiasolol
0
(-)-nigrosporione D
0
(-)-rel-acora-2,4(14),8-trien-15-oic acid
0
(4R)-4,5-dihydro-4-hydroxygeldanamycin
0
(R)-4''-methoxydalbergione
0
12-methyl-5-dehydroacetylhorminone
0
12-methyl-5-dehydrohorminone +
0
15-Hydroxygeldanamycin
0
2,4-Dodecadienamide
0
2-O,3-dimethylflaviolin
0
2-methoxy-1,4-naphthoquinone
2
21-deoxyconcanamycin A
0
3-[(1-carboxyvinyl)oxy]benzoic acid
0
4,5-dihydro-7-O-descarbamoyl-7-hydroxygeldanamycin
0
4-(Hydroxymethyl)-3-methoxy-5-methylcyclopent-2-enone
0
5-O-ethyl embelin
0
5-O-methyl embelin
0
6-linalyl-2-O,3-dimethylflaviolin
0
7-O-geranyl-2-O,3-dimethylflaviolin
0
7-methoxypraecansone B
0
8-demethyl-8-(2,3,4-O-trimethyl-alpha-L-rhamnosyl)tetracenomycin C
0
8-demethyl-8-(2,3-O-dimethyl-alpha-L-rhamnosyl)tetracenomycin C
0
8-demethyl-8-(2-O-methyl-alpha-L-rhamnosyl)tetracenomycin C
0
8-demethyl-8-(alpha-L-rhamnosyl)tetracenomycin C
0
8-demethyltetracenomycin C
0
Colomitide D
0
Epoxypholamin A
0
Epoxypholamin B
0
Luteoxepinone
0
Metachromin W
0
Nigrosporione B
0
Nigrosporione C
0
Seiridiasteriscane A
0
acalyphin
0
aignopsane ketal
0
antroquinonol
17
azoxystrobin
729
azoxystrobin acid
0
botrallin
0
burchellin
0
cephalotaxine +
32
comosone A
0
coumoxystrobin
0
cuevaene A
0
cystothiazole A
0
divinyl ether fatty acid +
0
drymaritin
0
elloramycin A
0
enoxastrobin
0
firocoxib
0
fluacrypyrim
0
flufenoxystrobin
0
flupyroxystrobin
0
futoenone
0
glycal +
0
isatinone A
0
isatinone B
0
laccaridione A
0
laccaridione B
0
lymphostin
0
mucidin
0
nalanthalide
0
omacetaxine mepesuccinate
32
oxaline
0
picoxystrobin
733
praecanson A
0
pyraoxystrobin
0
pyriminostrobin
0
silyl enol ether
0
strobilurin B
0
strongylophorine-26
0
yanuthone X1
0
yanuthone X2 +
0
Path 2
CHEBI ontology
26034
subatomic particle
26009
composite particle
26009
hadron
26020
baryon
26009
nucleon
26009
atomic nucleus
26009
atom
26009
main group element atom
25834
p-block element atom
25834
carbon group element atom
25434
carbon atom
25403
organic molecular entity
25392
heteroorganic entity
24766
organochalcogen compound
24378
organooxygen compound
24054
ether
19866
enol ether
1172
(+)-(4S,5S)-4-hydroxy-3-methoxy-5-methyl-2-cyclopentenone
0
(+)-nigrosporione D
0
(-)-(4R,5R)-4-hydroxy-3-methoxy-5-methyl-2-cyclopentenone
0
(-)-Acorenone
0
(-)-microdiplodiasolol
0
(-)-nigrosporione D
0
(-)-rel-acora-2,4(14),8-trien-15-oic acid
0
(4R)-4,5-dihydro-4-hydroxygeldanamycin
0
(R)-4''-methoxydalbergione
0
12-methyl-5-dehydroacetylhorminone
0
12-methyl-5-dehydrohorminone +
0
15-Hydroxygeldanamycin
0
2,4-Dodecadienamide
0
2-O,3-dimethylflaviolin
0
2-methoxy-1,4-naphthoquinone
2
21-deoxyconcanamycin A
0
3-[(1-carboxyvinyl)oxy]benzoic acid
0
4,5-dihydro-7-O-descarbamoyl-7-hydroxygeldanamycin
0
4-(Hydroxymethyl)-3-methoxy-5-methylcyclopent-2-enone
0
5-O-ethyl embelin
0
5-O-methyl embelin
0
6-linalyl-2-O,3-dimethylflaviolin
0
7-O-geranyl-2-O,3-dimethylflaviolin
0
7-methoxypraecansone B
0
8-demethyl-8-(2,3,4-O-trimethyl-alpha-L-rhamnosyl)tetracenomycin C
0
8-demethyl-8-(2,3-O-dimethyl-alpha-L-rhamnosyl)tetracenomycin C
0
8-demethyl-8-(2-O-methyl-alpha-L-rhamnosyl)tetracenomycin C
0
8-demethyl-8-(alpha-L-rhamnosyl)tetracenomycin C
0
8-demethyltetracenomycin C
0
Colomitide D
0
Epoxypholamin A
0
Epoxypholamin B
0
Luteoxepinone
0
Metachromin W
0
Nigrosporione B
0
Nigrosporione C
0
Seiridiasteriscane A
0
acalyphin
0
aignopsane ketal
0
antroquinonol
17
azoxystrobin
729
azoxystrobin acid
0
botrallin
0
burchellin
0
cephalotaxine +
32
comosone A
0
coumoxystrobin
0
cuevaene A
0
cystothiazole A
0
divinyl ether fatty acid +
0
drymaritin
0
elloramycin A
0
enoxastrobin
0
firocoxib
0
fluacrypyrim
0
flufenoxystrobin
0
flupyroxystrobin
0
futoenone
0
glycal +
0
isatinone A
0
isatinone B
0
laccaridione A
0
laccaridione B
0
lymphostin
0
mucidin
0
nalanthalide
0
omacetaxine mepesuccinate
32
oxaline
0
picoxystrobin
733
praecanson A
0
pyraoxystrobin
0
pyriminostrobin
0
silyl enol ether
0
strobilurin B
0
strongylophorine-26
0
yanuthone X1
0
yanuthone X2 +
0